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Abstract 
Single doses of phenobarbitone decreased the turnover r a t e of dopamine 
(DA) and noradrenaline (NA ) and increased t he ,·rhole brain l evel s of 
5- hydroxytry pt amine (5-RT ) and Y - a m i n n b u u J r i c c acid ( ( A A ~ ) . . Habituation 
to phenobarbi tone increased the l evels of DA in stria t a and midbr ain 
and decreased that of cerebral hemispheres , l eavi ng the tota l a a o u n t t
unchanged. Habituation resisted the de pletion other-,ri se caused by 
a - m e t h y l - ~ t y r o s i n e e (a-m. p.t. ) in the striata for DA and in the cerebral 
hemispheres for both DA and NA . 1;[ i thdrawal of phenobar bitone decreased 
the levels of DA in the striata and both catecholamines in the cerebral 
hemispheres. ;:iithdrawal increa sed the de pletion or DA in t he stria t a ane. 
cerebral hemispheres and that of NA in the cerebral hemis pher es and midbr ai n 
caused by a-m.p.t. ',v'ithdrawal convulsions increased the l evel s of DA 
in the striata and decreased it in the cerebral hemis pheres , leaving the 
total amount unchanged. NA was less in this grou p than it was in controls. 
a-m. p.t. protected animals from convulsions . This group sho\.,ed l ess DA 
in the striata and in the cerebral hemispheres and less t ~ ~ in midbrain . 
Habituation to phenobarbitone i ncreased the levels of ~ o t h h 5-HT and 5- RIAd . 
;i[ i thdrai.,al returned both levels to control values. l:/hile '1Ti t hdravral 
convulsions decreased the levels of 5-HT, 5- HIAA l evels were increased. 
Single doses of phenytoin increased the levels of DA in stria t a and ~ ~ ~ in 
~ d b r a i i . . It also increased the l evels of 5-aIAA in whole br ai n and 
decreased the de pletion of 5-HIAA caused by p - c h l o r r p h h n y l a a ~ ~ i n e e ( ~ ~ . p . a a ) )
or pu-gyline . L ~ n g g term administration of phenytoin increa sed the l evels 
of dopamine in the striata and the r r ~ d b r a i n n and decreased t hat of t he 
cerebral hemispheres . It also produced an i ncrease in t he l evel s of ~ r A A in 
the cerebral hemispheres . Similar effects I-rere observed aft er CX- m. p. t . 
'!/hole brain levels of 5- HT and 5- tIIAA -tlere increased after long term 
treatment with pheny.toin . Sin le doses of carbamaze pine increased 
the levels of NA in the midbrain and de creased the de pletion of 5 - H H ~ ~
after ~ ~ . p . a . . and pargyline . The long term treatment Ivi th carbamaze pine 
increased the total brain levels of 5- HT and 5-HIAA and those, of DA in 
the striata and cerebral heoispheres ~ ~ d d for NA in the cerebral hemi-
s pheres and midbrain . -The same effect ','las seen after <x- m. p. t . 
-dhile ilrA and GAM levels were decreased in the primary focal area one 
week after cobalt implantation , 5-HI.!\A levels 1'1'er e increased . The 
same effect was seen for NA and 5 - H L ~ ~ levels t1'I'o weeks after cobalt 
itlplantation . 
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I 
I NTRODUCTION 
Ever since certain chemical substances in the br ain wer e recognized 
to act a s mediators in synaptic t r ansmi ssion , a grea t deal of interest has 
been centred on the possi ble involvewent of cer t ain neurotransmitters i n 
the mechanisms of epilepsy . Chen, Ensor and Bohner (1954) found that re8-
erpine (a drug >-ihich depletes brain monoamines) decreased sei zU!'e thresholds 
to c h e ~ c a l l y y and electrically induced seizures . Using di fferent drugs 
~ " h i c h h depleted brain monoamines to a di ffer ent degr ee . other ·,., or1<:er s reac!led 
the same conclusion as t hat put f O O 1 1 r d d by Chen and his co-workers . that br ain 
monoamines are i nvolved in the manifesta tion of sei zures . 
That epile psy might be associa ted with a deficiency in t he oono-
aminergic systems was a lso supported by several findings t hat the concen-
trations of 5 - h y d r o o y i ~ ~ o l e e acetic a cid and homovanillic a cid i n the 
cerebrospinal fluid T,Tere reduced in adults and child.r en with epilepsy 
(Shaywi tz, Cohen and BOlvers, 1975 ; Papeschi , ;iolina- ,.Jigro, Sourkes and 
Erba , 1972 ) . 5-Hydroxy'indoleacetic acid and, to a lesser degr ee, homo-
vanillic acid , ,,,ere reported to be increased in the cerebros pi nal flui d 
of epileptic patients receiving t t ~ r a p e u t i c c doses of phenobar bitone and 
phenytoin (ChadT;Tick, Jenner and Reynolds , 1975 ) . ~ 1 1 r e o o e e , , 5- hydroxy-
trypto phan in combination Tll i th a peripheral decarboxyl ase i nhibitor ''las 
found by Chadi'Tick , Har ris , Jenner, Reynolds and. ~ 1 1 r s d e n n (1 975) to be 
capable of ~ r i i g g n g g about a consider able improveoent or a complete 
cessation of myoclonus . The:-e ar e al s o sever al ... ·eports confirming 
the original observation re ported by ~ o n n y c a s s l e , , Giar man and Paasoned 
(1 957 ) , t hat d.ifferent anticonvul sant drugs i ncreased the brain level s 
of 5- hydroxytryptam1ne . 
II 
In our effort to examine the monoamine systems in a more compre-
hensive 'flay , , ; ; e e studied the effect of acute and chronic trea t ment 'tT i t h 
conventional anticonvulsant drugs on t he levels and turnover of monoami ne s 
in ''I'hole and discrete regions of rat brain (Cha pters 1 to 7 ) . :ie made 
use of the original observation by Crossland and L e o ~ ~ ~ d d (1 963) t ha t 
barbi turate vTi thdrai'Tal after its long ter m adrninistra tion r enders none pile ptic 
r a ts acutely epile ptic after subjecting them to s ound stinula tion , a nd ~ ' T e e
studied, ~ h e r e f f r e , , the monoamine systems during wi thdrai'la l from pheno-
barbitone and during the subse quent convulsi ons . The level s of the 
monoamines i'lere studied as loJell in a model of chronic epilepsy produced 
in rats by cobalt implantation (Chapter 9) . 
'6-Aminobutyric acid is another neurotransmi tter ~ " h i c h h is believed 
to be involved i n epilepsy. Drugs which decrea se GABA levels ',Till produce 
convulsions and some of those ,'I'hich increase its coneen tra tion have a 
protective effect against seizures (Heldrum , 1975 ; 1:Iood , 1975). \'i e 
studied the brain GABA levels after acute treatment with the anticon-
vulsant drugs \'I'e used (Cha pter 8) and as I'Tell in brains of r ats rendered 
chronically epileptic by cobalt implantation (Chapter 9). The gas 
chromatographic analysis of these anticonvulsant drug s in rat blood and 
brain and their levels after acute and chronic treatment is r eported 
in chapter 10. 
The result s ere di scussed i n c ~ ~ p t e r r 11. 
PAR T I 
PAR T I 
CHAPrER 
DETERHlNATION OF RAT BRAIN DO PAHI Nr.: AND NORAD3.E:fALI Nr.: CONTENT 
The basis of the method used was first described by Anton and Sayre 
(1962, 1964) ruth the modifications suggested by Tonge (1 969) . It 
permits the determination of both dopamine and noradrenaline in the 
same extract . It has been successfully used in our l aboratories over 
a number of years. 
1.1 Preparation of extract 
Rats were killed by cervical dislocation and decapitat i on, their 
brains were quickly removed and placed on an ice cooled glass plate. 
The brain tissue was freed from s u p e ~ f i c i a l l blood clots and homo-
genized for five minutes in 10 ml of ice cold 0.4 !1 perchloric acid, 
using an Z,1SE top drive homogenizer. The homogenization tubes were 
washed with 2.5 ml perchloric acid and the homogenates were centrifuged 
at 2500 rpm for ten minutes. 
Ten millilitres of the supernatant solution were transferred to 
a 50 ml plastic beaker containing 10 mg sodium metabisulphi te, 200 mg 
disodium ethylenediamine tetraacetic acid and 400 mg activated alumina . 
The preparation of the alumina is described in section 1.6. Fifteen 
millilitres of 0.4 M perchloric acid were added to the mixture and the 
pH rll"as adjusted to 8 .5 ~ ~ 0.1 with 5 N sodium hydroxide solution and 
maintain ed wi thin these Iii limits for ten minutes with 1 N sodium 
hydroxide solution . During this time the mixture was stirred using 
a glass stirring rod attached to an overhead motor. The mixture 
was then centrifuged at 20c0 rpm for ten minutes . The supernatant 
- 2 -
solution was carefully decanted and t ile r esidue \'las \'lashed vTi th 
successive portions of 20 ml and 10 ml of di stilled wa t er. The 
catecholamines \<Tere eluted by shaking for twenty minutes with 
3 ml of 0.05 M perchloric acid solution on a wrist-action shaker. 
The resulting mixture \'TaS transferred to a glass centrifuge tube 
and centrifuged at 2500 rpm for fif teen minutes. 
1.2 FOrmation of noradrenaline fluoro uhore 
The noradrenaline fluorophores ,'lere formed before assaying the 
dopamine. The method used to assay the noradrenaline content 
incorporates the modification suggested by Gunne (1963 ) . 
A 1.0 ml aliquot of perchloric acid eluate was added to 1.0 ml 
of acetate buffer in a test tube. Leaving an interval of ten 
sec,onds between additions, the oxidation was performed by the 
addition of 1.0 ml of freshly prepared ferricyanide solution and 
the mixture was stirred on a vortex mixer. Exactly three minutes 
later, starting with the first tube t o which the ferri'cyanide solution 
had been added and again leaving ten seconds between each addition , 
1.0 ml of freshly prepared alkali ascorbate solution was added to 
each tube. The mixture \'las stirred on a vortex mixer and 1.9 ml 
of dis tilled water was then added. The fluorescence of this 
solution was read 'ti'lenty minutes later at 505 run after activation 
at 400 run using a Farrand spectrophorofluorimeter. 
A calibration curve l'las const ructed by carrying solutions of 
standard. noradrenaline in 0 .4 M perchloric a cid through the ''lhole 
procedure side by side ltTi th the tissue extr act . 
curves are given in Fi gure 1.1 
E:xawplES of such 
FIGURE 1.1 
~ J p i c a l l calibration curves for the fluoricetric assay 
of noradrenaline obtai ned on ~ d O O separate occasions 
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1.3 Recovery of standard noradrenaline added to brain h o m m ~ e n a t e s s
Ten rats i-Tere tilled, their brai ns ·Nere removed and. each i'laS homo-
genized in 16 I:ll 0.4 ~ 1 1 perchloric acid . After centrifugation the 
supernatant solutions were pooled, mixed and divided into fifteen 
equal portions of 10 ml each . To eight port ions , various concen-
trations of standard noraQrenaline were added and the mixtures ~ e r e e
treated as described for the assay of noradrenaline . 
The recoveries of standard noradrenaline added to pooled br a in 
homogena te s are shot-Tn iYl Table 1.1 
Table 1.1 
Recoveries of noradrenaline added to pooled brain homogenates 
Amount added Amount recovered Reco;::eI! 
------- - .---------
~ ~ IJg % 
0.2 0.157 78 .5 
0.2 0.157 78.5 
0.3 0.229 76 .3 
0.3 0.250 83 .3 
0.4 0.374 93.5 
0.4 0.338 84 .5 
0.6 0.501 83 .5 
0 .6 0.519 86 .5 
Mean recovery 8 8 ~ ~
1.4 Formation of dQ!amine fluoro ohores 
Another 1 ml portion of the perchloric acid eluate \'las added to a 
mixture of 0.05 ml of 7Cir:J V/V ethanol and 0 . 5 ml of phos phate buffer 
in a test tube. The oxidation tNaS performed by adding 0 . 1 ml of 
- 5 -
perioda te s olution and the mixture ',las stirred on a vortex mi xer . 
Exactly one minute after the addition of t he periodate solution , 0 . 5 ~ ~
of alkali sulphite solution 'tlas added and. the mixture ,las again agi t a ted . 
As quickly as possible, 1.4 ml of distilled water , 0 .5 ml of citrate 
buffer and 0.85 ml of 3 r'T orthophosphoric acid vTer e incorporated int o 
the mixture and stirred on a vortex mixer . 
The fluorescence of thi s solution was read in the Farrand spectro-
photof luorimeter at 375 nm after activation at 330 nm . 
A calibration curve, using standard doramine in 0 . 4 r·f ~ ~ c h h o r i c c
acid, vras constructed for each experiment. Three sampl e curves a re 
shOvtn i n Figure 1.2 . They underline t he necessity of preparing ~ ~
calibr a tion curve for aach experiment. 
1.5 Recovery of standard dopamine added t o brain h o m ~ g e n a t e s s
The recovery experiment '(las carried out in a similar fashion t o tha. t 
described for noradrenaline . The results are shown i n Table 1. 2 . 
:r'he blank was obtained by carrying 25 ml of 0 .4 H perchl oric 
acid, free of dOPlmine and noradrenaline, t hrough the ;ihole procedure . 
The composition of the various buffers and r eagents i s given in the 
f ormulary. (Appendix I ) . 
1.6 Pre ffiration of alu:nina 
One hundred grams of aluminium oxide f or thin layer chromatogr aphy 
(EDE) ~ . . e r e e added to 500 ml of 2 N hydrochloric ac i d and heated to a 
temrere. ture betvleen 900 e and 1 oooe, "7ith continuous stirring , f or 
J; 
forty-five minutes . The alurrina was allowed to settle for tvo and 
a half minutes a.nd the yellO'.v-tinged su pernatant solution 'iras 
dis carded together with the f ine particles of a l u u i n a a f l oa ting i n it . 
FIGURE 1 . 2 
~ J p i c c l l calibration curves for the fluorimetric a ssay 
of dopamine obtained on three separate occasions 
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Table 1.2 
rteco'reri cs of dopamine added to pooled brain homogenates 
Amount added Amount recovered ":) 
----- ---------
: : : ~ ~ ~ ~ : : l l
Ilg !lg c-' j :l 
0 .2 0 . 143 71.0 
0 .2 0 . 162 '31 . 0 
0 .3 0 .232 77.0 
0.3 0 .271 90 .0 
0 .4 0 . 324 81.0 
0.4 0.324 81.0 
0.6 0 .539 90 . 0 
0.6 0.489 81.0 
Hean recovery 81 . 5% 
Two successive 250 ml portions of 2 M hydrochloric acid l ~ e r e e stirred 
with the residue at a temperature of 70°C for fifteen minutes and the 
supernatant solution was discarded as before . In the final acid iITa sh 
o the alumina was stirred with 500 ml of the acid at 50 C for fift een 
minutes and the supernatant solution was again discarded. 
The alumina ''1as then 'Nashed i-Ti th distilled 'Na ter , discarding the 
wasning and finer particles , until the acidity of the s s p p r p ~ ~ a n t t
solution reached about p..ij 3. About 25 - 30 wa shes ..,ere needed t o 
achieve t his . The alumina was then dried by heating at a temper a ture 
of 1100C for one hour, follONed by heating at 2000 over ni g!lt . 
The alumina · .... as used TITithin one month of its prepars.t ion . 
- 8 -
CRAnER 2 
CATZCHOLA!.ITNZ lZ'IELS A ID TURNOVE:1 AFTEa SINGI.2 DO::5ES 
OF ANTICONVULSA11T DRUGS 
Nuch of the information in the literature suggests that stinn.l-
lations of central dopamine and noradrenaline r ece ptors has a 
predominantly inhibitory action . One might expect, therefore. that 
endogenous dopamine and noradrenaline in the brain might exert an 
inhibitory effect on seizure activity . 
Kilian and Frey (1973) shOi .... ed that an increase in the brain con-
centratioh of noradrenaline elevated the thresholds for maximal 
electroshock and pentylene tetrazole seizures in both rats and mice. 
on the other hand decreasing the brain concentration of the amine 
increased seizure susceptibility. 
These data from the literature led us to investigate t he effect 
of anticonvulsant drugs on the concentrations of dop;unine and noradre-
naline in rat brain. 
2.1 ~ f f e c t t of single doses of anticonvulsant drugs on brain dopamine 
and noradrenaline content 
Female Ash ~ i s t a r r rats weighing between 140 and 160 gms were u sed . 
The animals were obtained one week before carrying out any experiment . 
They 'ITere caged in sixes and allow'ed free access to food. and water . 
Drug doses vlere calculated according to the animals I body \'/'eight and 
were injected intraperitoneally in a solution or suspension volume of 
0 . 5 ml per 200 gIn weight . 
Phenytoin was given i n a dose of 75 mg/kg suspended in saline 
containing 15b 'l\leen 80 , phenobarbitone in a dose of 100 mg/kg in 
- 9 -
saline, sodium bromide in a dose of 1 gm/kg also dissolved in 
saline and carbamazepine in a dose of 50 mg/kg in p p o ~ l e n e e glycol. 
Control rats received the appropriate vehicle . 
Apart from sodium bromide, all the ant iconvulsant drugs , in 
the doses employed in these experiments , produced ataxia . In the case 
of phenobarbitone, loss of righting reflexes occurred. The ataxi a 
produced by carbamazepine and phenytoin started to disappear about 
ninety minutes after the injection, \'lhile the phenobarbitone group 
were affected for up to three hours, although they regained their 
righting reflexes about ~ N O O hours after injection. 
Half or one hoUr after receiving the doses stated . the animals 
were killed by cervical dislocation and their brains were quickly 
removed, homogenized and centrifuged. 
The supernatant solutions were kept in the deep freeze until the 
second day when they were assayed for their dopamine and noradrenaline 
contents by the methods described in chapter 1. 
done between 14 .00 and 16.00 hours. 
All killings were 
As sho\it1 in tables 2.1(i) and 2.1(U). none of the anticonvulsant 
drugs tested had any significant effect on dO!Rmine or noradrenaline 
content of rat brains whether the animals were killed t hirty minute s 
or sixty minutes after injection. 
It will be seen that the estimates obtained for both the noradrena-
line and the dopamine content of the brains of the untreated animals 
were different in the two experiments . 
in the discussion. 
This point i s taken up again 
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Effect of anticonvulsant drugs on brain catecholamine 
content thirty minutes after injection 
Drug D o ~ ~ ~ ~ Noradrenaline 
------
ng/gm ng/gm 
Vehicle ( 16) + 24 372 + 725 - - 5 
Phenytoin (8) 729! 15 371 + 
-
15 
SodiWl bromide (8) + 740 - 25 + 343 - 15 
Carbamazepine (8) + 754 - 20 404 + - 30 
Phenobarbitone (8) + 392 + 725- 35 - 10 
Each value is the mean: standard error from the number of animals , 
shown in parenthesis . 
The figures were obtained in two diff erent experiments. 
Ta bl e 2 • 1 (ii) 
Effect of anticonvulsant drugs on brain catecholamine 
content sixty minutes after injection 
~ ~ ~ DOP32!ine Noradrenaline 
-------
ng/gm ng/gm 
Vehicle ( 16) 829 + 30 443 + 10 - -
Phenytoin (8) 806 + + - 10 421 5 
(8) + 421 + Sodium bromide 785 5 - 10 
(8) 788 + 429 + Carbamazepine - 5 - 5 
Phenobarbitone (8) 818 + - 10 431 + - 20 
+ Each value is the mean - standard error from the number of animals. 
sho'iTn in ~ E m t h e s i s . .
The figures ,.Tere obtained in t\oro different experiments. 
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2 ,2 Zffect of single doses of anticonvulsant drugs on t he turnover 
rate of catecholam;nes in the rat brain 
Costa in 1972 suggested that neuronal activity controls the r ate of cate-
cholamine turnover leaving the steady state concentration virtually unchanged . 
The simple measurement of the catecholamine concentration is therefore 
relatively uninformative in elucidating the extent to which catecholaminergic 
neurones participate in behavioural changes and in defining t he sites of action 
of drugs that affect catecholamine systems . Nore useful inforoation shoul d 
come frot:l measurements of turnovers , ~ ' l le chose t o assess the turnover of 
catecholamines by means of a- methy;L-.Q-tyrosine vThich acts by inhibition of 
tyrosine hydroxylase . Dolphin, Jenner and r ~ r s d e n n (1 975) reported an 
interference by a-methyl-.Q-tyrosine in the assay procedure of. noradrenaline 
using the method described by ~ ~ i c k e l , , Cox , Saillant and uller (1 968 ) , 
iTe therefore performed an experiment to see ,<[hether a-i:lethyl-,?-tyrosine 
interferes ,'lith the assay procedure l<fe used, 
One hundred ~ ~ of a-methyl-.Q-tyrosine me thyl ester hydrochloride 
, .. ere added to poolea. brain homogena tes and external noradrenaline and 
dO:p3.mine standards and the assay ~ T a s s performed as described in chapter 1. 
No alteration in dopamine , noradrenaline or bla.nk fluorescence ,.;ere 
observed, 
The · first experiment to be done vTas to deter mine the time 
course effect of a-methyl-,?-tyrosine . A dose of 250 mg/ k.-s of a-methyl-
,?-tyrosine methyl ester hydrochloride in saline was injected intra-
peritoneally and the animal s TiTere killed by cervical dislocation and 
decapitation at various times thereafter . 
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The results are presented in table 2 .2 and figure 2.1. As can 
be seen from the figure, the rate of depletion of brain dopamine is 
greater than that of noradrenaline during the first three hours, 
indicating that dopamine turns over at the faster rate. By ten 
hours, however, the amount of dopamine in the brain is virtually 
indistinguishable from that of noradrenaline. 
Table 2 .2 
Time course effect of 250 mg/kg a - m e t h y l - ~ t y r o s i n e e
on brain dopamine and noradrenaline content 
Time D o ~ ~ ~ ~ ~ ~ _ f ~ ~ ~ Noradrenaline C h a n ~ ~ f E ~ ~ ~
--------
zero time zero time 
----- -----
hrs. ng/gm per cent ng/gm per cent 
0 + 834 - 28 (6) + 4 22 - 12 (6) 
1. 5 496 ! 11 (3) - 40 . 50 322 ! 17 (3) - 23 .60 
:3 308 ! 29 (3) - 63 .06 + 246 - 11 (3) - 41 .70 
6 180 : 4 .6 (3) - 78 .40' + 163 - 11 (3) - 61 . 37 
10 + 154 - 3.4 (3) - 81 . 53 + 126 - 2 .8 (3) - 70 . 14 
24 + 95 - 1.7 (3) - 88 .60 + 82 - 6 .0 (3) - 80. 50 
+ Each value is the mean - standard error from the number of animals 
shovm in parenthesis . 
As can be seen from figure 2. 1, the maximum depletion of both 
ca techolamines occurred between ten and t\·renty- four hours after injection 
of a - m e t h y l - ~ t y r o s i n e , , so we decided to investigate the effect of 
FIGUrtE 2 . 1 
Time course effect of 250 mg/kg a - m e t h y l - ~ t y r o s i n e e on brain 
dopamine and noradrenaline content 
+ Each bar indicates mean - standar d error for the number of anioals 
inside t he column 
Open columns represent dopamine and hatched c o l ~ ~ ~ represent 
noradrenaline 
o 
R o o M 8 ..-
~ U ! l D U · J P O J O N N pUD -U!WDdoQ w6/6u 
o 
~ ~
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anticonvulsant drugs on the turnover r a tes at t he eighteen hours 
depletion point. 
Anticonvulsant drugs Her e admini s tered in the doses used in t he 
previous experiments . 
The rats \'1ere injected intraperitoneally with 250 mg/kg cx- methyl-
~ t y r o s i n e e and killed eighteen hours later , but thirty minutes before 
death each group of rats received by intr peritoneal injection one of 
the anticonvulsant drugs shown in table 2. 3 . The r esults show tha t 
only phenobarbitone significantly influenced the rate a t which ~ r a i n n
dopamine and noradrenaline were depleted by a - m e t h y l - ~ t y r o s i n e . .
In the second experiment, the anticonvulsant drugs were injected 
simul taneously with c x - m e t h y l - ~ t y r o s i n e e and t he animals llTere again 
killed eighteen hours after the injections . In this experiment the 
anticonvulsant drugs would have had more t i me to manifest any effect 
they might have on catecholamine turnover. 
table 2.4. 
nesults are shown in 
Phenobarbitone and sodium bromide significantly reduced the rate 
at which brain doramine \'1as depleted. \'1hile other drugs had no ef fect 
on either dopamine or noradrenaline turnover . 
2.3 Time cOurse effect of phenobar bitone on brain ca t echolamine 
turnover 
The results just presented make it obvious t t ~ t t the effect of pheno-
barbitone on dopamine turnover w'as more evident I'Then it lias injected 
simultaneously with a - m e t h y y - ~ t y r o s i n n . .
On the other hand , its effect on noradrenaline de pletion. quite 
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Table 2 . 3 
The effect of anticonvulsant drugs on turnover 
rate of brain catecholamine 
~ ~ ~ Doramine Noradrenaline 
-------
ng/gm ng/gm 
+ ( 12) + 10 .0 '(12 ) Vehicle only 828 
-
30 . 0 416 -
a - m e t h y l - ~ t y r o s i n e e 91 + 5. 1 ( 12) 97 + 5. 7 (12) -
per cent change - 89 .0 ?; - 76 .7 r6 
a - m e t h y l - ~ t y r o s i n e e + 
+ 5.7 (4) + 3 .4 (4) phenytoin 80 
-
105 -
per cent change 
- 90.0 % - 77.2 % 
P (t test) N.S. N.S. 
a-metbyl-lrtyrosine + 
+ 5.7 (4) + 5.7 (4) phenobarbitone 131 
-
138 
-
J;er cent change - 84 .0 7; - 66 .8 % 
P (t test) < 0 . 02 < O ~ 0 2 2
a - m e t h y l - ~ t y r o s i n e e + 
+ + 5. 7 (4) sodium bromide 92 
-
5.7 (4) 95 -
J;er cent change 
- 88 .9 % - 7'7.1 % 
P (t test) N .5. N.S. 
"-methyl-Jrtyrosine + 
+ (4 ) + 4 .8 (4) car bamaze pine 97 - 7.7 103 -
per cent change - 88 .2 % - 75.2 % 
P (t test) N.S. N.S. 
The animals were killed half an hour after the anticonvulsant drugs 
and eighteen hours af ter the a-methyl-Jrtyrosine . 
+ Each value is the m e a . ~ ~ - standard error from the number of animals 
shown in parentheses . 
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Table 2.4 
The effect of anticonvulsant drugs on turnover 
rate of brain catecholamine 
Drug D O P 9 m i n ~ ~ Noradrenaline 
ng/gm ng/gm 
Vehicle only 828 + 30.0 ( 12) 416 + ( 12) - - 10.0 
a - m e t h y l - ~ t y r o s i n e e 93 + 5.7 (12 ) - 106 + - 5.1 ( 12) 
~ r r cent change - 88 .7 % - 74 .5 ~ 6 6
a - m e t h y l - ~ t y r o s i n e e + + 5.7 (4) + 5.7 (4) phenytoin 107 
-
106 -
~ r r cent change - 87.0 % - 74.5 ~ b b
P (t test) < 0.1 N.S. 
a - m e t h y l - ~ t y r o s i n e e + 
+ + (4) phenobarbitone 184 
-
5.7 (4) 111 
-
1.1 
~ r r cent change 
- 77 .7 % . - 73 .3 % 
P (t test) < 0.001 N.S. 
a - m e t h y l - ~ t , y r o s i n e e + 
+ 5.7 (4) + 4.0 (4) sodium bromide 129 
-
110 -
~ r r cent change 
- 84 .4 ~ b b - 73.5 % 
P (t test) < 0.02 N.S. 
a - m e t h y l - ~ t y r o s i n e e + 
+ 6.3 (4) + 6.0 (4) car bamaz e pine 95 - 105 -
fer cent ch9.nge - 88 .5 % - 74.7 % 
P (t test) N.S. N.S. 
The animals i'lere killed eighteen hours after the simultaneous i njection 
of the anticonvulsant drug and a - m e t h y l - ~ t y r r s i n n . .
Each value is the mean ~ ~ standard error from the number of animals 
shown in parentheses . 
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evident when it was injected thirty minutes before death, ' .. las not seen 
when it was injected simultaneously with a - m e t h y l - ~ t y r o s i n e . . This 
unexpected result led us to study the effect of phenobarbitone on the 
time course depletion of noradrenaline and dopamine caused by a-methyl-
~ t y r o s i n e . .
Ash Wistar rats, divided into groups, received an intraperitoneal 
injection of either a - m e t h y l - ~ t y r o s i n e e (250 mg/kg) or of a - m e t h y l - ~ ~
tyrosine and phenobarbitone (100 mg/kg) together. They were killed 
after different time intervals. 
Results are shown in tables 2.5 and 2.6 and figures 2.2 and 2.3. 
The results show that phenobarbitone produced a significant 
decrease in the rate of depletion of dopamine at all times studied, 
whereas it was only capable of preventing significantly the depletion 
of noradrenaline at the three and six hours period . The depletion 
was potentiated at the eighteen hours period . This point '/lill be 
dealt with in detail in the discussion. 
2.4 Behavioural studv on a-methyl-p-tyrosine 
C L - H e t h y l - ~ t y r o s i n e e is a potent inhibitor of tyrosine hydroxylase, 
the enzyme responsible for the rate limiting step in the synthesis of 
the catecholamines. 
The catecholamines are thought to regulate mood and behaviour , 
and their reduced availability may lead to depressive disorders . In 
our experiment ,,,e noticed that rats ,,,hich were treated with a-methyl-
~ t y r o s i n e e showed behavioural symptoms reminiscent of reser pine syndrome. 
, 
They looked quiet most of the time and their response to external 
stimuli was reduced. ~ o d e r a t e e piloerection was also noticed and all 
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Table 2.5 
Time course effect of phenobarbitone on brain do pamine turnover 
Time ~ ~ ~ l ~ ~ l r o s i n ~ ~ = ! ! ! e t ~ ~ : ~ t : r : : ~ ~ ~ ~ sta tis tical 
+ phenobarbitone sigmficance 
hrs ng/gm --ng/gm--- --r-
806 + 10 (4) 806 + (4 ) 0 
- -
10 
3 348 + (3) + 10 (3) < 0.001 - 494 -
6 213 + 8 (3 ) 346 + 6 (3 ) < 0.001 - -
12 170 + - 9 (3) 210 + 8 (3 ) < 0.005 -
+ 10 (3 ) 166 + 8 (3) < 0.005 18 93 - -
Each value is the mean :: standard error from the number of animls 
shown in parentheses 
Table 2.6 
Time course effect of phenobarbitone on brain noradrenaline turnover 
Time ~ ~ : J C ! y r o s i ~ ~ ~ ~ ! ! : y l - J t t y r ~ ~ ~ ~ statistical 
------
+ p h e ~ b i t ~ ~ ~ ~ ~ ~ ~ ~ ~
hrs ng/gm .ng/gm p 
0 420 + 8 .0 (4) 420 + 8 .0 (4) - -
3 247 + 4.6 (3) 289 + (3 ) < 0. 005 - .. 2 .3 
6 + 9.8 (3) + (3) < 0.005 159 - 213 - 1.7 
+ 7 .0 (3) + (3 ) N.S . 12 100 - 110 - 10.0 
127 + 9.8 (3) 104 + 5.7 (3 ) < 0 .05 18 - -
+ Each value is the mean - standard error from the number of animals 
shmfn in parentheses . 
?IGURE 2.2 
Time course effect of p h e n o b a r b i i o ~ e e on b r a i ~ ~ d o ~ n e e ~ n o v e r r
+ Each bar i ndicates r.lean - s tandard. error ~ o r r the number of ar.ioals 
i nside the columns . 
Open columns r e present a - oet hyl-.]2-tyrosine treabten: . hatched 
columns r epresent treatment 'IIi th a - !:le"'hy - .J2-t-Jrosi. e and phe:1O-
barbitone . Both drugs Ner e inject ed simultaneously . 
** Significantly different by t he t test (** P < 0 .005 and * * P < 0 . 001 ) 
from those of control r ats treated ~ ' 1 i i th a - rnethyl-.J2- ~ r r o s i n e e only . 
I I ~ ~ ~______ ~ ~______ ~ ~____ ~ ~______ ~ ~____ ~ ~
~ ~ I ~ ~ ~ ~ ~ ~ § 
FIGUrtE 2 . 3 
Tioe course effect of phenobarbitone on b r a L ~ ~ noradrenaline turnover 
+ Each bar L ~ d i c a t e s s mean - standa:d e r ~ o r r for the n ~ ~ e r r o ~ ~ a p ~ ~ l s s
inside the column . 
Open colunns represent a - m e t h y y - ~ ~ y r r s i r r e e treatcent , hat c. ec c o l Q ~ s s
r epresent trea t:nent 'IIi th a- metnyl-.Q-t'yrosine and phenobarbitone . :i3oth 
drugs 'ITere tnject.ed sioul taneously . 
it 
Significantly different by the t test * P < 0 . 05 and * ~ ~ P < 0 .005) 
from those of control rats injected i'lith cx- me thyl-..2-t'.rrosine cnl] . 
o 
~ ~ 8 .... 888 ~ ~ M N 
~ U ! I D u a . J f X l J O N N w6/6u 
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the rats were gather ed t ogether in a corner of their cage . 
clearly less active than t hose treated ,'lith sa line . 
They i'Tere 
However , the group of ra ts receiving the combined t rea tmen t \'lith 
phenobarbitone (100 mg/kg) and CX-methyl -2-tyrosine (250 mg/kg) shOi'Ted 
much more striking behavioural changes. The dose of phenobarbitone 
used on its own produced hypnosis and loss of righting ref lex for a 
time of up to one hundred and ten minutes after i ts injection . but t he 
same dose of phenobarbitone combined with CX-methyl-2-tyrosine hypnotized 
the rats for a much longer time . They r emained completely sedated and 
inactive until they were killed t"Tenty-four hours l a ter . These obser-
vations led us to study the effect of phenobarbitone and of phenobarbitone 
and C C - m e t h y y - - t y r o s i n e e together on body temperature and slee ping time . 
Rats were divided into several groups. One group r eceived an 
intraperitoneal injection of phenobarbitone (1 00 mg/kg) , another group 
received an intraperitoneal injection of C C - - e t h h l - ~ t y r o s i n e e (250 mg/ke) 
and the other groups received the combined ~ r e a a m e n t t of phenobarbitone 
and C C - - e t h y y - - t y r o s i n e e together , and t he measurements were made at 
different time intervals . The body temperatures of all animals vTere 
monitored at the different time intervals using electrical thermometers 
(Light laboratories ) equipped iii th rectal thermistors . At the same 
time the rats were observed for loss and gain of righting reflex . 
Induction time , sleeping time (taken when the righting r eflex \'las lost) 
and recover'J time (taken when the righting reflex ,.,as regained) ''lere 
recorded. During the experiments the animals i'Tere kept in a quiet 
room, the temperature of which Nas kept be tween 200 anti 22oC. The 
resul ts are sho'tTn in table 2 .7 and figure 2 .4 . 
Rats treated Ttd th cx-methyl-2-tyrosine alone gradually deyeloped 
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Table 2.7 
Effect of a - m e e r ~ ~ - ~ t y r o s i n e e on sleeping 
time induced by injection of phenobarbitone 
Induction time 
minutes 
Phenobarbitone 21 .66 ~ ~ 2.9 (6) 
Phenobarbitone 
+ a - m e t h y l - ~ ~ 14.33: 2.18*(6) 
tyrosine 
minutes 
~ ~ . 2 ~ £ Z Z
( i n ~ ~ ! ~ ~ ~ _ ~ ~ ! ~ E ~ n g ) )
minutes 
83 .3 ! 0.67 (6) 105 : 3 . 6 (6) 
+ **( ) + ** 220.0 - 3.84** 6 241.7 - 4.4**(6) 
+ Each value is the mean - standard error from the number of animals 
shown in parentheses. 
Significantly different by the t test (* p < 0 .05 
rats treated with phenobarbitone. 
** 
** p < 0 .001) from 
signs of hypothermia. The body temp:lrature was still dropping twenty-
four hours after the injection (Figure 2.4). Phenobarbitone produced 
a significant decrease in body tempera ture that reached a maximum aft er 
one hour and lasted for up to six hours after injection. It then 
started to recover. . The combined treatment with phenobarbitone and 
a ~ m e t h y l - ~ t y r o s i n e , , however, produced a progressive and continuous 
fall in body tempera ture. For the first t wo hours. the fall in temp-
erature occurred at the same r ate as that f ollowing admini stra tion of 
phenobarbitone only. Thereafter , l'ihereas phenobarbitone produced no 
further change in body temperature, the combined trea tment continued to 
cause hypothermia, s o that after four hours the temp:lra ture of the 
FIGURE 2. 4 
Time course effect of phenobarbitone (A) , a- e t h y y - ~ ~
tyrosine (B) and the combined treatment with phenobarbitone 
and a-met hyl-,;Q-tyrosine (C) on rats ' body temperatures . 
. + 
ach point is the mean - standard error for three rats , 
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combined treatment group was significantly lovler than that of the group 
given phenobarbitone only . 
Ta ble 2 . 7 ShO'ITS tha t CX-me thy l -rtyrosine reduced signifi can tly the 
induction time and prolon ed the sleeping time caused by phenobarbitone . 
These results support either of two hypotheses . It might be that 
a a m e t h y y - - t y y o s i n e e potentiates the effect of phenobarbitone (syner gism) 
or . al terna ti vely . t i".B. tit either competes "'ith pheno barbi tone · or 
inhibits the microsomal enzymes in the liver on which the metabolism of 
phenobarbitone depends . These possi bili ties l'lere investiga. ted by 
studying the effect of a - m e t h y l - ~ t y r o s i n e e on blood and brain levels of 
phenobarbitone. The results of thi s study wil l be presented aLd discussed 
later in this thesis . 
2 . 5 The intraventricula r injection of 6- hydroxydopamine 
Tranzer and Thoenen (1967 and 1968) discovered that 6- hydroxydopamine 
(an isomer of noradrenaline) caused a destruction of the t e ~ i n a l l axons 
of sympat heti c neurons . Not l ong after that , Ungerstedt (1968) reported 
t hat 6- hydroxydopaoine injected directly into the bra in would a lso destroy 
central neurons containing dopamine and noradrenaline . This leads to a 
decrease in the content of the catecholamines in the brain . 
Quattrone , Crunelli and Samanin (1976 and 1978) reported after the 
intraventricular injection of 6- hydroxydopamine that seizure threshold was 
lOI{ered and. the anticonvulsant effect of carbamazepine, di phenylhydantoi n 
and phenobarbitone was partly antagonized . !;fe have adopted. this technique 
to study the effect of anticonvulsant drugs on the levels of catechol-
aoines de pleted by 6- hydroxydopamine . 
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Method of injection of 6- hydroxydommine into l ateral ventricle : 
The method for injection of materials into the lateral ventricle I'laS 
first described by Noble , -,'lurtman and Axelrod (1967) . Ash 1; i s t ar r e.ts 
were anaesthetized with sodium pentobarbitone (50 m g / y y ) ) anc the head 
was pl a ced in a horizontal position and in line ~ r i i th t he long axis of 
the body . Using a sharp scalpel, a mid- sagittal incision 1,I1aS made . 
The bregma was exposed and cleaned of muscle and fascia . Us ing a 
dental drill , a small hole 'ITas made 1 . 5 - 2 . 0 mm lateral to the crossing of 
the sagittal and coronal sutures (Figure 2.5 (i)) . The skin i'las then 
sutured using sterile cotton thread and the rat s i'lere left to recover 
in their cages . The procedure iTas carried out under semi sterile 
conditions using instruments sterilized in 7(jfb alcohol. 
One ueek later , the rats ,'mre very lightly anaesthetized lvi th ether . 
a 50 III syringe equipped \'1'1, th a Z7 gauge needle and having a sto p at 
3. 5 nnn from its tip ,'TaS held in vertical pos ition and 20 ~ l l of 6- hydroxy-
dOp;unine (containing 200 ~ ~ of the hydrochloride in normal saline \'d th 
1 / ~ ~ ascorbic aCid) ',Tas injected sloHly through the hole into the ventricle . 
The needle '\'las allovled to remain in place for about fifteen se conds a nd 
'\'las then I'll t hdr avm . The second step in t ile ex periment l'la s to detercine 
l'lhether this method of administration vTould deliver the material i nto 
the ventricles . 
TvT O rats i-ler e preIru'ed as described , 20 III of myodil io phendylate 
(Glaxo ) i-laS injected into t he ventricles as described befor e and ,the head of 
the rat vTaS exposed l a terally to X- ray film . Photographs i'lere taken i I:lllled-
i a tely and again tI'ro minutes after inje ction . From the plate in Figure 
2 . 5 (ii) it is clear that the solution injected i'Tas distributed 
Dra\'Iing of r a t skull to indicate the position of the 
injection hole 
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to all the ventricles , but it did not f ill the first ventricle completely . 
From this result vi e 'I'lere satisfied t hat the injection ',IaS t r ul y intraventricular . 
Br eese and Traylor (1 970) reported th3 t t he intraperi toneal injection 
of p a r ~ J l i n e e ( 50 mg/kg) before the intraventricular injection of 6- hydroxy-
dopamine increased the degree of de pletion of dopamine . 
consideration when designi ng the next experiment . 
This '!la s taken into 
2 .6 Time course effect of 6- hydroxydopamine on rat brain dope.min'? and 
noradrenaline 
Ash l:T i s t ar r a ts divided into roups of f our .vere prepared for intraventricula r 
i nject ion i n t he manner t hat Has described before . S u b s s q u e n t t ~ r r each 
group of r a t s received an intraperitoneal in jection of either sal ine or 
pargyline (50 mg/kg) foll oi'led thirty minutes l a ter by an int r aventricular 
i njection of 6- hydroxydopani ne hydrochloride (200 ~ ~ in 20 ul saline contain-
ing 1% ascorbi c aci d) . Each group had a control group treated in the same 
manner but saline containing 11 ascorbic acid , .. as injected intravent ricu,larly 
instead of 6- hydroxydopamine . The rats i-rere killed a t various times there-
after . Results are presented in t ables 2 .8 and 2 .9 and figures 2 . 6 and 
2.7. 
The r esults shOi" that 6- hydroxydo:p3.lJine on its o'tln Nas capg.ble of 
de ple ting only 14?b of the Nhole brain do pamine . On the othe r hand . Hhen the 
administration of pargyline preceded 6- hydroxydopamine t r e a t ~ e n t t by thirty 
minutes , t he de pleting action was greatly potent i ated , up to 501", of the dop9.-
mine being l ost . 'iii th noradrenaline , on the ot ller hand , 6- hydroxydo!:e.mine 
produced about 6ei/a depletion which lIas not potentia ted T:Tith pagyline 
pre trea kent . The unusually l a r ge standard error associated 
o 
2 
4 
8 
12 
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Table 2 .8 
Time course effect of i ntraventricular injection 
of 6-hydroxydopamine on dopamine content of rat brain 
6 - h y d r o x y ~ o o ~ m i ~ ~ C h a n ~ ~ ~ 6-hydroxydopamine + 
- - - - p a r ~ ~ i n ~ - - - - - -
ng/gm per cent ng/gm 
+ (8) 830 + 10 (8) 830 - 10 -
+ (4) 766 + 36 (4 ) 791 - 58 - 4.70 -
+ 780 - 35 (4 ) - 6 .02 638 + - 41 (4) 
+ (4) 415 + (4) 784 - 54 - 5 . 54 - 44 
713 + (4) - 14.09 - 58 450 + (4) - 44 
per cent 
- 7 . 71 
- 23 . 13 
- 50 .00 
- 45 .78 
Each value is t he mean ! standard error fr om the number of animals shown 
in p3.rentheses. 
Zero time r efer s to control animals . 
Table 2 . 9 
Time course effect of intraventricular injection 
of 6-hydroxydopamine on noradrenaline content of r a t brain 
Days 6-hydr oxydo :ramine C ~ g ~ ~ 6-hydroxydopamine + £ h a ! ! ~ ~
---------
---- ~ ~ n e - - - - -
ng/gm per cent ng/gm :fer cent 
+ (8) 441 + 31 (8) 0 441 - 31 -
2 263 + - 16 (4) - 40 . 36 301 + - 23 (4) - 31 .74 
+ (4) 187 + (4) 4 219 - 12 - 50 .34 - 12 - 57 .60 
+ (4) 161 + 16 (4) - 63 . 49 8 197 - 22 - 55 .33 -
12 186 + (4) - 57 .82 179 + (4 ) - 12 - · 1.4 - 59. 41 
Each va lue is the mean ~ ~ standard error from the number of animals shown 
in parentheses . 
Zero time refers to control animals. 
FIGURE 2 .6 
Ti.me course effect of 6- hy roxydopaoine on brain dopacine conten 
+ Each bar indicates mean - standar ' error for the nUl:lber of an:in:als inSide 
t he column . 
Open columns r epresent 6- hydroxydop:uni. e tre tcent . hatched colunns 
re present treatment with 6- hydroxydo!E-mine nd}8.r ine . 
Pargyline was injected i ntraperi toneal y ha f an hour before the 
intraventricular injection of 6 - h y d r o x y d o p a ~ n n . .
8 
to 
- - - - - - - - - - - - - - - - ~ ~ ~ ~ ~ ~ ~ ~ ~
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FIGURE 2.7 
Time course effect of 6-bydroxydopamine on brain noradrenaline content 
Each bar indicates mean ~ ~ standard error f or the number of animals inside 
the column. 
Open columns represent 6-hydroxydopamine treatment. hatched columns 
re present treatment with 6- hydroxydopamine and p p r ~ J l i n e . .
Far gyline was injected intraperitoneally half an hour before the 
intraventricular injection of 6-hydroxydo pamine . 
o 
..... 
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with dopamine and noradrenaline measurements sugges t that the brains Here 
not uniformly de pleted . This implies t r ~ t t t here was a variation i n the 
degree of destruction of catecholamine neurons caused by 6-hydroxydo pamine . 
2 .7 Studies on bep.avioura l alteration produced bv the combined treatment 
of Fargyline and 6- hydroxvdo-::amine 
Since the. discovery of 6- hydroxydopamine and its actions on e a t e c h o l l m i ~ e e
neurons, there has been a very large number of studies on t he behavioural 
changes brought about by 6- hydroxydopamine . HOvlever, most of t hese 
studies were made several hours a f t e ~ ~ the administ ra tion of the drug and 
t h e ~ e e are few re ports in the literature on t he early behavioural eff ects 
of 6-hydroxydopamine . 
In ·some of our early experiments , .'{e administered the combined 
treatment with 6- hydroxydopamine and pargyline t o rats under dee p pento-
barbitone anaesthesia . 'de found , before the method ,,,as abandoned . t hat 
the mortality among these animals ''1as very high. r eaching as much as 
8(j}b. VIe explained this effect at t he time by the interaction of pento-
barbitone anaesthesia lofi t h pargyline , as the group t hat r eceived no 
pargyline sholtled no mortality , even though t he 6-hydroxydopamine ',Tas 
given by the intraventricular route . \'Te r everted therefore to ether 
anaesthesia and since , in the procedure He used , the animals r ecover ed 
from anaesthesia Itii thin thirty seconds, we had the oppor tunity to r ecord 
behavioural responses to the drug . These , '"hieh have not been r eported 
before , were striking in t heir reproducibi l ity i n all the animals . 
After the i ntr aventricular administration of 6- hydroxyd opamine only , 
no more than slight changes in behaviour appeared to be produced in the 
rat . D u r i i ~ ~ the first fe'll hours the animals a ssUI:led a postur e '.'lith 
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hunched back and raised fur , and , though they appeared to be a little 
irritable and excitable, they could be handled without any difficulty . 
On the other hand , when the intraventricular administra tion of 6-
hydroxydopamine was preceded by the intraperitoneal injection of 
pargyline, compl etely different responses ~ ~ r e e observed. The r a ts 
assumed a posture with hunched back , neck extensor muscles contracted , 
;'lhich led t o a raised head (as if they "Tere staring to t he ceiling , 
Figures2 .8 , 2 .9 ·and 2 . 10) _ and sat i n that position \'lithout showing 
any movement until they were disturbed , whereupon they moved to stand 
in another place, shm'ling littl e sign of a lertness. The rat s were 
vocalizing most of the time and this increased on t ouch . They ','lere 
irritable, appeared t o be very f r ightened . their res ponse to pain vias 
greatly potentiat ed and they displayed increased r espiration on handling . 
They semTed some increase i n muscle tone but they 'lTere not catatonic . 
Tail t'lTi. t chi ng or shaking r esulted on t ouching their backs . None of 
these behavioural changes had been seen in r a t s trea ted with 6-hydroxydopa-
mine only . 
injections . 
These effects started to disappear three hours after the 
On the second day, most of the rats wer e normal a lthough a few still 
showed vocalization on t ouch . A scoring system ( ( ~ f i n n primary · test) 
was used in which t he behavioural, neurological and autonomic responses 
were measured . The results are shown in table 2 .1 0 . 
The total score for the behavioural responses is not very different 
in the three dif ferent groups , but as we can see f rom t he table . some 
behaviours were increased and other s were decreased in the group of r ats 
treated with 6- hydroxydo pamine and pargyline . These would compensate 
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Table 2.10 
Comparison between the behavioural changes brought about by 6- hydroxy-
dopamine, 6-hydroxydopamine and pargyline or saline and pargyline 
I. BEHAVIOURAL 
----------
Alertness (4) 
visual placing (4) 
rnssivi ty (0) 
Vocalization (4) 
Irritability (0) 
Fearfulness (0) 
Reactivity (4) 
S pon taneous 
activity (4) 
Touch response (4) 
Fain response (4) 
Total 
II. NEUROLOGICAL 
Abnormal gait (0) 
Body tone (4) 
Abdominal t ~ n e e (4) 
Body posture (4) 
Limb posture (4) 
Total 
'Irwin primary tests ' 
Saline + 
4.0 
4 .0 
0.0 
0.0 
0 .0 
0 .0 
4.0 
4 .0 
4 .0 
4.0 
24 .0 
0.0 
4.0 
4 .0 
4.0 
4.0 
16.0 
~ - - , , 9 ! 0 ~ d o r : a a
mine 
4.0 
3.5 
0 .0 
b.o 
0 .0 
0 .0 
4.0 
4 .0 
4.0 
4 .0 
23.5 
0 .0 
4 .0 
4 .0 
4 .0 
4 .0 
16.0 
6-hydroxydopa-
--------
mine + pargyline 
----------------
1.5 
1.0 
1. 5 
4.0 
2.0 
2.0 
1.5 
1.5 
2.5 
8 .0 
25.5 
1.5 
6.0 
6 .0 
6 .0 
4.0 
23 .5 
contd •••••• 
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Table 2 .1 0 - contd . 
III. AUTONONIC 
-----------
Piloerection (0) 0 .0 1.0 2 .0 
Hy!X)thermia (0) 0 .0 0 .0 0 .0 
Skin colour (4) 4 .0 4 .0 4 .0 
Heart rate (4) 4 .0 4 .0 6 .0 
Respiration (4) 4 .0 4 .0 6 . 0 
Tai 1 S h a k i n ~ ~
on touch 0) 0 .0 0 .0 8 .0 
Total 12.0 13.0 26 .0 
Sum 52 .0 52 . 5 75 . 0 
The numbers are the mean of observations on nro different rats . 
The peak effect listed is assessed on a scale ranging from zero t o eight . 
Numbers in parentheses indicate the score ivhich is given to untreated r a ts. 
each other leaving the final score the same as for other groups . On the 
other hand when the neurological and autonomic scores "lere totalled a 
great difference appeared between the three different groups . Here it 
is noticeable that most of the neurological and autonomic responses were 
aggravated by the combined treatment with 6-hydroxydopamine and pargyline. 
Audiogenic seizure susceptibilitv in rats treated i'lith 6-hydroxydom.mine 
Rats ';lhich i'lere not initially susceptible to audiogenic stimulation 
and which were treated with 6- hydroxydopamine showed no convulsive 
response to audiogenic stimulation (details of \'lhich are given in chapter 
3) one . two , three and four weeks aft er treatment . 
FIGURE 2 . 8 
To illustrate the attitude t aken up by ra ts tha t had r eceived 
6-hydroxydo Farnine and I11r gyline (A and C) in cornIE-ri son "'Ii t h 
t hat of an untrea ted r a t (B) . 
(A) 
( B) 
(e) 
FIGUrtE 2 . 9 
To illustrate the a ttitude taken up by rats that had 
r eceived 6- hydroxydopamine and pargyline (A and C) in 
comparison with that of an untrea ted rat (B) 
(A) 
(B) 
(C) 
FIGURE 2 . 10 
Details as in Figure 2 . 9 : animals (A) and (C ) 
had received 6-hydroxydopamine and pargyline; 
animal (B) 'IlaS untreated 
(A) 
(B) 
(( ) 
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2 .8 Effect of single doses of anticonvulsant drugs on brain dopamine and 
noradrenaline content de pleted by 6- hvdroxydooamine 
Female Ash '.'iistar rats were prepared for the intraventricular in jection 
as described befor e. One week l a t er the rats i,ere injected intra-
peritoneally ivith pargyline (50 mg/kg) , follm·Ted half an hour l ater by 
intraventricular injection of 6-hydroxydo pamine (200 ~ g g of the hydro-
I 
chloride in normal saline vii th 1 % ascorbic acid) . Tivelve days l a ter . 
the rats ,,'[ere divided into groups of four, and each group received an 
intraperitoneal injection of either saline or one of the anticonvulsant 
dr ugs shown in table 2 . 11 in the same doses as before . They vlere killed 
one hour later and their brains were quickly removed and assayed for their 
dopamine and noradrenaline content by the method described in cha pter 1 . 
The results are sho'tm in table 2 . 11 . 
The results show that while carbamazepine increased only noradrenaline . 
phenobarbitone and phenytOin were capable of i n c r r a a i i ~ ~ significantly 
the amount of both dopamine and noradrenaline in the brains of r a t s treated 
wi th 6- hydroxyd0 pamine • 
2 .9 The regional distribution of brain dopamine and n o o a d r e ~ ~ l i n e e in 
rat brain 
Results in section 2 . 1 shm. that the amount of dOp3.mine and noradrer..a.line 
in whole brain did not change after , the administration of singl e doses of 
anticonvulsant drugs tested . As the levels of dopamine and noradrenaline 
vary among the diff erent brain regions , any change in the concentr tion 
of dopamine or noradrenaline in small areas of the brain might have been 
masked in an assay of the i,hole brain . So we decided to look at t he 
effect of the anticonvulsant drugs on dopamine and noradrer..a.line content 
in parts of the brain . 
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Table 2 .11 
Effect of single doses of anticonvulsant drugs on brain dopamine and 
noradrenaline content after an intraventricular injection of 6- hydroxy-
dop:tmine 
The animals were killed one hour after the anticonvul sant 
drugs and twelve days after the 6-hydroxydo p3.mine 
Treatment 
Vehicle 
6-hydroxy-
dOp:!.mine 
6-furdroxy-
dOIS-mine + 
phenobarb-
itone 
6-hydroxy-
doramine + 
phenytoin 
6-hydroxy-
dOpimine + 
carbamaze-
pine 
D o ~ m i ~ ~ C h a a g ~ ~
ng/gm per cent 
822 :: 13 (8) 
+ (8) 
- 42 .7 471 - 45 
+ ()** 663 - 26 4 ** - 19.3 
+ )** 591 - 32 (4 - 28 .1 
N oradrena line 
-------
ng/gm 
430 :: 20 (8) 
130 :: 13 (8) 
C h a . 2 : ~ ~ ~
per cent 
- 69 .7 
+ )** 189 - 5.6 (4 ** - 56 .0 
+ )** 206 - 26 (4 - 52. 1 
+ Each value is the mean - standard error from the number of animals 
sho ... m in psrentheses. 
Significantly different by the t test (* p < 0 .05; ** p < 0 .02 ; 
** ** p < 0.C(1) from those obtained after treatment ~ n n th 6-hydroxydop3.mine . 
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Method of dissection 
The method used for dissection \-las t hat \-Thich has previously been 
used in our laboratories (Jepson , 1975; Hebron, 1977). Rats ;'lere 
tilled by cervical dislocation and decapi ta tion, t heir brains ' ... ere 
quickly removed and placed on an ice-cooled glass plate . The cerebellum 
was removed first by cutting the cerebellar peduncles, then the pons und 
medulla which lie immedia tely below the cerebellum were separated from 
the r est of t he brain. The cerebra l cortex was then pulled a'-llay to 
expose the corpus callcsum. An inci sion was made through t he midl ine 
of the cor pus callosum to expose the latera l ventricles . The striata 
protruding from the inner surface of the cerebral hemispheres into the 
ventricles together with t he caudate nuclei, were r emoved by gently 
scraping the i nside of t he ventricle iii th a sharp sca l pel. The cerebral 
hemispheres .. "ere then dissected from the rest of the brain . Each part 
\'las homogenized a s soon as it had been isola t ed and i'Teighed . It was 
then asSayed for its dopamine and noradrenaline content. 
An exampl e of the reproducibility of this procedure i s given in 
table 2 .1 2 . The lOi., coefficient of variation indicates that the 
procedure i s confi dently reproducible. 
The 'rest of the brain ' T,oT hich '-ITill be r eferred to l a t er as ' mid 
brain ' i ncludes the mid brain proper, the thalamus , subthalamus , 
hypothalamus and hi ppocampus . 
2 .1 0 Effect of sinole doses of anticonvulsant drugs on the rehional 
distribution of dOPamine and noradremline 
These experiments were performed in t he same ~ a n n e r r as those carried 
out ','lhen studying the effect of t he anticonvulsant drugs on whole 
brain catecholamines . 
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Table 2 . 12 
Reproducibility of the dissection procedure 
Pons and 
medulla (10) 
Cerebellum (10) 
Striata (10 ) 
Cerebral 
hemispheres (10) 
Midbrain (10) 
M e a n ~ ~ i g ! : ~ ~
mg 
+ 144 - 6.5 
242 + - 10. 1 
+ 38 - 2 .0 
762 ! 43 .0 
368 ! 31 .0 
9. 26 
2 . 4 
49.0 
23 .7 
Coefficient of 
-varIation---
4.5 
4 .2 
5.2 
5.6 
8 .4 
+ Each value is the mean - standard deviation from the number of animals , 
of body weight between 150 and 160 gmS t shown in parentheses 
Female Ash vlistar r ats "Teighing approximately 150 gms "rere obtained 
one week before carryi ng out the experiments . Animals ,'rere killed one 
hour ufter the injection of the stated doses and their brains were 
quickly removed , placed on an ice cooled glass plate and dissected as 
described i n section 2.9 . Each part was homogenized as soon as it had 
been isolated and weighed . It was then assayed f or its ca techolamine 
content . 
Results in tables 2.13 and 2 .1 4 s h ~ d d that phenytoin increased the 
amount of dopamine in the striata where the greatest concentration of 
dopamine has been found and this attained a statistical significance 
(p < 0 .(01) . Hmolever , it did not affect the concentration of dorru;:d.ne 
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Table 2. 13 
Effect of single doses of anticonvulsant drugs 
on the regional distribution of brain dopamine content 
D r u ~ ~ Striata Cerebral Nidbrain 
-
--- -----
ng/gm ng/gm ng/gm 
Saline 6210 :!: 92 (6 ) + 433 - 7 (6 ) 260 :!: 7 (6 ) 
Pnenobarbitone 6130 :!: 94 (6 ) 453 :!: 15 (6 ) 264 :!: 17 (6 ) 
P N.S. N. S. N.S. 
Saline 5710 :!: 24 (6) 431 :: 28 (6) 251 :!: 21 (6 ) 
Pnenytoin 6168 :!: 29 (6) 4C6 + (6) + (6 ) - 10 265 - 21 
P < 0.001 N.S. N.S • 
. + 
Propylene glycol 6120 - 78 (6) 443 :: 14 (6 ) 288 :!: 10 (6 ) 
Car bamaz e pine 6200 :!: 23 (6 ) 448 :!: 14 (6) 259 :!: 21 (6 ) 
P N. S. N.S . N.S . 
+ . 
Each value is the mean - standard error from the number of animals 
sholtTn in IErentheses 
Table 2 .1 4 
Effect of single doses of anticonvulsant drugs 
on the regional distribution of brain noradrenaline content 
D r : : ! ~ ~ Pons and medulla Cerebellum Cerebral Midbrain 
------- ----- ---- ------
ng/gm ng/gm ng/gm ng/gm 
·Saline 682 :!: 42 (6 ) 4C6 :!: 41 (6) 381 :!: 14 (6) 707 :!: 35 (6 ) 
Pneno-
704 :!: 56 393 :!: 16 barbitone (6 ) (6 ) 391 :: 14(6) 681 :!: 49 (6 ) 
p N.S. N. S. N.S. N.S. 
Saline 716 :!: 35 (6) 385 :!: 7 (6 ) 392 :: 42(6) 668 :!: 21 (6 ) 
Pnenytoin 801 :!: 35 (6 ) 380 :!: 21 (6) 338 :!: 31 (6) 749 :: 35 (6 ) 
p < 0 . 1 N.S. N. S. < 0.05 
Propylene 
672 :!: 21 384 :: 21 :: 14(6 ) 697 :: 35 (6 ) glycol (6) (6) 341 
Carbamaze-
659 :: 63 374 :: 28 (6) pine (6 ) 391 :!: 12 .(6) 802 :: 35 (6 ) 
p N.S. N. ;::, . < 0.02 < 0.05 
Each value is the mean :!: standard error from the number of animals 
shown in parentheses . 
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in other parts studied . Phenytoin also increased significantly t he 
amount of noradrenaline in the midbrain and shOl'led a tendency to lOtTer 
it in the cerebral hemispheres, and to increase it slightly in the pons 
and medulla. Carbamazepine increased significantly noradrenaline con-
centration in midbrain (p < 0 .05) and cerebral hemispheres ( p < 0 .02) . 
Phenobarbitone had no effect on either dopamine or noradrenaline in 
any of the parts studied . 
2 . 11 Effect of a single dose of phenobarbitone on dopamine turnover in 
selected brain regions 
The results presented in section 2 . 2 show tha t phenobarbitone reduced 
the change produced by a - m e t h y l - ~ t y r o s i n e e on dopamine concentration 
in whole brain . Ne therefore performed experiments to study the effe ct 
of phenobarbitone on the change in dopamine concentration induced by 
a - m e t h y l - ~ t y r o s i n e e in discrete brain regions in order to see whether 
this effect was limited to one region or whether it had a more widespread 
effect on all the regions . 
Female Ash Wis t ar rats were divided into groups and injected intra-
peritoneally either with saline and a - m e t h y l - ~ t y r o s i i e e (100 mg/kg ) or 
~ ~.. i th , phenobarbi tone (100 mg/kg) and a - m e t h y l - ~ ~ y y o s i n n . . The animals 
were killed three hours after the injection and their br ains "Tere 
r e ~ o v e e , , dissected as described before and the parts were assayed f or 
their dOpamine cont ent . Results are presented in t able 2 .1 5. The 
depletion of dopamine in the mid brain was so great t hat the amount 
remaining could not be detected by our method . a-!1e thyl-,l2-tyro sine 
reduced the amount of dopamine in the striata by 56% and in the cerebral 
hemispheres by 61 %. 
Phenobarbitone r educed significantly the degree to which d o p p ~ ~ n e e
was depleted in the cerebral hemispheres but it did not affect the 
change in the striata . 
Saline 
cx-Me thy 1-2-
tyrosine 
% change 
Fhenobarbitone 
+ cx-methyl-k" 
tyrosine 
% change 
P (t test) 
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Table 2.15 
Effect of a single dose of phenobarbitone on 
dopamine turnover in parts of rat brain 
Striata Cerebral Mid brain 
--- ---- ----
ng/gm ng/gm ng/gm 
6320 :!: 74 (6) 422 :!: 16 (6 ) 260 ! 8 (6) 
2668 :: 122 (6) + 163 - 8 (6 ) (see text) 
- 57 .78 - 61 . 37 
+ 2799 - 77 (6 ) 343 :: 8 (6) (see text) 
- 55 .71 - 18 .72 
N.S. < 0.001 
+ Each value is the mean - standard error from the number of animals 
shown in parentheses . 
The figures vlere obtained in two different experiments . 
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CHAPl'SR 3 
BRAIN CATECHOLAr:IINES DURI NG HABITUATION 
Al'ID T,HTHDRMAL FRO'1 
Treatment of grand mal epilepsy requires long term treatment with 
anticonvulsant drugs . Long acting barbiturates were found to be eff ec-
tive in this disorder. However , the ioTithdrawal of bar b itura tes from 
those habituated to them can cause epileptiform convulsions even in non-
epileptic individuals and the exacerbation of seizures in epileptic 
patients . 
Crossland and Leonard (1963) developed a method by which rats became 
physically dependent on sodium barbi tone ~ T h e n n the drug was given in their 
drinking water . Animals treat ed in this ,",ay develop a supranormal 
seizure threshold during the administra tion of the drug and a reduced 
threshold during abstinence (Leonard , 1968) . 
We have adopted the method of Crossland and Leonard to examine the 
effect of habituation to and withdrawal of phenobarbitone on the levels 
and turnover of dOIRllline and noradrenaline in the \-lhole brain . as wel l as 
on the regional distribution of the catecholamines in ra t brain . 
3. 1 f1ethod of habituation 
Female Ash \'iistar r a +,s weighing approximately 80 gIn were o b b a i n e ~ ~ from 
our usual source . All animals w e ~ e e first subjected to auditory s t i ~ ~ ~
lation by placing them singly in a glass fronted wooden box lofi th an 
electric door bell attached to the roof . The wooden box 'tlaS divided 
into tioro chambers. each 30 x 30 x 30 cm, and was itself enclosed in a 
large glass fronted case . Each rat was exposed t o the sound of the 
bell for one cinute . Any animal that exhibited convulsions after sound 
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stimulation was excluded from the experiment. In the course of our 
study, this kind of experiment was carried out several times and on ea ch 
occasion the number of animals used was about forty . In ea ch group no 
more than one animal usually showed convulsions, but on just one occasion 
we found that three rats out of the forty convulsed when subject ed to 
a u d i ~ o r y y stimulation. 
After the initial screening , the ra ts were housed in individual 
cages, \'Ihere they \'lere allol'led free access to food and water . Their 
food and water intakes were measured daily and their body wei ghts lvere 
taken every three days. One week l ater, the rats were divided into two 
groups. One group received phenobarbitone in their drinking 1'la ter. 
The . bi tter taste of phenobarbitone \'las disguised by adding saccharine 
to the drinking water to a concentration of 0 . 0 2 2 ~ ~ . . The othe r group of 
rats served as controls and received only saccharine in their drinking 
water. 
The concentration of phenobarbitone in the drinking water was 
initially such as to ensure a daily intake of about 50 mg/ kg f or the 
first two weeks. The concentration was adjusted s o as to increase the 
daily intake of phenobarbitone by about 50 mg/kg every other week , until 
the concentration of phenobarbitone in drinking water reached a fina l 
concentration of 150 mg/kg at vThich level it was continued for the last 
two weeks of the administration . The dose of phenobarbitone VIas 
corrected every three days in the light of c r r n g g s s i n the fluid intake 
or body ueight of individual animals. The drinking wa t er was changed 
ever-J day. The dose of phenobarbitone intended I·ras calculated every 
three days from the follmdng : 
mg per 100 ml = intended dose (mg/kg) x Vl eight in grams 
fluid intake x 10 
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The calculated dose was obtained by taking an appropriate amount of a 
freshly prepared solution containing 1 gm per 100 ml of phenobarbitone 
and making it up to 100 ml with tap water . 
Table 3.1 illustra tes the mean daily intake for each 'ieek of 
habituation . 
Week 
2 
3 
4 
5 
6 
Table 3.1 
Intake of phenobarbitone 
Intended intake 
mg/kg/day 
50 
50 
100 
100 
150 
150 
Actual intake 
--------
mg/kgjday 
55 .2 + 10.6 (25) -
47 .6 + - 5.7 (25) 
109 .3 + 
-
10 .2 (25) 
97 .3 + 12.6 (25) -
129 .9 + - 20 .9 (25) 
+ 13.6 (25) 135 .3 -
+ Each value is the mean - standard error from the number of animals 
shown in parentheses . 
Preliminary experiments in our department revea l ed that there was 
a fluctuation bet\ieen the morning and afternoon body weights, ranging 
benieen three and five grams for an individual rat , so we took a l l the 
measurements at the same time of the day (between 10 .00 and 11 .00 hours), 
during the whole period of treatment . 
3 . 2 Behavioural studies on uhenobarbitone habituation 
Treatment 'iTith phenobarbitone started at a daily dose of 50 mg/lr.g . In 
spite of the slightly high pH of the phenobarbitone soluti on in drinking 
wa ter, rats tolerated the taste and t dose very "I'lell. There "Tas no 
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sign of ataxia at this dose level, although rats on phenobarbitone 
appeared to be less active than control rats . 
After the first day of treatment. rats on phenobarbitone drank much 
more water and ate much more food than did the rats "Tith saccharine only 
in their drinklng \ora ter. These differences in food and water intake 
attained a high degree of significance which lasted for three or four 
days before both groups ate and drank the same (Figures 3 .1 and 3.2). 
After about ten days of treatment with daily doses of 50 mg/kg 
phenobarbitone, rats became slightly aggressive and exhibited a noticeable 
increase in biting behaviour. This disappeared after increasing the 
daily dose to 100 mg/kg. This latter dose produced a slight ataxia 
which lasted up to four days then it started to disappear. Again the 
food intake was increased Significantly by increasing the dose of 
phenobarbitone, water intake remined unchanged. The aggressiveness 
and biting behaviour were seen again towards the end of the period of 
treatment with -doses of 100 mg/kg. and disappeared when the daily dose 
was increased to 150 mg/kg . At this dose level, ataxia became apparent , 
as did a striking degree of passiveness, so that the rats could be 
positioned on the hand without showing any movement. The amount of 
water drunk dropped progressively till it reached a plateau which 
effectively prevented any further increa se of barbiturate dose . The 
food intake did not change much at these high dose levels . Figures 
3.3 and 3.4 show the changes in food and water intakes immedia tely 
after increasing the dose of phenobarbitone . 
The body weight of rats treated wi th phenobarbitone increased 
progressively as did that of aniID3-ls ,00i th sacch;;,.rine only in their 
drinklng water . After increasing the daily dose to 100 mg/kg , rats 
FIGURE 3 . 1 
Changes in water intakes durin long term tree. tment vii th different 
doses of phenobarbitone 
+ Each bar indicates mean - standard error for 24 rats ( o p e ~ ~ columns) 
and 8 r a ts (hatched columns • 
Open co lumns represent r a ts receivi ng phenobarbitone and saccharine 
in t heir drinking water, hatched columns represent control rats 
receiving saccharine only in t heir drinking ~ a t e e . .
Significantly different by the t test (* p < 0 .05 , ** p < 0 .02 , 
** ) ** p < 0 .001 from those of control rats receiving saccharine only 
in their drinking \'1a ter . 
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FIGURE 3.2 
Changes in food intakes during long term treatment ." ith different 
doses of phenobarbi t one 
3ach bar indicates mean! standard error for 2 rats (open columns ) 
and 8 rats (hatched columns) . 
Open columns represent r ats receiving phenobar bitone and saccPBrine 
in their drinking water , hatched columns represent control r a ts 
receiving saccharine only in their drinkin water . 
Significantly different by the t t est (* p < 0 .05 , ** p < 0 .02 , 
** ) ** P < 0 .001 from those of cont rol ra:s receivin saccharine only 
in their drinking \'1a ter . 
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Days Withdrawal 
FIGURE 3.3 
Daily changes in food intakes 1cmediately after 
increasing the dose of phenoba=bi t one 
Each bar indicates mean: standar error for 24 rats (open c o l ~ ~ s ) )
and 8 rats (hatched columns) . 
Open columns re present rats receiving phenobar bitone and saccharine 
in their drinking water , hatched columns represent control rats 
receiving saccharine only in their drinking water . 
Significantly different by the t test (* p < 0 .05 . ** p < 0 .02 , 
* ** 
** p < 0 .005 and ** P < 0. 001) from those of control rats receiving 
saccharine only in their drinking water . 
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Daily changes in ;'later intakes immediately after 
increasino the dose of phenobar witone 
Each bar indica tes ~ e a n n : standar error for 24 rats (open c o l ~ ~ ) )
and 8 rats (hatched c o l ~ s s . .
Open columns represent r ats r eceiving phenobar bitone and saccbarine 
in t h h i ~ ~ drinking water , hatched columns represent control r ats 
re cei ving saccharine only in t ~ ~ i r r dri n}d.n i'la ter . 
Significantly different by the t test (** * < 0 .02 , ** < 0 .005 and 
** ) ** p < 0 .001 from those of control ra ts receiving saccilar i ne only 
in t heir drinking water . 
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FIGURE 3. 5 
Changes in body 'lI'eights during long term 
treatment with different doses of phenobarbitone 
+ Each bar indicates mean - standard error for 24 r ats (open columns) 
and 8 rats (hatched columns ) . 
Open columns represent r ats receivino phenobarbitone and s s c c h a r i i e e
in their drinking water, hatched columns represent control r ats 
r eceivin saccharine only in t eir drinking ~ T a t t r . .
** Significant ly different by the t test (** p < 0 .02 and ** P < 0 .001) 
from t hose of control rats receiving saccharine only in their 
drinking wa ter • 
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on phenobarbitone gained slightly more we i ght than did control r a ts , 
al though the differ r;nce in "leight betl'i'een the t wo grou ps of animals 
had not attained statistical significance (Fig . 3 .5) . Ti{hen the da ily 
dose was increased f rom 100 mg/kg to 150 mg/kg , the extra wei ght pre-
viously gained by the trea t ed animals Has l ost . 
3.J Screening for audi t ory c o ~ v u l s i o o s s in ~ a t s s habituated to and 
~ v i i thdrawn from phenobar bit one 
At the end of the sixth 'tleek of administrat i on of phenobarbitone , trea ted 
r ats ';lere divided into five equal groups . One group cOntinued to 
receive phenobarbitone while the drug Illas 'Iii thdraHn from the other groups 
by replacing the phenobarbit one solution by one conta ining saccharine 
only. The animals in these latter four groups "Jere ex pos ed to the 
sound of the bell (as described earlier) for one minute. one, t vro, three 
or four days respectively after 'llithdr8.I'i'al in order to determine the 
peak time of any convulsive actiVity occurring after vii thdravl8. l. 
The withdrawn rats vlere observed for one hour every day in order 
to assess behavioural changes other than those revealed by the sound 
stimulus . Their body weight and food and water intake s were measured 
at different time intervals after withdrawal. Follm'l'ing drug I"ri thtirawa l , 
rats which were on phenobarbitone lost an average of 10 gm in weight during 
the first 48 hours . Their Hater intakes Vlere sharply increased duri ng 
the first 24 hours and decr eased sie;nificantly a t 48 hours af t er ''1 ithdra''i'al. 
Food intake was sharpl y reduced 48 hours after ,vi t hdravlal. h nety- six 
hours after wi thdraloTal. animals began to recover . . They ate and dr ank 
the same amount as did control r a t s and started to regain wei ght ( F'i,sures 
3.1, 3.2 and 3.5) . 
• 
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These changes in food and ''later intakes and body , ... eights during 
habi tuation to and ,'Ii thdra, ... al f rom phenobarbitone, took the same p3.ttern 
in each experiment in which phenobarbitone was admini s tered . ~ I l l n n y -
four hours after the removal of the drug , withdrawn r a ts were easily 
distinguished from control rats. They looked excited and restless, 
and were disturbed by the smallest noi se . When subjected to auditory 
stimulation, three out of six rats showed wild running , one of the three 
showed convulsions and it was obvious that t he other rats were upset by 
the sound of the bell. unlike the control rats which maintained an 
apparent .equanimity during exposure. Two days after withdrawal, all 
rats subjected to auditory stimulation exhibited convulsions . The sound 
of the bell 'tTas stopped as soon as the convulsions started . T'nese con-
vulsions were characterized by a latent period in which the r at sat 
silent almost as if it were expecting something to happen. The animal 
then started to look for an escape from the sound then there follo'tTed 
immediately a period of wild running and jumping , in'tThich the rat ran 
vigorously in close circles. After that it stood on its hind legs and 
started to jump violently, often reaching the roof of the box . This 
jumping was follo, ... ed by clonic convulsions that culminated in an extensor 
tonic spasm. The convulsions continued in some rats for up t o one 
minute after stopping the sound of the bell. In some cases death 
follo, ... ed the severe convulsions. Some r a ts r r ~ o o e d d from the box and 
returned to their cages still showed sporadic . jumping behaviour over a 
period of severa l minutes . Spontaneous convulsions I'ler e seen in some 
wi thdra,m rats at the forty-eight hours withdrawal period. ' . ~ ~ e made no 
effort to measure the percentage of animals that exhibited spontaneous 
• 
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convulsions as that would have required the continuous observa tion of t he 
wi thdra\ofn rats over the whole tvlenty-four hours reriod, "Thich \vas not 
possible at the time of the exreriment . 
Three days after withdrawal of phenobarbitone, fifty per cent of 
the animals still showed convulsions in response to auditory stimula tion. 
The latent and wild running periods were longer and the duration of con-
vulsions was shorter than at the forty- eight hours withdrawal reriod. 
Table 3.2 and figure 3.6 ShOTl1 that the m a x i ~ ~ convulsion activi ty 
occurred forty- eight hours after the drug bad been withdrawn. At the 
peak of convulsion activity , there 1<[ere strong negative correlations 
between the latent reriod and the duration of both the phases of wild 
running and that of the subsequent convulsions (r =--0.880 and - 0.772 
respecti vely ) • The correlation coefficient of the r elationship betvTeen 
the period of wild running and that of the convulsions prorer reached 
+ 0.952 . These relationships are expressed graphically in figures 3.7, 
3 .8 and 3 .9 . 
S e v e n t t - ~ v o o hours after withdrawal, the excitability of the animals 
was considerably reduced and the latent reriods of the convulsions was 
considerably lengthened (up to 36 seconds) and the duration of convulsions 
was shortened (11 to 16 seconds) . Interestingly enough the period of 
wild running r e m a i ~ e d d unaltered but too much cannot be made of these 
observations , since so fev1 animals exhibited conV\l.lsions a t this s t ~ g g . .
Table 3. 2 
Convulsion activity of rats habituated t o and wi thdrawn from phenobar bitone 
Hours after 
\<Ii t hdrawal 
o 
24 
48 
72 
96 
Number of 
a nina Is 
6 
6 
6 
6 
6 
Number of 
aninals showing 
- convulsions-
o 
6 
3 
D u r ~ ~tion ~ ~ t h h _ p ~ ~ ~ ~ ~ ~ u d d ~ g g n i c c _ ~ ~ ~ ~ ~
I a t e e ~ J ; l 8 r i o d d
sec. 
o 
30 :!: 0. 00 
+ 10.8 - 0 . 95 
+ 28 . 33 - 2 . 71 
+ 45 . 00 - 0 . 00 
, 1 i l l _ ~ i n ~ ~ Convulsions 
s e c . sec. 
o o 
+ + 15 .00 - 0.0 10. 00 - 0 . 0 
+ + 12 . 60 - 1. 17 48 . 00 - 1. 46 
+ + 13 . 30 - 2 . 18 13 . 50 - 2 . 00 
+ 16 . 00 - 0 .00 0 . 00 
+ Each va lue i s t he mean standard er ror from the number of animals shown in column three 
V1 
CX> 
FIGURE 3.6 
Duration of convulsions after 'In thdrawa of 
pheno'b:1rbi tone 
+ Zach bar indicates mean - standard error for the number of animals 
inside the column. 
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Regression line of the re lationship b b ~ ~ e e n n the dura tion of the 
latent per iod (in seconds) against t he sum of durations of wild 
running and convulsions (in second s ) , mea sured forty- eight hours 
after the withdr awal of phenobarbi one 
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3.4 Brain c'techolanines during habituation to and ioJ' i thdra'lval from 
phenobarbitone 
Phenobarbi tone \'ras administered to rats in drinking water in an increas-
ing dose schedule as described before . At the end of t he sixth 1/Teek 
of administration , animals vlere divided into two groups . One group 
was used to measure the effect of habituation on the levels of dopaoine 
and noradrenaline in the brain , using the method described in Cha pter 1. 
The other group i'laS withdrawn from phenoburbi tone by re placing its drinking 
i'later by one which contained saccharine only and the members of the group 
were killed forty - eight hours after vTithdrawal. at vThich time their con-
vulsion activity had presumably reached its peak . Resul ts are shorm in 
table 3.3 and figure 3 . 11(A) . 
Table 3.3 
Effect of habituation to and withdrawal from phenobarbitone on 
the amount of catecholamine in r a t brain 
Treatment D O I B m i ~ ~ Noradrenaline 
---- ----------
ng/gm ng/gm 
Control 1202 + (6 ) + 20 (6 ) 
- 77 .5 410 -
1212 + (5) + 8.9 (5) Habituated - 31. 5 424 -
','1 i t hdra,m 953 + 26 .8** (5) 332 + 4 . 4** (5 ) - -
+ ~ a c h h value is the mean - s t a a ~ a r d d error f " om the number of anirrals shovrn 
in parentheses . 
Significantly different by the t test (** p < 0 .02) from those of 
control rats 
As can be seen from table 3.3 , habitua tion to phenobarbi t one had 
no effect on the levels of either dopamine or noradr enaline . On the 
other hand , wi thdra.'ITal of the drug de creased significantly the a!!lount 
of both ca techolamines in rat brain . 
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FIGURE 3 . 11 (A) 
Effect of habituation to and l-lithdrawal from !*lenobarbitone on the 
levels of dopamine and noradrenaline in rat b r a i ~ ~
+ Each bar indicates mean - standard error for the number of animals 
in the text . 
Open columns represent dopamine and hatched columns r e ~ e s e n t t nor-
adrenaline . 
C = Control rats R = Habituated rats 1';= ':Iithdrawn rats 
Significantly different by the t test (** p < 0. 02) from those of 
control rate . 
FIGURE 3 . 11 (B) 
Effect of habituation to and "Tithdrawa f rom !*lenobar bitone on the 
de pletion of dopamine and noradrenaline caused by a - m e e h y y - ~ ~ y r o s i n e e
+ Each bar indicates mean - standard error for the number of animals in 
the text . 
Open columns represent dop:u:rine , hatched columns represent noradrenaline . 
C + a .m. p. t . = Control rats treated "lith a-methyl-j?-tyrosine 
H + a .m. p. t . = Habituated rats treated with a - m e t h y y - - ~ o s i n e e
11 + a .m. p. t . = ti1i thdrawn rats treated 'lIitb a-methyl-..ctyrosine 
** Significantly different by the t test (** p < 0 . 001) from those of 
control rats t reated with a-oethyl-lrtyrosine only . 
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3 . '5 Effect of habi tuation to and :d thdrayra l of nhenobarbi t one on the 
de nletion of catecholamine by a-methyl-jttyrosine 
At the end of the sixth ;-leek of administra tion of phenobarbitone , rats 
\-1ere divided into t:-10 groups . <x-l·Iethyl-k-tyrosine (250 m ~ / k g ) ) ',ms 
injected to one of the habitua t ed group and animals were killed ei ghteen 
hours after the injection . The other ,;rrou p of habituated r ats .Tas Hi t h-
dravm fr om phenobarbitone and killed f orty-eight hour s after wi thdrmval ; 
but eight een hours before death each rat r e ceived an injectior. of <X-methyl-
~ t y r o s i n e e (250 og/kg) . Control rats rece ived <X-methyl-k-tyrosine only 
at the same dose level and at the corresponding time • 
. Result s in table 3.4 and figure 3.11 (B) shmv tha t habituation 
significantly decreased and vlithdrawal increased the degree of de pl e tion 
of dopamine caused by a-methyl-k-tyrosine. Habituation had a tendency 
to decrease the depletion of noradrenaline but it only rea ched a low 
degree of significance ( p < 0 .1 ) . . 
Table 3.4 
Effect of habituation to and \dthdra\'1a l from phenobarbitone on the 
depletion of catecholamines caused by <X-methyl-lrtyrosine 
Treatment D o ~ i ! ! ! : . . Noradrenaline 
------- ----------
ng/gm ng/gm 
110:!: 3 .8 (6) 56 + 2 . 2 (6 ) a-He thy l-.2-tyr 0 sine -
Habituated + <X- methyl- + ** + (5) 
.2-tyrosine 155 - 1 .7**( 5) 64 - 4.4 
ldi thdrm'lP + a- methyl-
+ ** ~ ~ J r o s i n e e 53 - 4 .4**(5) + 64 - 4.4 (5 ) 
+ &.ch value is the mean - standard error f rom the nunber of aninels shmTn 
in parentheses . 
** Significantly different by the t test (** P < 0.001) frem those of 
control r ats trea ted ,'lith CX- methyl-k-tyrosine only . 
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3.6 Effect of habitua t i on to and ltTithdra'lla l from nhenobar bi t one on t he 
regiona l distribution of ca techolamine in r a t brain 
Results presented in section 3 .4 of this chapter sho".; that, while habi t-
uation to phenobarbitone had no effect on the levels of the catecholamines. 
withdrawal decreased significantly the amount of both dopamine and nor-
adrenaline in rat brain . Habituation reduced the degree of de pletion of 
dopamine caused by <X-methyl-2""tyrosine, while withdrawal potentia ted it. 
There was no eff ect on the depletion of noradrenaline. 
In view of thare resul ts , lt/e performed eXferiments to study the eff ect 
of habituation to and withdra,.,al from phenobarbitone on the regional 
distribution of the catecholamines in order to locate the sites at 'Ifhich 
withdrawal had brought about the changes in both dopamine and noradrenaline . 
Rats were habituated to phenobarbitone by the method described before . 
They were either killed at the end of the sixth week of administ r a tion or 
killed forty-eight hours after the wi thdrar,lal of the drug . Their brains 
r,lere quickly removed and placed on an ice-cooled glass pla te and dissected 
as described in section 2.9. The dissected areas of the brain were' 
homogenized and assayed for their dOJamine and noradrenaline content . 
Results are shor,m in tables 3.5 and 3.6 and figure s 3 .1 2 and 3 . 13 . 
Habituation to phenobarbitone increased signif icantly t he amount 
of dopamine in the striata and in the mid brain, and decreased it in the 
cerebral hemispheres . The t otal amount of dOIBmine r emained unchanged . 
~ ~ i t h d r m . , a l l of t he drug decreased the con entration of d o ~ i n c c i n the 
st riata and the cerebr a l hemi spheres . DOpamine in midbrain s tayed 
el evated . The total amount of do mine in the brains of Ilithdravrn 
ra tel decrensed si gnificantly belol-T that in aninnls that r eceived 
only saccharine in their drinkinG 'If a ter . These results are in good 
:l. 
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agreement with the ones reported earlier (section 3 .4) . Habituation had 
no effect on the noradrenaline l evels in any part studied , but 1'1i thdrawal 
of phenobarbitone decreased signif icantly the concentra tion of noradrena-
line in the cerebral hemispheres. The total amount of noradrenaline in 
the brains of withdrawn rats was significantly lower than that in untrea ted 
rats. 
Table 3 . 5 
Regional distribution of brain dopamine 
in rats habituated to and withdrawn from phenobarbitone 
Parts of brain Untreated (4) Habituated (6 ) \ ~ ~ i thdrawn (6) 
-------- ------- ---------- ----------
ng/gm ng/gm ng/gm 
+ + + ** Striata 11647 169 12245 - 259* 9714 - 49** 
CerE;!bral + + ** + ** hemispheres 693 9 .7 593 - 21** 573 19** 
+ + ** + ** Hid brain 2(J7 1.96 239 
-
8** 231 4** 
+ + + ** Total dOpunine 882 - 33 .4 909 - 40 709 - 30  
+ Each value is the mean - standard error from the number of animals 
shown in parentheses. 
Significantly different by the t test (* p < 0 . 05: 
from those of untreated rats. 
** 
** P < 0. 001) 
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Table 3 .6 
Regional distribution of brain noradrenaline 
in rats habituated t o and withdrawn from phenobarbitone 
Barts of the brain Untreated (4) Habituated (6) iH thdrawn (6) 
----.------- ------ ---------
--------
ng/gm ng/gm ng/gm 
Pons and medulla + 672 + 20.0 651 + 28 .0 674 - 22 . 2 - -
+ + 28.0 315 + 15.0 Cerebellum 300 - 7.8 332 - -
+ + + ** Cerebral hemispheres 325 
-
16.0 330 - 17 .0 205 - 4.0** 
Mid brain 620 + 650 + 41.6 624 + 16.0 - 40.0 - -
Total noradrenaline + 415 5.6 + 437 14.5 + ** 352 - 9 .5** 
Each value i s the mean: standard error from the number of animals shor,Tn 
in pirentheses . 
** 
** Significantly different by the t t est from those of untreated rats . 
FIGURE 3 . 12 
Regional distribution of brain dopamine 
in rats habituated to and 'I:ithdrawn from phenobarbitone 
+ lach bar indicates mean - standard error for the nuober of animals 
in the text . 
Open columns represent untreated rats , hatched columns represent 
habi tuated rats and dotted columns re present "Iii thdra1lrn rats . 
:: Significantly different by the t · test (p ( 0 .001 ) from those 
of untreated rats . 
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FIGURE 3. 13 
Regional distribution of brain noradrenaline 
in rats habituated to and withdrawn from phenobarbitone 
+ Each bar indicates mean - standard error f or the number of animals 
in the text . 
Open columns r epresent untreated rats , hatched columns r e ~ e s s n t t
habituated rats and dotted columns represent withdrawn rats . 
:: Significantly different by the t test ( p < 0. 001) from those 
of untreated rats . 
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3 .7 Regiona l di stribution of brain c a t e e h o o a m i ~ ~ s s in ~ z z i i u u t t d d ond 
\,1i t hdr a"m rats after de -;Jletion .d th a-me t hyl-,Q-tyrosine 
The design of these experiments is the same as tha t described i n section 3.5, 
exce pt that t he dose of Cl:-methyl-.Q-tyrosine I'las 100 mg/lq- and t he r a t s ';lere 
killed three hours after i nje ction . The brains of habituated and uithdrs.wn 
rats injected with a- methyl-.Q-tyrosine were dissected as described i . chap-
ter 2 , section 9. Results are presented in tables 3 .7 and 3 .8 and fiGUre 
3 . 14 . i'1hile habituation to phenobarbitone decreased si gnificantly the 
degree of depletion of noradrenaline and dopamine in the cerebr a l hemi spheres 
and the depletion of dora-mine in striata , TtTithdralval increased the de pletion 
of both catecholamines in the cerebra l hemispheres and t hat of n o o a a r r r ~ ~ i n e e
in the mid brain and of dopamine in the striata . 
The depletion of dopamine in the midbrain '(las so gr ea t t hat the 
amount remaining could not be detected . 
in pons and medulla and cerebell um. 
The se.rr.e applies to n'oradr enaline 
The total amounts of both noradrenaline and dopamine in t he brains 
of habituated rats treated wi th a- methyl-.Q-tyrosine were higher, and in 
the brains of Tt1i thdrawn rats t reated ,'1i th a- methyl-..J?-tyrosine l..rere 10lfer . 
than them in r ats treated \>li th a- methyl-.Q-tyrosine only . 
3.8 Effect of auditory stimulation on the levels of dot:a.:ni ne and. norad-
renaline in j'lithdra,m r a ts and i n ,-Tit dra,m :ra t s ,(Tith their ca echolaP.'.ines 
depleted by a-methyl-lttyrosine 
In the previous sections of thi s eha pter 11e demonstrated t hat· withdr.:l. 1al 
decreased t he concentration of catechola::ines i n t he br a ins of r <:. t s : · T ~ : : : ' c r . .
had been habituated to phenobarbitone . In addition . ,\e h.::.ve identified 
the areas i n '!Thich ivi thdravTal of phenobarbitone had b r r u ~ h t t lloout tfie se 
changes . 
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Table 3.7 
Effect of habituation to and ,vi thdrawal from phenobarbitone 
on the levels of dOpamine in brains de pleted by a - m e t h y l - ~ ~ y y o s s n e e
Part of the brain 
Striata 
Cerebral 
hemispheres 
f'f.:id brain 
Total dOIBmine 
ng/gm 
+ 5174 - 228 
395 + 25 
see text 
+ 584 - 7 
Habituation + 
a:methyl:U:--
t y r o o i ~ ~ = = 4 1 1
ng/gm 
+ 5938 - 241* 
541 + ** - 13** 
see text 
+ ** 792 - 30** 
~ l l i t h d r a a · ; ; l l + 
i i - ~ ! ~ ; : f 4 4) 2 _____ _ 
ng/gm 
+ ** 3722 - 58** 
+ 254 - ** 3** 
see text 
+ ** 390 - 15** 
----------------------------------------------------+ Each value is the mean - standard error from the number of animals 
shown in parentheses. 
** ) Significantly different by the t test (* p < 0.05 ; ** P < 0.001 
from those of control rats treated with a a m e t h y y - ~ t y r r s i n n . .
Table 3.8 
Effect of habituation to and withdrawal from phenobarbitone 
on the levels of noradrenaline in brains de pleted by a - m e t h y l - ~ ~ y r o s i n e e
Pons and medulla 
Cerebellum 
Cerebral 
hemispheres 
Mid brain 
see text 
see text 
164 :: 6 
284 ! 24 
+ Total noradrenaline 207 - 5 
see text 
see text 
+ ** 226 - 10** 
+ 304 - 15 
+ 254 - 15** 
\'/ i thdrawa 1 + 
a : : e t ! } Y Y = ~ ~
tyrosine-(4) 
- - g g - -
see text 
see text 
+ ** 121 
- 5** 
225 d'- 6* -
+ * 159 - 10** 
+ ~ c h h value is ~ h e e mean - standard error from the number of animals 
shOvm in pirentheses. 
* Significantly different by the t test (*p < 0.05 ; **p < 0.02 ; **p < 
0.005 ; ::P < 0.001) from those of control r at s treated with a-methyl-
:£-tyrosine only. 
FIGURE 3 .1 4 
Regional distribution of brain catecholamines in 
habituated and withdrawn r a ts after depletion with a a m e t h y y - ~ t y r o s i n e e
+ Each bar indicates the mean - standard error for the number of animals 
in the text . 
Open columns represent control rats t reateQ with a - m m t h y y - ~ t y r r s i n n , ,
hatched columns r epresent habituated rats treated ~ ' l i t h h a-methyl-l!-tyrOSine 
and Aotted columns represent withdrawn rats treated with a - m e t h y l ~ ~
t yrosine . 
Signif icantly different by the t test (* p < 0.05; ** ** p ( 0 . 001) 
from those of r a ts treated .'I'i th a-methyl-.,2-tyrosine only. 
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In vie\"[ of t hese results \"[e P3rformed eXP3riments to study the 
effect of auditory stimulation on the levels of catecholamines in 
wi thdrawn ra ts and in ,'Ii thdrawn rats 1'li th their do parnine and noradrena-
line depleted by a - m e t h y l - ~ t y r o s i n e , , in order t o see whe t her t he state 
of convulsions had any effect on the utilization of the catecholamines . 
Rats "Tere withdrmm from phenobarbitone after si x weeks of admin-
istration in the manner described before. \H thdrai'm r ats Tlfere divided 
into. ti'ro groupa , one gr oup ,."as subjected to the auditory stimulation 
forty-eight hours after \·Tithdrawal ·and killed at the time of convulsi on. 
The other group was treated in the same manner as the f irst one but 
received an injection of a-methyl-lrtyrosine (100 mg/kg) three hours 
before the auditory stimulation. They were killed a t the time of 
convulsion or, if they did not convulse,at t he end of t he sound of st i mu-
lation which lasted for one minute. 
Control rats received an injection of either a a m m t h y y - ~ t y r o s i n e e
(100 mg/kg) or the corresponding volume of saline and were killed three 
hours later after subjecting them for one minute t o the sound of t he bell . 
As described earlier. withdrawal of phenobarbi tone r enderei rats 
which had been habituated to the drug very restless, aggressive and 
difficul t to handle. All ,."i thdral .... n rats shm-red convulsions when sub-
jected to sound stimuli forty-eight hours after withdrawal. \Ilhen t he 
withdrawn rats were injected with a - m e t h y l - ~ t y r r s i n e , , we found t hat they 
lost their aggressiveness and became easier to handle . VThen subjected 
to the sound of the bell. only one out of four showed convulsions and t hese 
lasted for a shorter period than those in withdrawn rats treated with sali ne . 
The other three shm .... ed wild running only (Table 3.9) . 
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Table 3.9 
Convulsive activity of vTithdravm r a ts trea ted with saline or CX-methyl-,l2-
tyrosine 
Treatment 
vi i thdrawn + 
saline (4) 
I,] i thdrawn + 
a - m e t h y l - ~ ~
tyrosine (4) 
Number 
---£ Q . ! ! Y U I : : ! ~ < i i
4 
latent 
---~ r i o d d\ ~ J J
20 30 
Convulsions 
-rsecY---
22 
+ Each value is the mean - standard error from the number of animals 
that show.ad c o n v u l s i ~ n s . .
Results relating to the catecholamines concentration ar e shown in 
tables ,.10 and. 3.11 and figures 3.15 and 3.16. Withdrawal convulsions 
had the effect of increasing the amount of dopamine in the striata and 
decreasing that in the cerebral hemispheres. These differences attained 
statistical significance of the P < 0.025 level of signif icance. Nor-
adrenaline did not change in either the cerebral hemispheres or the mid 
brain. \'lithdrawn rats treated w·ith o:-meth,yl-,l2-tyrosine had significantly 
less dopamine in their striata and cerebral hemispheres than did control 
rats treated with CX-meth,yI-,l2-tyrosine. Noradrenaline in the mid brain 
vTas significantly less in witmrawn rats treated 'iTith cx-methyl-,l2-tyrosine, 
while the total amount of brain dOJamine in convulsed ,'I'i t hdrawn rats v,as 
not significantly different from t r ~ t t in control rats , noradrenaline , ~ s s
less in this group of anims.ls . Ho,,,ever, \'1i thdrawal still increased the 
degree of depletion of b o t ~ ~ catecholamines caused by B-meth,yl-,l2-tyrosine. 
Table :3 .10 
Effect of auditory stimulation on the levels of dopamine in withdrawn rats and in withdrawn rats with their 
dopamine de pleted by a - m e t h y l - ~ t y r o s i n e e
Treatment Part 
~ t . t i . i l l l
ng/gm 
Saline + auditory stimulation (4) 11175 ~ ~ 123 
\l ithdrawal + auditory 
stimulation (4) 
a a m m t h y y - - t y r r s i i e e + auditory 
stimulation (4) 
';[ i thdrawal + audi tory 
stimulation + a - m e t h y y ~ ~
t yrosine (4) 
11 600 + 87** 
5538 ~ ~ 104 
+ ** 4206 - 50** 
o f ~ ~__ the 
C e ~ ~ L h e m i ! ! E h ~ ~ ~ ~
nejgm 
771 ~ ~ 24 
681 ~ ~ 38* 
330 ~ ~ 7 
+ ** 289 - 8** 
___ .Q..1"-1l-i_n_ 
l-1id brain 
-----
ndgm 
279 ~ ~ 2 
269 ~ ~ 10 
Reading below 
blank values 
'r.ot.a.l 
d O f B m i ! ! ~ ~
ndgm 
842 :!: 7 .1 
830 ~ ~ 9.2 
574 ~ ~ 15 
Reading belOt-T 462 ~ ~ 30** 
blank va lues 
Each value is the mean ~ ~ standard error from the number of animals shown in parentheses . 
Significantly different by the t test (* P < 0 .05 ; ** ** P < 0 .025 ; ** P < 0 .001) from those of 
corresponding controls . 
-J 
.po. 
Table 3.11 
Effect of auditory stimulation on the levels of noradrenaline in withdrawn rats and in withdrawn rats with their 
noradrenaline depleted by a - m e t h y l - ~ t y r o s i n e e
Treatment 
Saline + auditory stimulation (4) 
\rl ithdrawa l + auditory stimulation (4) 
a a m e t h y y - - t y r o s i n e e + auditory 
stimulation (4) 
vlithdra\ia l + auditory stimulation + 
a - m e t h y y - - t y r o s i n e e (4) 
Bart of the brain 
Cerebrai hemispheres Mid brain 
----
ng/grn ng/grn 
306 ~ ~ 14.0 603 :!: 16 
295 + 2.5 572 + 15 
178 : 12.0 249 :!: 6 
155 + 1.0 223 :!: 10* 
Total noradrenaline 
ng/grn 
421 :!: 2.83 
385 :!: 10.0** 
204 :!: 0.7 
+ ** 183 - 4 .5** 
Bach value is the mean ~ ~ standard error from the number of animals shmm in p:u'entheses . 
Significantly different by the t test (* P < 0 . 05; 
corresponding controls. 
" 
** 
** P < 0 .01; ** P < 0 . 001) from those of 
---J 
V1 
FIGURE 3 . 15 
Effect of auditory stimulation on the levels of dopamine in withdrawn 
rats and in withdrawn rats treated with a a m e t h y y - ~ ~ ~ s i n e e
+ Each bar indicates the mean - standard error for t he number of animals 
in the text . 
(A) , (C) and (E) open columns represent control r a t s injected with 
saline and subjected to audiogenic stimulation; ha tched columns 
represent 'Il ithdrai"m rats injected with saline and killed at the time 
of convulsion during audiogenic stimulation . 
(B) arA (n) open columns represent control rats injected wi t h 
a - m e t h y y - ~ t y r o s i n e e and subjected to audiogenic stimula tion; hatched 
columns represent ,'Ii thdrawn rats injected r/i th (l-methyl-Jrtyrosine 
and subjected to audiogenic stimulation. 
Significantly dif ferent by the t test (* p < 0 .05 ; ** p < 0 . 02 ; 
** ) ** p < 0 .001 from those of the corresponding controls . 
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FIGURE 3 . 16 
Effect of auditory stimula tion on the levels of noradrenaline in .. Ii thdrawn 
rats and in wi thdrawn rats treated \iith a-methyl-]C-tyrosine 
+ Each bar indicates the mean - standard error f rom the number of animals 
in the text . 
(A) and (C) open c o o ~ s s represent control rats injected with saline 
and subjected to audiogenic stimulation ; hatched co lumns represent 
withdrawn rats injected with saline and killed a t the time of convulsion 
durin ~ ~ audiogenic stimulation . 
(B) and (D) open columns represent control rats injected ',vi th CX-methyl_ t>-
--tyrosine and subjected to audiogenic stimulation; hatched columns 
represent 1vithdra'/m rats injected ~ i i th a - m e t t y y - - ~ ~ ' J r o s i n e e and subjected. 
to audiogenic sttoulation. 
Significantly different by the t t est (* p < 0 . 05) from those of 
corresponding controls . 
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3 ,9 Surrmary of results presented in c ~ ~ D t t r r 3 
Results of the experiments described in this chapter are summarised in 
table ) , 12 for dopamine and table 3 , 13 for noradrenaline . Habituation 
to phenobarbitone had no effect on the total brain content of either 
dopamine or noradrenaline . On the other hand, habitua tion incr eased 
the dopamine content of the striata and the mid brain and decreased 
that of the cerebral hemispheres leaving the total amount of dopamine 
unchanged , 
; ' l i t h d r a ~ i a l l of phenobarbitone decreased the content of both cate-
cholamines in the brains of rats which had been habituated to the drug , 
These changes occurred in the striata for dopamine and i ~ ~ the cerebral 
hemispheres for dopamine and noradrenaline . \ofi thdra\m rat s , hOvTever , 
still showed higher dopamine values in the mid brain t han did untrea ted 
rats . 
Habituation to phenobarbitone resisted the depletion of dopanine and 
noradrenaline otherNise caused by a - - e e h y y - ~ t y r o s i n e , , in the striata f or 
dopamine and in the cerebral hemispheres for both catecholamines. 
Withdrawal of phenobarbitone increased the de pletion of both do pa-
mine and noradrenaline in vThole brain which took place in the stria t n. and 
cerebral hemispheres for dopamine and in the cerebra l hemis pheres and 
the mid brain for noradrenaline . 
When rats withdrawn from phenobarbitone were subjected to auditory 
stimulation and killed at the time of convulsions , \ie found t ha t their 
brains had the same amount of dopamine as did untreated rats ; hmlever, 
they shOlofed significantly higher amounts of dopa:nine than did Hi thdra',m 
rats which had not been stressed by sound stimula tion . The amount of 
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noradrenaline was smaller in this group of rats than in the cont rol group, 
but was significantly greater than in withdrawn rats which had not been 
stressed by sound stimulation. 
Pretreatment 'ili th a-methyl-]2-tyrosine prevented audiogenic convulsion 
in the majority of withdrawn rats. This group of animals sho\'/ed less 
dopamine in the striata and the cerebral hemispheres and less noradrenaline 
in the mid brain when compared with the corresponding controls. 
However, the total amount of the depleted dopamine and noradrenaline 
in withdrawn rats stressed by audiogenic stimulation was slightly higher 
than in withdrawn rats with depleted catecholamines which had not been 
stressed by audiogenic stimulation . 
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Table 3 •. 12 
Summary of dopamine results 
Treatment 
Control 
habituation 
withdrawal 
Striata Cerebral 
h e m i s p h e r ~ ~
ng/gm 
11647 ! 169 693! 9.7 
+ . + ** 12245 - 259* 593 - 21.0** 
+ ** + ** 9714 - 49** 573 - 19.0** 
Control + a-methyl-
~ t y r o s i n e e 5174 ! 228 395! 25 
habituation + 
cx-methyl-J?:-
tyrosine 
wi thdrawal + 
C X - m e t h y l - ~ ~
tyrosine 
Audiogenic 
stimulation 
+ saline 
+ withdrawal 
5938 ! 241* 541 ~ ~ 13:: 
11175 ! 123 771 : 24 
11600 ~ ~ 87** 681 ! 38* 
+ control + a-methyl- . 
,lC-tyrosine 5538 ~ ~ 104 330 ~ ~ 7 
+ withdrawal + + ** + ** 
a - m e t h y l - ~ t y r o s i n e e 4206 - 50** 289 - 8** 
Mid brain Total 
dOp:!.mine 
ng/gm 
+ + 207 - 1.96 882 - 33 .4 
+ ** + 239 - 8.0** 909 - 40.0 
+ ** + ** 231 - 4.0** 709 - 30** 
blank 
279 : 2 
269 ~ ~ 10 
{
ReadingS} 
below 
blank 
584 + 7 
+ ** 792 - 30** 
+ ** 390 - 15** 
842 : 7.1 
+ 630 - 9.2 
574 ! 15 
462 ! 30** 
+ Each value is the mean - standari error from the number of animals 
shown in the text. 
Significantly different by t he t test (* p < 0.05; ** p < 0.025; 
* ** 
**p < C.C05 ; ** P < 0.001) from the corresponding control . 
* 
** 
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Table 3.13 
Summary of noradrenaline results 
Treatment 
Untreated 
habituated 
withdrawn 
Control + a-methyl-
Jttyrosine 
habituation + 
a-me thy 1-]2-
tyrosine 
withdrawal + 
a-methyl-]2-
tyrosine 
Audiogenic 
stimulation 
+ saline 
+ withdrawal 
Cerebral 
h e ~ s p h e r e ~ ~
ng/gm 
325 :!: 16.0 
330 :: 17.0 
+ ** 205 - 4.0** 
+ 164 - 6.0 
+ ** 226 - 10.0** 
+ ** 121 - 5.0'** 
+ 306 14.0 
295 :!: 2.5 
+ control + a-methyl-l t ~ ! r o s i n e e 178 : 12.0 
+ wi thdrawal + 
+ 
a-metlwl-,:2-tyrosine 155 - 1.0 
Mid brain 
+ 620 - 40.0 
+ 650 - 41 .6 
624 :!: 16.0 
284 :: 24 .0 
+ 304 - 15.0 
225 :!: 6.0* 
603 :: 16.0 
572 :!: 15.0 
249 :!: 6.0 
223 :!: 10* 
Total 
noradrenaline 
ng/gm 
415 :!: 5.6 
437 :: 16.5 
+ ** 352 - 9.5*"* 
2(J"{ :!: 5 
+ ** 254 - 15** * 
+ * 1 59 - 1 O * * ~ - + + .... 
421 + - 2.83 
385 ! 10 .0** 
+ 204 - 7.0 
+ 183 -
+ Each value is the mean - standard error from the number of animals 
sho\m in :the text. 
* Significantly different by the t test (*p < 0 .05 ; ** P < 0 .02 ; ** p < 0.005 ; 
** ** p < 0.001) from corresponding controls. 
* 
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CHAmR 4 
BRAIN CATECHOLAHlNES AFTER . LONG-TE Iv! TREATr'lENT (HTH PH.c;NYTOIN! 
CARBAMAZEPINE AND SODIUM BROMIDE 
Bromides were the first antiepileptic d r u g ~ , b e i i g g introduced in 
1857 by Locock. Because of their low ratio of the therapeutically 
effective dose to tOxicity, their use was gradually abandoned when better 
drugs such as phenobarbitone (discovered in 1912) and phenytoin (in 1938) 
became available. 
Carbamazepine is one of the most recent drugs for trea t ment of 
epilepsy. Blom · in 1962 discovered that oarbamazepine i s of use in 
the treatment of trigeminal neuralgia and it has been applied to the 
treatment of diabetes insipidus. 
~ e e have seen in chapter 2 that single doses of phenytoin, sodium 
bromide and carbamazepine had no effect on total brain levels of either 
dOP3JIline or noradrenaline. On the other hand, when \'1e looked at the 
effect of these drugs on the regional distribution of the catecholamines . 
we found that phenytoin increased the amount of dopamine in the striata 
and that of noradrenaline in the mid brain. HO'tTever, carbarnazepine 
increased only noradrenaline content in the cerebral hemispheres and it 
had no effect on the dopamine content in any of t he brain regions studied . 
The fact that most antiepileptic drugs are used over a long period 
of time for continuous control of seizures in epileptic patients led us 
to investigate the effect of long term treatment with these drugs on the 
levels of catecholamines in rat brain . 
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4.1 !>1ethods of admini etra ti on 
Female Ash ~ V i s t a r r r ats "reighing approximately 160 gInS ,vere obtained f rom 
our usual source . They were housed in individual cages where they 'vere 
allowed free access to food and water for one week before the beginning 
of the experiment . During this 'fleek their food and water intakes were 
monitored daily and their body weights were t aken every three days . 
Carbamazepine is soluble in proP,ylene glycol after ooderate heating. 
phenytoi n can be sus :t:ended in saline vri th the aid of 1,0 Tlveen 80. and 
sodium bromide is soluble in normal saline . 
The animals "rere divided into three group:!. each of ,V'hich received 
one of the three drugs tvTice daily by the i n t t a a r i t o o e e l l route . The 
first injection was given at 10.00 hours and the other injection was 
given at 18 .00 hours . 
Phenytoin was injected in saline containing 1% Tween 80 in a volume 
not exceeding 2 .5ml/ kg body "leight , a t a dose level of 25 mg/kg for the 
first week of treatment . The dose was raised to 50 mg/kg twice daily 
during the second week of treatment and finally to 75 mg/kg during the 
third and final week of treatment. Control rats received the same vol-
ume of saline containing 1% TI'leen 80 . 
Carbamazepine was injected in proP,ylene glycol in a volume not 
exceeding 1 ml/kg body weight at a dose level of 20 mg/kg tlnce daily 
for the first ten days of administration . The dose was then incr eased to 
40 mg/kg for the next eleven days . Control r a ts r eceived the corres-
ponding volume of proP,ylene glycol. 
Sodium bromide 'vas injected in a volume of saline not exceeding 
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2.5 ml/kg body weight , at a dose level of 100 mg/kg brice daily for the 
first week of treatment. It was then increased to 250 ~ g / k g g during 
the second week of treatment and finally to 500 mg/kg during the thir d 
week. The corresponding controls r eceived the same volume of saline 
twice a day. 
All drug solutions for injection were prepared daily_ The food 
and water intakes were monitored daily and body weight s were taken 
every three days. 
All the measurements for food and i-ra ter intakes and body \ieight s 
were taken at the same time of the day (between 10 . 00 and 11.00 hours ) , 
during the whole period of treatment. 
4.2 Behavioural studies durine the long term treatment wit h anticonvul-
sant drugs 
! t ~ ! ~ i n n
The first doses of phenytoin' (25 mg/kg tvlice daily) produced a slight 
ataxia fifteen minutes after injection which disappeared completely about 
two hours later. Rats looked normal after the disappear ance of ataxia 
and were as active as control rats treated \d th sa line solution. They 
did not gain weight during the first i .... eek of treatment as did the control 
group, in fact there was a slight but nonsignificant loss in body ,,[e i ght. 
There was a fluctuation in the food i nt ake which fell during t he first 
two days of treatment, recovered for the next two days and t hen fell again . 
Water intakes did not change much during the first week of trea tment . 
When the dose was increased to 50 mg/kg ~ i i c e e daily at the beginning 
of the second iieek of treatment, phenytoin treated rats s tarted to show 
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slight ataxia after injection which persisted till the next injection. 
Moreover, their gait nov, showed obvious differences f rom t hat of control 
rats with loss of muscle tone. In association Ivi th the loss of tone. 
the animal grip strength was 'l,eakened. They were not a s active as 
control rats and showed hair discoloration, indicating that the r a ts 
were not cleaning themselves. They urinated a lot and we had sometimes 
to clean their cages daily , a process which was normally done only twice 
a week. 
The animals' food intakes dropped immediately after increasing the 
dose and started to recover after the second day of trea tment at this 
dose level. i'iater intakes Ivere increased by a considerable amount. 
Just before the end of treatment at this dose level, r at s injected 
with phenytoin started to tolerate the dose; they regained a normal 
gait, became more active and lost most of their ataxia about three hours 
after injection . leaving just a little weakness of the limb muscle s 
which could be assessed by pushing the limbs of the rat against the 
f:8,lm of the hand. In all other respect the rats appeared perfectly 
normal . In spite of the increase in food and water intakes . their 
b ~ d y y weights did not change noticeably . 
On increasing the dose of phenytoin up to 75 mg/kg twice a day at 
the end of the second week of treatment, ataxia became more pronounced 
than it was with 50 mg/kg , rats remained ataxic all the time, lost their 
grip strength completely. looked very sedated and their muscle tone \'1as 
very poor . The ra ts spent most of their time sleeping in a corner of 
their cages. They urinated a lot, their fur took on a yello\'! co l our 
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and they drank much more water than previously. 
and started to recover four days later. 
Their food intake dropped 
At the end of the third week of treatment, r a ts injected with pheny-
toin started to recover slightly, but they were still a t axic most of the 
time and were clearly less active than control rats. 
the end of the treatment. 
This persisted till 
Figures 4.1 , 4.2 and 4 ~ ~3 shOlv the changes in food and wa ter intake s 
and body weights during the course of long term treatment with different 
doses of phenytoin. 
C a r ~ ~ E i n e e
The first doses of carbamazepine (20 mg/kg twice daily) produced slight 
ataxia which started. to disappear two hours after the injection. The 
food intake of rats treated ,nth carbamazepine decreased after the f irst 
day of treatment. This was accompanied by a decrease in the body weight. 
Water intake increased during this time. Near the end of treatment at 
this dose level (20 mg/kg twice daily) rats on treatment with carbamazepine 
started to eat more and gained more weight, and the ataxia after injection 
became less apparent, indicating t hat r a ts tolerated the dose very well . 
When the dose of carbamazepine was increased to 40 mg/kg ~ w i c e e
daily · on the eleventh day of treatment, ataxia became pronounced and 
after the third dose at this dose level, it pe . sisted till the next in-
jection. Righting reflexes were lost about fifteen minutes after 
injection and were gained around three hours later. The muscle tone 
was l ~ v , , and the rats moved with difficulty , cr awling around their cages 
with extended hind limbs . Rats on carbamazepine continued t o gain 
weight, there was a transient decrease in food intake whi ch recovered 
after two days. The water intake was increased much more and the r at s 
FIGURE 4 . 1 
Changes in food intakes during long term treatment with different 
doses of phenytoin 
+ Each bar indicates mean - standard error for the number of animals 
inside the column . 
Open columns represent rats treated ",lith phenytoin an he. tched columns 
represent rats trea ted iii th saline containing 1 % T\.,..een 80 . 
* Significantly different by the t test (*p < 0 .05; **p < 0. 02; **p < 0 .005 and 
** **P < 0 .001) from t hose of controls treated "lith saline only . 
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FIGURE 4.2 
Changes in '{later intakes during lona term trea tment TITi th different 
doses of phenytoin 
+ Each bar indicates mean - standard error for the number of animals 
inside the column . 
Op:m columns re present rats treated \'li th phenytoin and hatched columns 
re present ra ts treated 'tTith saline containing 1% T:'reen 80 • 
.. * Significantly different by the t ·t est ( .... p < 0 . 001) from those of 
control r ats treated with saline only . 
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FlGORS 4.3 
Changes in body Iveights during long term treatment 'tli th 
different doses of phenytoin 
+ Each bar indica tes mean - standard error fo r the number of animals 
inside t he column . 
Open coluzms represent rats treated ",ith phenytoin a ~ d d hatched columns 
represent r a t s trea ted \'lith saline containing 1fc, T\'l een 80 . 
Significantly different by the t test ( * p < 0 .05 ; ** p < 0 .002 ; 
* ** ) ** p < 0 .005 and. ** P < 0 .001 from those of c'ont rol rats t r eated 
"ri t h saline only . 
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started to urinate a lot, their fur taking on a yelloyT tinge . Rat s 
remained less active and ataxic , although they showed slight improvecent 
near the end of the third week of administration . 
Figures 4 .. 4, 4 .5 and 4.6 show the changes in food and water intakes 
and body weights during the course of long term treatment Hi th different 
doses of -carbamaz e pine • 
Sodium bromide 
The first hTO dose levels of sodium bromide (100 ~ g g and 250 mg/kg twice 
daily) did not produce noticeable behavioural changes , exce pt for s ome 
aggressiveness ''lhich l'las noticed at the beginning of the second week of 
administration and disappeared when the dose was rai sed up to 500 mg/kg 
tldce daily . Ra ts treated with sodium bromide gained more rreight during 
the first ~ i O O weeks of treatment than did control rats injected with 
saline. This faster gain in weight 'fas retarded a fter the dose of 
sodium bromide was increased to 500 mg/kg hTice daily, so that at the 
end of the third \-Teek of administration, sodium bromide treated rat s 
weighed exactly the same as did control rats injected loTi th saline . The 
third dose level of sodium bromide made the rats less active than control 
rats injected with saline. The muscle tone l'las very weak near the end of 
the third week of administration , and showed slight paralysis of the limbs 
ifhere the grip strength was lost and there was a sign of piloerection . 
During the whole p3riod of administration , rats on s odium brOmide 
treatment drank the same volumes of '-Tater as did control rats injected 
wi th saline. 
Figures 4 .7 and 4 .8 show the changes in body wei ghts and loJ'ater 
intakes during the long term treatment with different doses of sodium 
bromide. 
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FIGURZ 4 .4 
Changes i n food intakes d d r i ~ ~ long t erm treatment 
l'li th different doses of carbamaze pir.e 
+ Each bar indicates oean - standard error for the number of a n n ~ l s s
ins ide the column . 
Open columns represent rats t t e ~ t e d d with carbamaze ine and hat ched 
columns represent control r a t s trea ted '"i t h proV.flene glycol. 
* Significantly differ ent by the t test (* p < 0 .05 ; ** < 0 .005 
** and ** P < 0 .001) from those of control r a t s treated 1tlith propylene 
glycol . 
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FIGURE 4.5 
Changes in vlater intake s during long term trea tment "(lith 
different doses of carbamazepine 
+ Each bar indicates mean - standard error for the number of animals 
inside the column. 
Open columns represent rats treated with carbarraz epine and hatched 
columns represent control rats treated ,'Ii th proPJlene glycol. 
Significantly different by t he t test (** p < 0 . 02 ; !* p < 0 .005; 
** ** p < 0 .001) from those of control rats treated Hi th propylene 
glycol only. 
36 
34 ... 
32 
-
30 
28 -
-
-
E 26 
-~ ~
oX 
c 
.5 
~ ~
*-
'- 24 ~ ~
... 
c 
~ ~
" ... 
8 
~ ~
tJ) 22 E 
~ ~
> 
« 
20 ~ . . ~ ~
~ ~
18 l- e 
16 
4 ~ ~J ~ ~ [ ~ ~ ~ ~ 1:.-: 8 ~ ~ ~ ~
~ ~ ~ ~~ ~ ~ ~ ~ ~~ ~ ~ ~~ ~ ~ ~ ~ ~ ~ ~/' / 
t 14 
20mg/kg twice daily 
o 2 4 6 
** 
** 
I"' 
Is 
** 
** 
.-
-It 
** ** 
** 
~ ~
** 
8 8 ] 
~ ~
~ ~ ~ ~4 
U' /. 1% .t ;::: ~ ~~ ~ 4 ~ ~~ ~ /' ~ ~ ~ ~ ~ ~~ ~ ~ ~8;:. :;- / 
t 
40 mg/kg twice daily 
, 
8 10 
Days 
12 
, 
14 16 
** 
** 
8 
.. 
~ ~
, 
18 
** 
** 
Is 
[ 
4 
~ ~~ ~~ ~1/ 
20 
FIGURE 4 .6 
Changes in body weights during long term treatment wi t h 
different doses of car bamazepine 
+ Each bar indicates mean - standard error for the number of animals 
inside the column. 
Open columns represent rat s treated with carbamazepine and hatched 
columns r epresent c o n t r ~ l l rats treated with p r o p ~ l e n e e glycol . 
Significantly d i f ~ e r e n t t by the t test (* P < 0 . 05 and ** P < 0 . 02) 
fr om t hose of control rats treated with propylene glycol . 
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Changes in water intakes during long term treatment 
with different doses of sodium bromide 
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FIGURE 4.8 
Changes in body weights during long term treatment 
with different doses of sodium bromide 
+ ~ a c h h bar indicates mean - standard error for the number of animals 
inside the column . 
Open columns represent rats treated with sodium brooide and hatched 
columns represent control rats treated with saline . 
* Significantly different by the t test (** P < 0 .005) from those of 
control rats treated with saline . 
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4 .3 Effect of r r P 9 9 t e d d administration of carbamazepine . ohenytoin and 
sodium bromide on \"hole brain levels of catecholamines 
lie have seen in chapter 2 of this thesis that single doses of phenytoin , 
carbamazepine and sodium bromide had no effect on t he flhole brain l evels 
of either dopamine or noradrenaline thirty minutes a nd sixty minutes 
after the injection . 
In another experiment i'Te tried to investigate the effect of re ~ e a a ted 
administration of the same doses of the anticonvulsant drugs for one ·.· ..eek 
on the levels of catecholamines i n r at brain . Phenytoin, carbamaze pine 
and sodium brol!1ide ~ l l r e e given by intra.:reri tonea l injection to differ ent 
groups of rat s twice a day for one vleek at a dose level of 75 mg/kg , 
50 mg/kg and 1 gm/kg respectively. The corresponding controls r ecei ved 
the same volumes of the appropriate v.ehicle . 
The animals wer e killed thirty minutes after t he l ast injection , 
their brains were quickly removed and assayed for their dopamine and 
noradrenaline contents by the method described in chapter 1 • 
The results in Table 4.1 shoN that none of the anticonvulsant drugs 
tested had any effect on the whole brain l evels of either dopamine or 
noradrenaline. 
4.4 Effect of long term administration of phenytOin . carbamaze ' ne and 
sOdityn bromide on the regional di stribution of brain ca t echolamines 
';lhole brain levels of dopamine and noradrenaline did not change af ter one 
week i s treatment Hi th phenytOin , carbamazepine and sodium bromide . Be-
cause a one week period of administr ation might ~ o t t have been enough to 
demonstrate the effect of long term treatment T.·lith t hese drugs on catechol-
amine levels, vTe decided to extend the :reriod of trea tment to three '.
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Table 4.1 
Effect of the repeated administration of anticonvulsant 
drugs for one week on the levels of dopamine and noradrenaline in rat brain 
D r u ~ ~ D0I!mine Noradrenaline 
--------
ng/gm ng/gm 
Vehicle 865 ~ ~ 30 (12 ) + 394 - 20 ( 12 ) 
1b.enytoin 906 ~ ~ 20 (4) 390 ~ ~ 20 (4) 
Sodium bromide 842 ~ ~ 35 (4) + 353 - 15 (4) 
Car bamaz e pine 864 ~ ~ 50 (4 ) + 403 - 5 (4) 
+ Each value is the mean - standard error from the number of animals 
shown in parentheses. 
in order to allow enough time for the anticonvulsant drugs to bring about 
any changes they possibly effect. Female Ash vistar r a t s weighing between 
150 and 160 gms were obtained one week before starting the experiment . 
They 'Ilere housed in individual cages where they were allm'led free access 
to food and water. Seven days later, the animals were divided into 
several groups, and each group was treated with one of the anticonvulsant 
drugs or its appropriate vehicle by the same schedule described in 
section 1 of this chapter. 
At the end of the third week of treatment with these anticonvulsant 
drugs, the animals \-lere killed by cervical dislocation and decapitation 
half an hour after the last injection. Their brains were quickly removed . 
placed on ' ice cooled glass plate and dissected by the method desdribed in 
chapter 2, section 9. Each rart t,las homogenized as soon as it had been 
isola ted and wei ghed. It was then assayed for its dopamine and noradrena-
line c o ~ t e n t t by the method described in chapter 1. 
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Table 4.2 
Effect of long term administration of anticonvulsant 
drugs on the regional distribution of dopamine 
D r u ~ ~ Striata C e r ~ ~ £ ~ ~ h e ~ ~ E h e £ ~ ~ ~ Hid brain 
---
-----
ng/gm ng/gm ng/gm 
Propylene glycol 11980 ! 28C) (6 ) 700 :: 17 (6 ) 159 ! 20 (6 ) 
Car bamaz e pine 14394 :: 360 (6 ) 937 ! 23 (6) 160 ! 12 (6 ) 
p < 0 . 001 < 0.001 N.S. 
Saline + 1% 
11680 :: 396 747 ! 11 Tween 80 (6) (6 ) + 161 - 6 (6 ) 
Phenytoin "13690 ! 298 (6) 695 :! 16 (6 ) 300 ! 8 (6 ) 
p < 0.001 < 0.02 < 0.001 
Saline 11721 ! 337 (6 ) 741 ! 29 (6 ) + 166 - 7 (6 ) 
11933 :t 300 (6 ) 796 :: 13 (6) + (6 ) " Sodium bromide 191 - 5 
p N.S. N. S. < 0 . 02 
+ Each value is the mean - standard" error from the number of animals shown 
in Jerentheses . 
The figures were obtained in ~ i O O different experiments . 
Results are presented in tables 4.2 and 4 .3 and figures 4.9 and 4 .10. 
The long term treatment with phenytoin increased the concentration of 
dopamine in the striata and mid brain and decreased it in the cerebral 
hemispheres, while carbamazepine increased the ' concentrati on of dopamine 
in the striata and cerebral hemispheres , sodium bromide increased it only 
in the mid brain, it had no effect on the levels of dopamine in other 
regions studied . 
The long" term administration of phenytoin and carbamazepine increased 
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Table 4.3 
Effect of long term administration of anticonvulsant 
drugs on the regional distribution of noradrenaline 
12.!ug Pons and medulla Cerebellum Cerebral 11id br ain 
------ ------ h 9 ~ s p h e ! : : ~ ~ ------
ng/gm .ng/gm ng/gm ng/gm 
Propylene glycol 604 ! 28 (6 ) 228 : 16(6) 309 : 6 (6) 752 : 20 (6 ) 
Car bamaz e pine 634 : 20 (6 ) 255 ~ ~ 20(6) 370 : 8 (6 ) 816 : 23 (8) 
P N.S. N.S. < 0.001 < 0.05 
Saline + TI'leen 80 616 ! 14 (6 ) 236 ! 16(6 ) 313 : 7 (6 ) 764 :!: 18 (6 ) 
Phenytoin 678 ! 18 (6) + 249 - 6(6) 362 :!: 10(6 ) 1058 : 23 (6 ) 
P < 0.02 N.S. < 0.001 < 0.001 
Saline 623 : 14 (6 ) 231 :!: 27(6) 311 :!: 17(6 ) 760 : 27 (6 ) 
Sodium bromide 617 ! 17 (6) 240 ! 18(6) 322 :!: 17(6) 771 : 32 (6 ) 
p N.S. N.S. N.S. N.S. 
+ Each value is the mean - standard error from the number of animals shown 
in :r:arenthe.ses. 
The figures were obtained in two different experiments . 
the levels of noradrenaline i n the cerebral hemispheres and the mid brain . 
Phenytoin also increased the levels of noradrenaline in t he pons and 
medulla. Sodium bromide had no eff ect on the levels of noradr enaline 
in any of tHe parts studied. 
4.5 Effect of long term administra tion of nhenytoin and carbamazepine on 
the turnover rates of catecholamines in discrete brain areas 
Results in section 4.4 show that the long t erm administra tion of either 
phenytoin or carbamazepine increased the level s of noradrenaline in the 
FIGmE 4.9 
Effect of long term administra tion of anticonvulsant 
drugs on the regional distribution of dOpamine 
Each bar indicates the mean ! standara error from t he number of · animals 
shOlm i n the text . 
(A) Open columns represent control rats trea ted with proRrlene gl ycol , 
hatched columns re present r ats trea ted ~ i i h h carbamazepine . 
(E ) Open columns represent control rats treated ,'lith saline containing 
1 ~ ~ ~ d e e n n 80 . hatched columns r epresent r ats treated ~ i t h h phenytoin. 
(c ) Open columns r epresent control rat s treated vri th saline . hatched 
columns r epresent rats treated wi th sodium bromide . 
** Signi ficant l y different by the t test ( ~ ~ ~ P < 0 .02 ; ** P < 0 .001 ) from 
those of corresponding controls . 
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FIGURE 4 . 10 
Effect of long term administration of anticonvulsant 
drugs on the regional distribution of noradrenaline 
+ Each bar indicates the mean - standard error from the number of am.IIJals 
shmm i n the text. 
(A) Op:!n columns represent control rats treated i · T i i h h proP'.f lene glycol 
• 
hatched columns r epresent r ats treated :li th carbamazepine . 
(B) Op:!n columns represent control rat s treated ~ i t h h saline c o n t a i n i ~ ~
1 % Tv,een 80 . hatched columns r e presen ra t s trea ted l-1i b phenytoin . 
(c) OFBn columns represent control rat s treated '"i th saline . hatched 
columns r epre sent rats treated 'N.lth sodium bromide . 
Si gnificantly different by the t test ( ~ ~ P < 0 . 05 ; ** p < 0 . 02 ; 
** ** P < 0 . 001) from those of c o r r e e p o n d i ~ ~ controls . 
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cerebral hemis pheres and the mid brain , phenytoin increased. as \'lell the 
levels of noradrenaline in pons and medulla . 'ilhile phenytoin inc!'eased 
the levels of dopamine in the stria ta and mid brain and decreased it in 
the cerebral hemispheres , carbamazepine produced an increase in dopamine 
levels in both striata and cerebr a l hemispheres . 
These results led us to investigate t he eff ect of long term admin-
istra tion vTi th these drugs on the turnover r ates of the ca t e c c o l l r . d n e s s in 
discrete brain areas . 
The design of this experiment is the same as tha t described in 
section 4 .4 . except that c x - m e t h y l - ~ t y r o s i n e e (1 00 mg/ kg) ':TaS in ject ed 
three hours before death and the animals were killed thirty minutes 
after the last injection of the anticonvulsant drugs . 
Results are presented in tables 4 .4 and 4.5 and figure 4 . 11 . 
They shovT that phenytOin and carbamazepine de .creased the depletion of 
dopamine in striata and cerebral hemispheres at a high degree of Sig-
nificance (p < 0 .001) and vThile phenytoin resist ed the depletion of 
noradrenaline Ln the mid brain , carbamazepine decreased the depletion 
of noradrenaline in the cerebral hemispheres . 
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Table 4 .4 
~ f f e c t t of long term administration of phenytoin a nd 
carbamazepine on the turnover r a te of dopamine 
Striata C e ~ £ ~ ~ ~ : . . s p ~ ~ : : ~ ~
---
Saline 
a - M e t h y l - ~ t y r o s i n e e
% change 
a - I 1 e t h y l - ~ t y r o s i n e e + 
phenytoin 
% change 
P (t test) 
a - ~ l e t h y l - ~ t y r o s i n e e + 
car bamaz e pine 
% change 
P (t test) 
ng/gm 
11980 + 270 -
+ 177 4018 -
- 66.46 
9687 + 632 
-
- 19.14 
( 0.001 
+ 8060 - 489 
- 32 .72 
< 0 .001 
ngjgm 
(4) 700 + 23 (4 ) -
(6) 238 + 16 (6 ) -
- 66 .00 
(6 ) 499 + - 20 (6 ) 
- 28 .71 
( ' 0 .001 
(6 ) + (6 ) 450 - 20 
- 35 . 71 
< 0 .001 
, + Each value ~ s s the mean - standard error f rom t he number of animals shmffi 
in IRrentheses . 
The figures ''lere obtained in two different exp:!riments . 
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Table 4. 5 
Ef fe ct of long term administrat ion of phenyt oin and 
carbamazepine on the turnover rate of noradrenaline 
Saline 
a-r1ethyl-.;Q-tyrosine 
% change 
a-Methyl-.;Q-tyrosine + 
phenytoin 
% change 
P (t test) 
a - H e t h y l - ~ t y r o s i n e e + 
carbamaze pine 
% change 
P (t test ) 
C e : : ~ ~ ~ m i i p h ~ ; : ~ ~
ng/gm 
315 ! 10 (4) 
+ (6 ) 150 - 8 
- 52 .38 
+ 8 (6) 169 
-
- 46 .30 
< 0.1 
202 :: 12 (6) 
- 35 .87 
< 0.005 
Hid brain 
------
ng/gm 
772 + 23 (4) -
+ 20 (6 ) 275 -
- 64 .37 
+ (6 ) 522 
-
8 
- 32 . 38 
< 0.001 
301 + - 8 (6) 
- 61 .01 
N.S. 
Each value is the mean :: standard error from the number of animals shOvTn 
in pu-entheses . 
The figures were obtained in two different experiments. 
FIGURE 4 .11 
Effect of long term administration of phenytoin and carbamazePine 
on the turnover rate of dopamine (A ) a nd noradrenaline (B) 
+ Each bar indicates the mean - standard error from the number of animals 
shovm in the text. 
Op3n columns r epresent control r ats t reated -,vi th a - m e t h h l - - t y y o s i n n . .
hatched c o l ~ s s re present r ats treated with phenytoin and a - m e t ~ ~ l - ~ ~
tyrosine, dotted columns represent rats treated ~ ' l i t h h carbamazepine and 
a - m e t h y y - - t y r o s i n n . .
* ** Significantly different by the t test (** p < 0 .005 ; ** p < 0. 001) 
from those of control rats injected with a - m e t h y y ~ t y y o s i n n . .
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PA RT II 
CHAPl'ER 5 
I>1EASUREHENT OF RAT BRAIN 5- HYDROXYTRY P1\ ~ I T N E E AND 5- HYDaOXYINDOL:: 
ACETIC ACID 
The method used for the assay of serotonin was that described by 
Snyder , Axelrod and Zweig (1 965 ) with s light modifications . The method 
involved the extraction of serotonin into 1-butanol from a salt saturated 
solution at pH 10 . The amine "las then returned to an aqueous solution 
(pH 7) by the addition of n-he ptane and reacted with n i n ~ y d r i n n by heating 
to yield a fluore s cent product. 
5-Hydroxyindoleacetic acid was assayed by the methcxi of Giacolone 
and Valzelli (1966), with slight modifications . The method involved the 
extraction of the indole into butylacetate from a salt saturated solution . 
The organic phase was ''lashed with salt saturated dilute acid , and the indole 
was re-extracted into phosphate buffer . ..The native fluorescence \'1as 
measured in strong acid solution . 
In ex periments i nvolving the measurement of both the amine and its 
metabolite , brains from two r ats were used . They I-lere divided into ti.;o 
halves and each half of one brain Has pooled ,d t h the opposite half of the 
other brain. Each of the pooled halves "las used for t he assay of either 
5- hydroxytr,y ptamine or 5-hydroxyindoleacetic a cid . 
5.1 Determination of 5-hydroxytryptamine 
~ l ( i l l__ F ! ~ ~ ~ i o ~ ~ t i s ~ ~ _ ~ ~ ! ! ~ ~ ! ~ ~
Rats "Tere killed by cervical dislocation and decapitation . Their brn.ins 
were quickly removed , freed from superficial blood clots , weighed and homo-
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genized in 10 ml ice-cold 0.4 N Ferchloric acid for five minutes usi ng an 
MSE top drive homogenizer . The homogenates were then centrifuged a t 
2500 r pm for ten minutes. The supernatant solutions together wi th standard 
solutions were processed in identical ways. 
Seven mill iIi tres of the supernatant solution ,"lere transferred to a plastic 
beaker and the pH of the solution was adjusted to 10 wi t h 5 N and N sodi um 
hydroxide. The solution was transferred to a 50 ml gl ass sto pper ed centri-
fuge tube containing 0.5 ml of 0 . 5 M borate buffer (pH 10) , 15 ml of n-butanol 
and approximately 1.5 g of sodium chloride. The mixture was t hen shaken 
mechanically for ten minutes, centrifuged at 2000 rpm for another ten min-
utes and the lOHer aqueous phase as pirated off and discarded. 
The organic phase was then shaken for three minutes vii th 2 ml of salt 
saturated borate buffer (adjusted to pH 10 before use). After centrifu-
gation at 2000 rpm, t t ~ ~ millilitres of the organic phase were transferred 
to another glass stoppered c e n t r i ~ u g e e tube containing 3 ml of 0 .05 M 
phosphate buffer (pH 7) and 15 ml n-heptane. After shaking for fifteen 
minutes, the tube was centrifuged at 2000 rpm and t he organiC phase was 
carefully aspirated off and discarded. 
5. 1(iii) Fluorophore formation 
------------------
Two millilitres of the buffer solution were transferre d to a test tube , 
and 0.3 ml of 0 .1 M ninhydrin solution were added . The mixture i·ras mixed 
on a vortex mixer and the test tube lola s then sealed vTi t h a gl ass marble 
and in cuba ted i n a iola ter bath for thirty minutes at 750 C. One hour 
after hea hng , t he solution \'las transferred to a quartz cuvet te and t he 
fluore scence measured at 490 m ~ ~ after activation a t 385 m ~ , , usi ng a 
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Farrand spectrophotofluorimeter. 
The reagent blank was obtained by carrying 7 ml of 0 .4 N perchloric 
acid solution through the whole procedure. 
A calibration curve was constructed by carrying solutions of standard 
5-hydroxytryptamine in 0 .4 N perchloric acid through the whole procedure 
side by side v1i th the tissue extract. Examples of such curves are given 
in Figure 5.1 and show the high degree of reproducibility of the method . 
The composition of various buffers and reagents is given in the 
formulary (Appendix I ) . 
5 . 1 1 ~ ~ 2 - _ ~ ~ ~ ~ ~ ~ _ ~ ~ ~ ! ~ ~ d a ~ _ 2 : ~ ~ d E o X l ! £ l E ! ~ ~ n ~ a d d e ~ _ ! ~ ~ ! ~ ! ~ ~
! ! ~ ~ ~ ~ ~ ~ ~ ~
The reliability of the method was examined by determining the r ecovery of 
standard 5-hydroxytryptamine added to aliquots of pooled brain extr act. 
The pooled supernatant solution of t he brain extract from t en rats 
was divided into ten equal portions, To six portions, various concentra-
tions of standard 5-hydroxytryptamine ~ ~.. ,ere added and the mixtures vlere 
assayed for 5-hydroxytryptamine by the method described before . The 
recovery of standard 5-hydroxytryptamine added to pooled brain homo enates 
is given in Table 5.1 
5.2 Determination of 5-hydroxyindoleacetic acid 
5 .21i) P r ~ ~ ~ ~ ~ _ ~ ! i s ~ ~ _ ~ : ! ! ~ c t ~ ~
Rats were killed by cervical disloca tion and decapitation . their brai ns 
were quickly removed, freed from superficia l blood clots and homoDenized 
in 5 ml ice-cold 0 .1 N hydrochloric aci d containing 0.5% ascorbi c aci d . 
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Table 5 .1 
Recoveries of 5-hydroxytryptamine added to pooled brain homo6 enates 
AmoWlt added Amount r ecovered ~ ~ ~ ; : ~ r y y
- .--.--- ----------
~ ~ ~ ~ of /0 
0 .2 0 .1 4 70 
0.2 0.16 80 
0.3 0.23 77 
0.3 0. 24 80 
0.4 0.36 go 
0 .4 0.34 85 
Hean recovery 8.0.3 % 
Another two millili tres of the acid were used to {'lash the homogenization 
tube and the "rashing was added to the rest of the homogenate. The homo-
genate was then deproteinized with one millilitre of 10% zinc sulphate 
solution and 0 .6 ml of N sodiUm hydroxide. The solutions I'rere mixed 
vigorously, using a vortex mixer, and centrifuged at 16000 rpm for half 
an hour. After centrifugation, the clear supernatant solution I'ras 
filtered through a thick filter bed made from fine glass wool fibres. 
The filtration was aided by using air suction. 
Although the original method centrifuged the brain homogenate at 
4000 rpm for only five minutes, we found that the high speed c e n t r i f f g a t ~ o n n
together .vrith the use of a thick filter bed of glass Hool for filtration 
was necessary . If this ,,,as not done, enough soluble protein Has left 
in the filtrate to interfere >'lith the assay by producing a colloidal 
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suspension during the extraction with butylacet a te or re-extraction int o 
the phos phate buffer. 
5.2(ii) Extraction of 5-hydroxyindoleacetic aci d and fluoro phore 
--------------------------------
formation 
Six millilitres of the clear filtrate were transferred to gl ass stopper ed 
centrifuge tubes conta ining one millilitre of 2% EDTA solution, one milli-
litre of 6% ascorbic acid, 0.65 ml of N hydrochloric acid and approxi mately 
three grams of sodium chloride. Three millilitres of butyl aceta te 'Ilere 
added to the tube and the mixture was shaken mechanically for ten minutes 
and centrifuged at 2000 rpm for another ten minutes. T\.m millili tres of 
the organic layer were transferred to another glass stoppered centrifuge 
tube. Another 2.5 ml of butylacetate were added to the first tube and 
the tube was shaken again and centrifuged as before. 
Three millilitres of the organic layer were pooled with the f i rst 
extract and shaken for ten m i ~ u t e s s with 4 ml of salt saturated 0.1 N 
hydrochloric acid containing 0.5% ascorbic acid . The mixture was then 
centrifuged at 2000 rpm for ten minutes. 
After centrifugation, a 4.5 ml portion of the organic l ayer 'flas 
transferred to another conical glass stoppered centrifuge tube containing 
2.5 ml of 0.1 H phosphate buffer (pH 7) with 0 .1 % ascorbic a cid . Aft er 
shaking for ten minutes, the tube was centrifUged a t 2000 rpm f or another 
ten minutes. The organic layer iias aspirated off and discarded . Tyro 
millilitres of the aqueous phase ',Tere then combined ''lith 0 .5 ml 9 N 
hydrochloric acid and the fluorescence produced was measured a t 540-550 m ~ ~
after activation at 295 m ~ , , using a Farrand spectrofluorimeter. 
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All solut ions containing a scorbic acid had t he ascorbi c acid added 
to them just bef ore use . 
The r eagent blank ",Tas obtained by carrying 6 ml of 0 .1 N hydrochloric 
acid through the whole procedure. 
A calibra tion curve was constructed by carrying solutions of s t andard 
5-hydroxyindolea cetic acid in 0 .1 N hydrochloric acid through the 'Thole 
procedure side by side ,d th tissue extract . Examples of such curves are 
given in Figure 5.2 . 
The composition of various buffers and r eagents i s given in the 
formulary (A ppendix I). 
5.2(iii) Recovery of standard 5-hydroxyindoleaceti c ac i d added t o 
----------------------------------
A double extraction with butyl aceta te was found to improve the r ecovery 
by at least 6%. 
The recovery experiment for 5-hydroxyindolea cetic acid was done in 
the same manner as that described for 5-hydroxytry ptamine and t he r esul t s 
are given in Table 5.2 . 
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Table 5 .2 
Recoveries of 5- hydroxyindoleacetic acid added to pooled brain homogenates 
Amount added Amount recovered R e c ~ ~ ! : Z Z
---- ---
Ilg ~ ~ % 
0.2 0.17 85 
0.2 0. 17 85 
0.3 0.26 86 
0.3 0.28 93 
0.4 0 .38 95 
0.4 0.37 92 
Mean recovery 89 .3 % 
FIGURZ 5 . 1 
~ ~ p i i a l l calibra t ion curves for the fluorimetr ic assay of 
5- hydroxytryptamine obtained on t hree separa te occasions 
FIGURE 5.2 
Typi cal calibra tion curves for t he fluorimetric a ssay of 
5- hydroxyindoleacetic acid obta ined on two se par a te occasions 
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CF..AfflR 6 
EFFECT OF ON 5-HYDROXYTitY 1-'1'.' i·IE !6 !,LET ..... BOLI SH 
I THS CENTRAL ) ERVOUS SY STE'-1 
5-Hydroxytryptamine is one of the monoamines ivhich are believed by 
a large number of authorities to be involved in the mechanisms of epilepsy . 
Thus treatments which depress the central levels of 5 - h y y r r x y t r r ~ t a m m n e e
have been reported to lmTer the threshold f or maximal ele ctroshock sei zures 
and to antagonize the anticonvulsant effect of phenobarbitone a 5 ainst 
electroshock convulsions (Kilian and Frey, 1973). It 'vas al so f ound 
that administration of l-5-hydroxytrypto phan to baboons "iT ith photosensitive 
epilepsy, completely prevented photically induced myclonus seizures ( el drum , 
Balza.6U:), 'ilada and Cacciuttolo, 1972) . The possibility of a defici ency in 
the aminergic ~ s t e m m was also supported by several re por ts that the concen-
trations in t he cerebrospinal fluid of 5-hydroxyindoleacetic acid and. homo-
vanillic aci d ,.,ere reduced in adults and children Ni th epilepsy (ShayvTi tz . 
Cohn and BQivers, 1975 ; Pa pes chi , Eolina- {egro , Sourkes and Erba , 1972). 
An increase in the concentration of 5-hydroxyindoleacetic acid has been 
described in the cerebrospinal fluid of epileptics r e c e i i i i ~ ~ t herapeutic 
doses of phenobarbitone and phenytoin (Chadwick , Jenner and eynolds , 1975) . 
Changes i n the cerebral content of 5-hydroxytry pt amine have fre-
quently been reported in animals r e c e i v v ~ ~ either Singl e or re pe ted 
i n j e c t i i ~ s s of some conventional anticonvulsant drugs (Bonnycastle , Giarcan 
and Faasonen, 1957; 30nnycastle, nonnycastle anQ ' nderson , 1 9 ~ ; ; Jenner , 
ChadTiTick , rl.eynolds and IvIarsden , 1975; Cha.d;dck , Gorrod, Jenner , Har sden 
and Reynolds , 1978). On the other hand some other author s have re ported 
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the lack of an ability of phenytoin to produce any change in the 5- hydroxy-
trypt amine concentration in brain in doses sufficient to show anticonvulsant 
activity (Prockop, Shore and Brodie , 1959). 
In the following chapters we are reporting r esults obtained after 
acute and chronic treatment vIi th some anticonvulsant drugs on the levels 
and turnover of brain 5-hydroxytryptamine and its major me t abolite (5-
hydroxyindoleacetic acid) , in an effort to study the system from a number 
of vievrpoints . 
6,' Effect of single doses of anticonvulsant druas on the l evels of 
5-hydroxytryptamine and 5-hydroxyindoleacetic acid in rat brain 
Female Ash i'listar rats i;eighing bet'fleen 140 and 160 gms were used . The 
animals were obtained one week before carrying out any experiment . They 
were caged in sixes and allOiTed free access to food and , ... a ter . Drug doses 
were ca lculated according to the animal ' s body weight and were injected 
intraperitoneally in a solution or suspension volume of 0 . 5 ml per 200 g 
weight. 
Phenytoin was given in a dose of 75 mg/kg suspended i n saline con-
taining 1 % Tween 80. phenobarbitone in a dose of 100 mg/kg in saline . 
sodium bromide in a dose of 1 gm/kg a lso dissolved i n saline . and cerbuma-
zepine in a dose of 50 mg/kg in proP,ylene gl ycol. Control rats received 
the appropriate vehicle. 
After receiving the doses stated , the animals were killed thirty 
minutes , one hour or ~ d O O and a half hours after being injected a ~ d d their 
brains ' .... ere quickly removed, homogenized and centrifuged . The sU}.'erna tant 
solutions were assayed for their 5- hydroxytry ptamine and 5- hydroxyindole-
acetic aci i contents by the methods described in chapter 5. 
Results are ShOl'ffi in t able 6 .1 
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Tabl e 6.1 
I 
Bffect of single doses of ant iconvulsant drugs on rat brain 
l evels of 5- hydroxytrJpt amine and 5- hydr oxyindoleacetic a cid 
Treatment 
Saline + 1 % Tween 80 
Phenytoin 
Saline 
F'henobarbi tone 
Saline 
Sodium bromide 
Propylene glycol 
Carbamazepine 
Time after 
i n J e c t i ~ ~ ~
hours 
0 . 5 
1.0 
2.5 
0 . 5 
1.0 
2.5 
0 .5 
1.0 
2.5 
0 . 5 
1.0 
2.5 
5-hydroxyt ryp-
--tamine-----
ng/gm 
473 :: 10 (8) 
453 ! 11 (4) 
498! 7 (4 ) 
501 ! 13 (4) 
463 ! 15 (8) 
489 ! 30 (4) 
459 :: 10 (4) 
533 ! 15:*(4 ) 
470 ! 13 (8 ) 
477! 9 (4) 
497 ! 11 (4) 
469 :: 10 (4) 
561 :: 20 (8) 
588 ! 25 (4) 
561 ! 25 (4 ) 
572 ! 16 (4) 
nd gm 
332 ! 7 (8 ) 
+ '* ) 378 - 10**(4 
362 ! 12* (4 ) 
366 ! 8:*(4) 
+ 10 35 1 
353 ! 15 
349 ! 20 
+ 339 - 15 
336 ! 7 (8) 
333 ! 10 (4 ) 
343 ! 14 (4) 
337 ! 10 (4 ) 
340 ! 10 (8 ) 
345 ! 10 (4) 
343! 5 (4) 
340! 7 ( ) 
+ Each value is the mean - standard error from the number of aninals shovm 
in p3l'entheses . 
* Significantly different by the t t est (* P < 0 .05 and ** < 0 .005 ) 
Only phenobarbitone increased the levels of 5 - h h d r o x y t r r ~ t ~ m i n e e s nd 
this e f f ~ c t t i.,ras only seen t vTO and a half hours after its injection . It i s 
interesting to note tha t pro pyl ene gl ycol produced a h h g ~ e r r va lue f or 
5- }-I..ydroxyt ryptamne than did saline . 
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Phenytoin increased the levels of 5- hydroxyindoleacetic ac i d at al l 
times studied , the maximum effect b e i i ~ ~ observed half an hour aft er in jec-
tion. This prominent effect of phenytoin on 5 - h y d r o o J i n d o o e a a e t i c c acid 
llTaS surprising, since we had thought tha t any effect produced by the drug 
should be evident for both the amine and its metabolite . Thi s proved no t 
to be so . The effect of phenytoin on the metabolite sUGgest s either an 
increase in the turnover of the amine (i.e. an increase in the rate of its 
synthesis and utilization) or that phenytoin inhibits the aci d transport 
system in the brain thus decreasing t he efflux of t he met aboli t e f rom t he 
brain . 
These possibilities ' .... ere examined by three diff erent experiments . 
The anticonvulsant drugs \'lere tested for their effect on the synt hesi s of 
5-hydroxytryptamine p:l.rtially inhi bi ted by p-chlorophenyla l anine ; by 
the accumulation of 5- hydroxytryptamine and the depletion of 5- hydroxyindole-
acetic acid caused by pargyline , a monoamine oxidase inhibitor; and finally 
by their effect on the rate of elimination of 5- hydroxyind'oleacetic acid 
after probenecid. 
6.2 Effect of .rchlorophenyla l anine on r a t brain 5-hydroxytryptami ne and 
5-hydroxyindoleacetic acid 
~ h l o r r p h e n y l a l a n i n e e i s a drug t hat potently inhibit s t he biosynthesi s of 
5-hydroxytryptamine (1<oe and ,\'i'eissman , 1966) and as \'lell deple t es br ain 
5-hydroxyindoleacetic acid . 
The first step in the present e x p e r r ~ e n t t was to det er mine the dose 
of ~ ~ h l o o o p h e n y l a l a n i n e e that produced a satisfactory depletion of 5- hydr oxy-
tryptamine and 5-hydroxyindoleacetic acid . 
been previous l y used in our department . 
\'Ie chose a scheDe , .... hich had 
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~ C h l o r r p h e n y l a l a n i n e e was given by oral intubation in 1 ml of 
mucilage of tragacanth (B.P . ) , two doses of the drug (320 me/kg) being 
given on alternate days . Control rats received 1 ml of mucilage of 
tragacanth at t he same time as the treated r ats received ~ c h l o r r p h e n n l l
alanine . Animals were killed t-tlenty- four hours after the l ast dose , 
their brains wer e removed , homogenized and assayed for their 5-hydroxy-
t r yptamine and 5-hydroxyindoleacetic a cid contents by the methods described 
in chapter 5. 
Results are presented in table 6.2 . 
Table 6.2 
Effect of lrchlorophenylalanine on the levels of 5- hydroxytryptamine and 
5- hydroxyindoleacetic acid in rat brain 
Treatment 
!vIucilage of tragacanth 
~ h l o r r p h e n n l a l a n n n e e
% change 
5 - h h ~ ~ x y ! r y p t ~ ~ ~ ~ ~ ~
ng/gm 
480 :: 20 (4-) 
899 ! 90 (4) 
+ 87 .3% 
5 - h y d r r ~ ~ i n d d l e a c c t i c c
- -acid------
n&1gm 
368 ! 10 (4) 
130 ! 10 (4) 
- 64 .6% 
+ Each value is the mean - standard error from the number of animal s shown 
i n p3.rentheses . 
Surprisingly, lrchlorophenylalanine did not depl ete 5- hydroxytrypta-
mine . Indeed , the reverse happened ; there was a substantial rise in 
the brain 5- hydroxytryptamine content . 5- Hydroxyi ndoleaceti c acid was 
de pleted as \.;e expected and only 36% of the original amount '118S left after 
p-chlorophenylalanine . vle thought at t he time t hat we might have made a 
mistake in the amine assay procedure vThich gave rise to these re sults
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Therefore we repeated the experiment, only to get exactly t he same r esult s 
as before . Our thoughts went in another direction, t01tTards t he vi e\." t hat 
the method of administration and the kind of vehicle used might have af fected 
the assay . To test this idea . we gave the drug by intraperitoneal in jec-
tion suspended in methyl cellulose (3%) . Again we 'tTere faced with the same 
results as before . The only possibility that remained wa s t ha t jC-chloro-
phenylalanine itself might have been interfering with our assay procedure . 
\ ~ e e tested this by IEr for ming e x ~ r i m e n t s s in which .,!!-chlorophenyla lanine Im s 
added to brain homogenates and external 5 - h y d r o x y t r ~ p t a m i n e e standar ds . 
~ h l o r r p h e n y l a l a n i n e e in a concentration of 1 mg/10 ml was added to 
different concentrations of standard 5- hydroxytryptamine . Another set of 
standard 5-hydroxytryptamine s olutions was prepared without the addition 
of .,!!-chlorophenylalanine . The final volume of the solutions was 10 ml. 
from which seven millilitres were used for t he assay . 
Results are s h ~ i n n in table 6.3. 
Brains from three rats were homogenized in 10 ml perchloric acid 
containing 1 mg ~ c h l o r r p h h n y l a l a n i n e . . After centrifuge. tion , the s ~ p e r r
natant solutions \iere pooled and divided into three equal portions which 
were then used for the assay . Another three rat brains \'Tere trea ted in 
the same manner . but no .,!!-chlorophenylalanine waS added to them. 
Results are shown in table 6 . 4 . 
It i s clear from these results that ~ c h l o r r p h e e y l a l a n i n e e inter-
feres with the assay procedure ~ T e e were using for 5- h..ydroxytryptamine . 
The fluorescence readings for the reagent blanks wi t h added ~ c c l o r r p h e n y y ­
alanine and the standard 5- hydroxytryptamines \V'ere much greater than t hose 
given by solutions without added ~ c h l o r o p h e n y l a a a n i n n . .
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Table 6 .3 
Effect of ~ c h l o r r p p e n y l a l a n i n e e on the relative fluorescence produced 
by external 5- bydroxytryptamine solutions in ninhydrin 
Concentration used 
Reagent blank 
Reagent blank 
0.4 
0 .4 
0 .8 
0 .8 
1.2 
1 . 2 
Relative fluorescence 
TNi thOU't7.c:F.X:-dded 
0.05 
0. 05 
0. 135 
0 . 145 
0.27 
0.27 
0 .39 
0.41 
Table 6 .4 
0 .23 
0 .24 
0 . 36 
0 .39 
0 .47 
0 .53 
0 .68 
0.60 
Effect of ~ c h l o r o p h e n y l a a a n i n e e on the rela tive fluorescence produced 
by brain 5- hydroxytryptamine extract in ninhydrin solution 
Number of brain extract 
2 
3 
Relative fluorescence 
wi thoutT.c":?: A.added. 
0.220 
0.210 
0.215 
Relative f l uorescence 
-With a d d e a - P P : P : : : -
0.34 
0 . 37 
0 .37 
Brain extract \rith added ~ c h l o r r p h h n y l a a a n i n e e showed more fluores-
cence than those of brain extract vTi thout added 2-chlorophenylalanine , but 
the differences \'lere not as high as those observed Hi th the blank and stan-
dard va lues . The reason for this might be that s ome 2-chlorophenylalanine 
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had been adsorbed by brain homogenat e and had not t hen been e x t t ~ c t e d d
by the butanol. 
6 .3 Ef fect of si nnle doses of anticonvulsant d r r ~ s s on the depletior. 0 
brain 5-Aydroxyindoleacetic a cid caused by ~ c h l o r r p h h n y y a l a n i n e e
Female Ash T:Ti s t ar rat s were divided into several groups . Each animal 
received by oral i ntubation hlo doses of ~ c h l o r r p h e n y l a l a a i n e e (320 mg/kg) , 
given on al ter nate days in one millilitre of mucilage of t r aoacanth . 
Control groups received one millilitre of oucila e of t ragacant h only . 
The animal s uere tilled t\venty- four hours after the second dose of ~ ~
chlorophenyla lanine but one hour before tilling some animals received an 
intraperitonea l injection of phenobarbitone (1 00 mg/kg) , phenytoin (75 mg/kg) 
or carbamazepine (50 mg/kg ) . 
Results are presented in table 6 . 5 . 
Table 6 . 5 
Effect of anticonvulsant drugs on the de pletion of 5-hydr oxyindol eacetic 
acid caused by ~ c h l o r r p h h n y y a l a a i n e e
Treatment 5 - h . y d r o x y i n d ~ ~ ~ ~ ~ ~ c i ~ ~
Nucilage of traga canth 
~ c h l o r r p h e e y l a l a n i n e e
P.C. P.A. + phenobarbitone 
p . c . p . ~ + + phenytoin 
P.C. P.A. + carbamazepine 
ng/gm 
+ 340 - 9 .0 
+ 140 - 5 .8 
+ 170 - 4 .0 
2CJ7! 4 . 0 ( 4 ) 
169! 6 .0 (4) 
Chan"'e 
- 58 .8 
* .. 
- 50 .0** 
** 
- 39 .1 ** 
+ Each va lue i s the mean - standard error from the number of anirre. l s shOlm 
in Pll'ent heses . 
* ** Si gni fi cantl y different by t he t t est (** p < 0 .005 ; ** p < 0 .001) from 
the values obt ai ned aft er treat ment ,.,rith ~ c h l o r r p h e n y l a l a n i n e e alone . 
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Results presented in table 6 .5 shm'1 that all the anticonvul sant 
drugs tested r educed the degree of depletion of 5- hydroxyindole cetic acid 
caused by ~ c c l o r r p h e n y l a l a n i n e . .
6 .4 Effect of anticonvulsant drugs on the changes nroduced by p a a ~ [ l l n e e
on brain 5-hydroxytryptarnine and 5-hydroxyindoleacetic acid 
U:.tdenfriend and i'Teissbach (1958) had suggested that the rate of increase 
of brain monoamine f ollowing inhibition of monoamine oxidase is indicative 
of the rate of biosynthesis. He have seen that phenytoin increased the 
levels of 5-hydroxyindoleacetic acid in the brain , and we have supposed 
that the increase was due to an increase in the turnover of 5- hydroxytry p-
tamine or decreased elimination of 5-bydroxyindoleacetic acid . Hence ',.re 
studied the effect of anticonvulsant drugs on the 5-hydroxytry ptamine system 
after inhibition of monoamine oxidase . 
Pargyline was used . The first step in the experiment was to deter-
mine the time at \'1hich the examination should be carried out . 
indoleacetic acid in rat brain 
Female Ash \'Tistar rats were divided into several groups and each oup 
received an intraperitoneal injection of pargyline hydrochloride (100mg/kg) . 
The animals were killed 'by cervical dislocation and de capitation ,t various 
times after dosing . Their brains i'lere , quickly removed and assayed for 
their 5- hydroxytryptamine and 5-hydroxyindoleacetic acid contentG by the 
methods described in chapter 5 . 
Resul ts are ShOlffi in table 6 .6 and figure 6 .1 . 
As i s clear from the table , the maximum effect of pargyline on 
5 - h y d r o ~ J t r r p t a m i n e e occurs one hour after the injection . i:/ e chose this 
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Table 6 .6 
Time course effect of JBrgyline on brain 5- hydroxy t rypt nmine and 
5 - h y d r o ~ J i n d o l e a c e t i c c acid 
Time 5-hydroxytryp- C h h n g ~ ~ 5-hydroxyindole- C h ~ ~ ~ ~
tainine----
--acetic-acid---
hours -ng,rgm % - - g g - - "f I" 
0 479 ! 13 (4) 358 ! 7 (4) 
0 .5 688 ! 15 (4 ) + 43 . 6 250 ! 20 (4 ) - 30 .8 
+ (4) 190 :t (4) - 46 .9 1 .0 740 - 40 -t 54 .4 9 
1.5 751 ! 30 (4) + 56.8 150 ! 10 (4) - 58 .1 
+ Each value is the mean - standard error from the number of pairs of 
animals shown in parentheses 
time to study the effect of anticonvulsant drugs on 5- hydroxytry pt amine 
and 5-hydroxyindoleacetic acid contents after pargyline . 
Rats were divided into groups . Each group received an intra perit-
oneal injection of pargyline (100 mg/kg) and the animals were killed one 
hour later . Thirty minutes before death , groups of r ats r eceived . by 
the intra peri toneal route , one of t he anticonvulsant drugs shmm in t able 
6 .7 in the doses used in the previous experiments . 
The results show t hat phenobarbitone significantly r educed the ra t e 
at i-lhich t he concentration of 5-hydroxytrypt amine ro se in the brain of rats 
after p3.r gyline treatment . whi"le carbamaze pine and phenytoin r educed t he 
extent to which the level of 5-hydroxyindoleacetic acid ~ ~ l a s s depl et ed by 
Inrgyline . 
6 . 5 Effect of anticonvulsant drugs on the l evel s of 5-hvdroxvtnd oleacetic 
acid after orobenecid 
\'/e have seen that after .rargyline , carbamaze pine and phenytoin r educed the 
FIGURE 6 . 1 
Time course effect of pargyli ne on brain 5- hydroxy-
tryptamine a nd 5- hydroxyindoleacetic acid 
+ Each bar i ~ ~ c a t e s s the mean - standard error for the number of pairs 
of animals indicated inside the columns . 
Open columns r epresent 5- hydroxytryptamine and hatched colurn..l'ls 
r epresent 5- hydroxyi ndoleaceti c aci d . 
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Table 6 .7 
Effect of anticonvulsant drugs on the chanbes in 
br ain 5 - h y y r o x y t t J p t a m i n e e and 5- hydroxyindolea cetic aci d by per gyl i ne 
~ e a t m e n t t
Vehicle 511 ~ ~ 10 (8) 
Pargyline 749 :!: 17 (8) + 46 . 5 
Pargyline + 
phenobarbitone 668 ~ ~ 37 (4 )* + 30 .7 
Fargyline + 
phenytoin 761 ! 20 (4) + 48 .9 
Pargyline + 
carbamaze pine 697 ~ ~ 32 (4) + 36 .4 
5- hydr oxyindole-
-acetiC-acid----
---n(i!gm---
353 :: 7 (8) 
199 :: 4 (8) 
- 43.6 
- 40 .8 
- 33 .7 
- 35 .4 
+ Each value i s the mean - standard error from the number of pairs of animals 
sho1>Tll in :r;arentheses . 
'** Significantly different by the t test (* P < 0 .05 , ** P < 0 .02 and ** P < 
0 .001 ) from the values obtained after treatment with pargyline a lone . 
degree of depletion of 5 - h y d r o ~ J i n d o o e e c e t i c c acid . On the other hand , 
phenobarbitone reduced the a ccumulation of 5- hydroxytryptamine . The 
t hree drugs resisted the depletion of 5- hydroxyindoleacetic acid cnu!Jed b:' 
~ c h l o r r p h e n y y a l a n i n n . . The percentage increase in t he metaboli te caused 
by phenobarbit one after ~ c h l o r r p h h n y y a l a n n n e e vias around t he same fizure 
as the percentage decre'ase in the accumulati on of the amine aft er p.1r \:;.!line . 
The percentaoe increase in the concentration of 5 - h y y r r ~ ~ i n n o o c ~ c e t i c c ci d 
brought about by phenytoin a.fter rchloro phenylalanine Has about double 
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t r..a t aft er pg.rgyline . This means that not a ll the effect ~ / / s s ue to an 
increase i n turnover r a te of 5 - h y d r o x y t r r p t a m m ~ e , , and an inhibitor; effect 
on the elimination of 5- hydroxyindoleacetic acid mi ht have been takin 
pl ace . This ,,-as examined by probeneCid , a dru which in:b.ibi ts the aci 
transport of 5-hydroxyindoleacetic acid out of the brai n ( -eff , Tozer and 
Brodie , 1967). 
Again, t he time course effect of probenecid on 5- hydroxyindol eacetic 
acid i-laS t o be de termined first, in order t o choose the time at 'lihich 
examination shoul d be carried out. 
Anima ls vere injected intraperit oneally iiith probenecid (200 mg/kg ) 
and wer e killed by cervical dislocation and deca pitation at various times 
thereafter . 
Results are presented in table 6 .8 and figure 6 .2 . 
Probenecid had a negligible effect on brain 5- hydroxytry ptamine . 
It produced a steady increase in the concentra tion of 5- hydroxyi ndoleacetic 
aci d content ,,,hich vIas still rising after s i x hours of injection. 
Anticonvulsant drugs \-Iere then tested f or their effect on the 
accumulat ion of 5- hydroxyindoleacetic acid produced by probenecid. 
Animals 'Ilere killed four hours after an i !1tr aperitone 1 i !1jection of 
probenecid (200 mg/kg) , but one hour before dea th anticonvulsant CruQs 
were injected intra peritoneall y in the same doses as before . 
Results are sho'lm in t able 6.9. 
Phenytoin and carbamazepine increased si gnificantly the r te of 
a ccumulation of 5- hydroxyindoleacetic a cid caused by probeneci ' . 
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Table 6.8 
Time course effect of probenecid on 5-hydroxytryptamine and 
5-hydroxyindoleacetic acid contents of rat brain 
Time 
hours 
o 
0.5 
2 
3 
6 
5-hydroxytryp-
--'tamiru;---
--lliJgm 
515 : 15 (4) 
484 ! 10 (4) 
51.3::!: 6 (4) 
517 :!: 23 (4) 
565 ::!: 9.8 (4) 
503 :t 16 (4) 
% 
- 6.0 
- 0.38 
+ 0.38 
+ 9.7 
- 2.3 
5-hydroxyindole-
aceticacicr---
---nglgm--
'" + 3b5 - 3 (4 ) 
+ 418 - 3 (4) 
490 :: 20 (4 ) 
686 : 20 (4) 
894 ::!: 14 (4) 
996 :: 10 (4) 
+ 14.5 
+ 34 .2 
+ 87 .9 
+ 144.9 
+ 172 .8 
Each value is the mean :: standard error from the number of pairs of animals 
shoi'ffi in parentheses . 
Table 6.9 
Effect of anticonvulsant drugs on the accumulation 
of 5- hydroxyindoleacetic acid after probenecid 
Treatment 
---
Vehicle 
Probenecid 
Probenecid + phenobarbitone 
Probenecid + phenytoin 
Probenecid + car bamaz e pine 
2 : h y d r o x y i n ~ ~ ~ ~ ~ ~ ~ ~ ~
350 + 9 (8) -
1048 + 
- 14 (8) 
1075 + - 12 (4) 
1180 + (4) -17 
1095 + - 13 (4) 
+ 199.4 
+ 207. 1 
'** + 237 .1 ** 
+ 212 .8** 
+ Bach value is the mean - standard error from the number of animals sho\lTn 
in :r:ar en the se s • 
** Significantly different by the t test (** p < 0 .02 and ** P < 0.001) from 
t he values obtained after treatment \'li th probenecid alone. 
FIGULB 6 .2 
Time course effect of probenecid on 5- hy ·rorJ r yptacine and 
5- hydroxyindoleacetic acid 
+ Each bar indicates mean - standard er:oor for he nuober of }:airs of 
anicals indicated inside the columns . 
Op::n coluons r epresent 5- hydroxytrJ ptamine an hatched cclumns 
r epresent 5- nydroxyindoleacetic acid . 
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6,6 Summary of t he r esults Presented in chapt er 6 
Single doses of phenytoin increased the bra i n levels of 5- hydroXYi ndol e-
acetic acid thirty minutes , one hour and "b"T O and a hal f hours after i t s 
injection. Phenobarbi t one i ncreased t he br a i n concentr a t ion of 5- hydroxy-
tryptamine but only a t t he ti'l O and a half hours :r;er iod f OUm-ling its injec-
tion. 
After ~ ~ h l o r r p h e e y l l l a n i n n , , the t hree drugs - phenytoi n , pheno-
barbitone and carbamaze pine - all reduced t he extent to which 5-hydroxy-
i ndoleacetic acid wa s depleted . 
After Plr gyline, phenobarbitone r educed t he degree to ioThich 
5-hydroxytryptamine '1'Ta S accumula ted in t he brains of treated r a. t s , .-,hile 
phenytoin and carbamazepine reduced the degree of depletion of 5- hydr oxy-
indolea.cetic acid caused by the monoamine oxidase i nhibi t or. 
After probenecid, both phenytoin and carbamaze pine i ncreased t he 
rate of a ccumula tion of 5-hydroxyindoleacetic acid . 
A summary of the results is ,given in figure 6. 3 
FIGURE 6.3 
ercenta e changes in the concentrations of 5-hydroxy-
indoleacetic aci (A) and 5- hydrox-trJptamine (B ) 
after different t r e a t ~ e n t t
Percentage change from corresponding controls 
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CHAPI':::R 7 
Bft-UN 5- HYDROXYTRYPrPJ·1nTE A!-D 5- HYDROXYI'-IDOL .. :1ACC:TIC .-i.CID 
AFT3. LONG TEill"l T R E A A ~ ~ S N T T iHTH ANTICmWULSANT DRUGS 
VIe have s een in chapter 6 that single doses of phenobarbitone 
increased the level of 5- hydroxytryptamine "t' .. 70 and a hal f hours after 
administration . ?henytoin , on the other hand , increa sed that of 5- hydroxy-
indoleacetic acid . ';/e a lso demonstrated hQT;l henyt oin a ccelerated the r a te 
of turnover of 5- hydroxy trypt amne and decreased the e f,rress of 5- hydroxy-
indoleacetic acid out of the brain . Carbamaz epine had an inhi bi tory effect 
on the elimination of the indole from the brain . 
'iTe performed experiments f therefore , to look for the effect of long 
term a.dministr ation ',Ti th these anticonvulsant drugs on the levels of 
5 - h y d r o ~ J J r y p t a m i n e e and its maj or metaboli te 5- hydroxyindoleacetic ecid , 
in order to see whether any of these drugs would exert any effect a f t er 
l ong term t r ea tment . 
7 . 1 Ef f ect of lon,'! term administration "7i th and 'tT i thdrmral of uhenobarb; t one 
on the l evels of 5- hydroxvtryptamine and 5- hydroxyind olea cetic acid i n r a t 
brain 
The me thod of he. bitua tion used here '1laS that described in cha pt er 3 . i n 
which phenobarbitone in incres.sing doses ioTas adminis tered in drinkin,S' I-la ter 
containing sa ccharine over a period of six 'freeks . The concentra tion of 
phenobarbitone was ad justed so as to increa se the da i l y intake of pheno-
barbi tone by a bout 50 mg/kg every other \>leek , until the concentration of 
phenobarbi tone in drinking ,-Tater r ea ched a f inal concentra tion of 150 rn..'!,/kg 
at \"hich level it i"as continued for the r emai ning t"TO "reeks . 
At the end of six \"eeks of administr ation . treated r ~ t s s ":rer e divi d.ed 
into three groups . One group continued to r ece i ve phenobar bi t one. I"hl l e 
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the drug Has ili thdra'lm fr om the other t HO groups by re placing the pheno-
barbitone solution by one conta i ning saccharine only . The a n n ~ a l s s in t hese 
latter groups ivere either killed forty- ei ght hours after 'ITl thdrm·ral or 
exposed t o the sound of the bell forty-eight hours after ;·ri thdra'lral (as 
described in cha pter 3), and killed during the subsequent convul sions . 
The h a b i t t ~ t e d d group was killed at the sane time. The brains of the 
habi tuated and the ~ ~ i i h h r a ' m m r a ts 'lTere removed, ;'reighed , homogenized and 
as sayed f or their 5-hydroxytryptamine a nd 5-hydroxyindoleacetic acid by 
the methons described in chapter 5. 
Re sul t s are shovrn i n table 7 . 1 • 
Habituation increased significantly the levels of both the amine and 
its metabolite. The ~ r c e n t t g e e increase in the level of the amine Nas much 
higher than that of its metabolite ,.;hich might i ndicate that habituation 
increased to a certain degree the turnover rate of 5-hydroxytryptamine , 
but it seems t hat it increased the synthesis at a higher rate than t v ~ t t of 
utilization . 
~ ~ i t h d d a w w l l brought dmm the levels of both the amine and its metabo-
lite, which indicates either a decreased turnover or the return of the 
seretoninergic neurons to their steady state activity . H H ~ ~ e v e e , , ivi t:b.draHal 
convulsior.s decreased the l evel s of the amine and i ncr eased t hat of its 
metabolite. The percent age increase in t he concent r a tion of the metabol-
i te ~ ' r a s s very much higher than the percentage decrease in t hat of the amine 
itself, whi ch indicates t hat both the r ate of synthesis and t ~ ~ t t of 
utiliza t ion increased dUring the convulsions. 
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Table 7.1 
Bra in 5-hydroxytryptamine and 5-hydroxyindoleacetic acid levels 
after habi tua tion to and \'7 i thdra\'Tal from phenoburbi t one 
Treatment 
Control 
Habituated 
\'lithdrawn 
Control + 
sound stimu-
lation 
VI i thdraim + 
sound stimu-
lation 
5-!lldroxytryp-
tamine 
--n:gJgm 
+ 522 - 5 (8) 
641 ~ ~ 22 (8) 
567 : 33 (8) 
530: 6 (8) 
487 ~ ~ 17 (8) 
Change 5 - h y d r o o Y i n n ~ ~ : :
acetic acid 
% na'gm 
361 ! 6.7 (8) 
** 397 : 17 (8) + 22 .8** 
+ 8.6 364 : 14 (8) 
365: 6 (8) 
- 8 . 1** 462 : 13 .8 (8) 
% 
+ 9.9* 
+ 0.8 
** 
+ 26.5** 
+ ' 
Each value is the mean - standard error from the number of Fairs of a nimals 
shown in parentheses . 
** Significantly different by t test (* p < 0 . 05, ** p < 0.02 and ** P < 0.001). 
The figures vere obtained in ti'TO different experiments . 
'L2 Effact of Ion ) term adminiStrll tiol1 of nhenytoin a n n l l Cft. 'oc1..1J),:".Z e nine on 
the levels of 5-hydroxytrynt3mine a nd 5- hvd oxyindoleacetic ncid 
Bot :. drugs ~ ' T e r e e injected i ntra!)eri tonea lly over a period of three vreeks 
in an increasin:; dosa:;e. 
Phenytoin Has injected a t a d03e l evel of 25 lIl6i'kg t ; ~ i c e e daily :or 
the first I'Teek of treatment. The dose Has raised t o 50 ng/lr.c durinc 
the seco:nd. v T e e ~ ~ and finally to 75 og/kg durinG the third and final ';oreek of 
treatment . 
- 134 -
Carbanazep:ine lias injected at a dose l evel of 20 mg/l-:g brice daily 
for the first ten days and then the dose \'Tas i ncreased to 40 mg/b·" f or t he 
last eleven days of treatment. Details of the methods are given in 
chapter 4. 
At the end of the third "reek of admini stration, rats Here killed by 
cervical dis location and decapitation, their bra-ins ,;rere quicY..ly r e!:loved , 
homogenized and assayed f or their 5- hydroxytryptamine and 5- hydroTJ indole-
acetic acid by the methods described in cha pter 5. 
Results are given in t able 7.2. 
Tacle 7.2 
Effect of long term administration of phenyt oin and car banuzepine 
on t he levels of 5-hydroxytryptarnine and 5-hydroxyindoleacetic a cid 
Treatment 
Saline 
Phenytoin 
Prowlene 
glycol 
Car be..ms.z e pine 
5- hydr oxytrypt-
amine 
--ngJgm 
511 ~ ~ 15 (8 ) 
598 ! 20 (8) 
549' ! 18 (8) 
668 ! 23 (8 ) 
of rat brain 
** 
+ 17** 
5- hydroxy indole-
acetic aCiCi--
.n;j-;;;:-
356 :- 4 .5 (8) 
422 ~ ~ 4.0 (8) 
336:- 9 (8) 
** + + 21 .7** 495 - 35 (8) 
** + 18 .5** 
** + 47.5** 
+ Each value is the mean - standard error from t he nuober of pairs of animals 
shOlID in ~ e n t h e s e e . .
.** 
Significantly different by the t test ( ~ ~ ~ P < 0 . 001) f ron contr ol value s . 
The figures ,·rere obtair..ed in hTO diff erent experiments . 
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Results s s ~ v v that both phenytoin and carbamezepine i ncreased the 
levels of the amine and its metabolite . The :r:ercentage cl18.nges :u:'od.uced 
by phenytoin in the levels of t he amine and its netabolite ,'Tas the same . 
On t he other hand, the percentage changes produced by carbamnze pine on the 
concentration of t he me t abolite \'las double that produced in the l evels of 
the amine itself . 
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CHAPrER 8 
BRAIN y-AHIUOBUTYRIC ACID 
y-Aminobutyric acid. is an amino acid vThich is present in large 
amounts in the ma.!!lI!l8.lian centra l nervous system and i'lhich is believed to 
act as an inhibit ory neurotransmitter substance t her e . Ex:t:erimental 
evidence ind.icates t hat central GABA f unctions in eyi lepsy may be depressed 
(Heldrum, 1975). 
Some of the anticonvulsant drugs (including barbiturat es) have been 
reported to elevate brain GABA concentration (Saad, Elmasry and Scott, 
1972) and to antagonize insulin convulsion in mice, by elevating the 
l m ~ e r e d d GABA levels induced by insulin (Saad, 1970) . These authors 
suggested that GABA might be a mediator in the anticonvulsant effect of 
the drugsthey used. In contrast , Crossland and Turnbull (1972) found no 
changes in the levels of GABA in the brain of rats during habitua tion to 
or wi thdravTal from sodium barbitone. Aminooxyacetic acid, in doses which 
doubled the GABA content of the brain, did not protect rats against audio-
genic seizures produced as a consequence of the barbitone withdr awal. 
They concluded that barbitone withdrawal convulsions did not ari se from 
deficiency in the brain G A R ~ ~ levels. In vieVT of t he above re ported 
findings , we decided to see whether any of the anticonvulsant drugs vIe 
used before have any effect on G A ~ \ \ levels in r a t brain . 
8.1 Paper chrornatogra -ohy of GRBA 
The method w'e fir s t used for the assay of brain GABA Ivas the one dimen-
sional IEper chrorretography method described by I1aynert, 7J.ingman and Kaji 
( 1962 ) , with some of our mm modifi cations vThich ai med a t increasing t he 
senpitivity of t he method . 
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8.1(i ) Preparation of tissue extracts 
------------------
Rats "Tere ld.lled by cervical dislocation and decapitation . their brains 
were quickly removed and homogenized in 5 ml ice cold 0 . 01 N h y d r o o ~ ~ o r i c c
acid, using an NSE top drive homogenizer. The brain homogenate 'Ilas then 
mixed with 12 ml ice cold absolute ethanol and left to stand in crushed 
ice ''later bath for one hour . The mixture "Tas then centrifuged at 11000 
o 
rpn at 0 C for ten minutes . The supernatant solution ,,,,as then removed and 
kept in evaporation tube, and the residue .. Tas ''lashed t hree times "'ith 4 ml 
portions of 75%V/V ethanol, and on each occasion the mixture was centri-
fuged as before . The ''lashings were pooled wi th the supernatant solution 
and the mixture was evaporated to dryness on a Buchler rotary evapora tor 
o 
under vacuum and at a temperature of 60 C. 
The residue was then dissolved in a mixture of 1 ml of distilled 
water, 2 ml each of chloroform and methanol and was centrifuged at 2000 rpm 
for fifteen minutes. 
The solvent used for chromatography was the aqueous phase of a mixture of 
50 ml of n-butanol, 12 ml of glacial acetic acid and 50 ml of water . The 
mixture was shaken in a sepu-ating funnel and the lower organic phase \'las 
used t o saturate the atmosphere of the chrom.s.tography jar for 'bTenty-four 
hours. 
Fifty microlitres of the upper aqueous phase of the brain extract 
were applied to a sheet of VIhatmann number 1 chromatography Inp:lr . The 
point of application ,>las mde 9 em from either edge of the p3.per and the 
size of the spot did not exceed 0.5 cm in diameter, leaving a t least 10 cm 
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bet'.Teen each point. The paper w'as then suspended in t he chroma toe;raphy 
j ar, 1'lith the sample origin closes t to the solvent trough at t he t op of 
the jar, and left f or ei ghteen hours at room temper a ture . 
8.1 (iii) D e v e l l p i i ~ ~ of t he chromatograph 
----------------------
At the end of eighteen hours , t he paper was removed from the tank and 
allOVled to dry in a fume cupboard f or h ro hours . The paper I.ras then 
sprayed 'Ilith freshly prepared 0. 5% ninhydrin solution in 9 9 / ~ ~ ethanol. 
It was a llOl-red t o dry for one hour in the fume cupboar d and 'lI a S t hen hen t ed 
in an oven at 90°C for five minutes. 
The GAM-containing spots , half 1'lay up the :fa ~ ~ , , "lere marked i-rith 
a pencil and pieces of the paper 2 cm in diameter around the centre of the 
spot 1'lere cut out, chopped into small pieces and ms.cera ted in 2 ml ninhydrin 
solution in 95% ethanol at a temper a ture of 1000 C f or five minutes. 
After the mixture had been cooled to room t e m ~ r a t u r e , , 5 ml of dis-
tilled water were added and it was allovled to stand for a further hour vlith 
occasional shaking. The optical density of the supernatant liquid .... las 
then measured at 570 m ~ u s i n g g a l l ~ E E Spectroplus spectrophotometer against 
a similar extract of a blank circle t aken from the same paper . 
A calibration curve was constructed every time by applying 50 ~ l l of 
different concentrations of standard GAB! in 0.01 N hydrochloric acid to 
the same Piper . An example of the curves is given in figure 8 .1 
8 .1 (iv) Recovery of standard GABA solution added to br ain homo-
------------------------------------
g e ~ t e ~ ~
Different concentra tions of standard GAB! solutions , added to pooled br ain 
homogenates and carried through the whole procedure were r ecovered in excess 
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of 144% (table 8.1). This means t hat there are other substances in the 
brain homogenate which reacted with the added G G R ~ ~ to give higher r eading 
values. 
\ .... hen the standard GABA. solutions .. rere added to the aqueous solu-
tion of the brain extract before application to the paper the recovery 
was only around 93% ( table 8.2). 
Table 8.1 
R e c o v e r ~ e s s of GABA added to pooled brain homogenates and 
carried through the whole procedure 
Amount added Amount recovered ~ ~ ~ ! Z Z
----- --------
~ ~ ~ ~ % 
50 62 124 
50 87 174 
100 166 166 
100 144 144 
150 193 128 
150 225 150 
200 280 140 
200 263 131 
Mean recovery 144 . . ~ " "
Although several modifications were made to the procedure which viaS always 
conducted "ri th great care, there \'lere serious drawbacks in the method , which 
led us to look for another means of assaying GABA. 
FIGtBE 8 . 1 
pical calibrati on c ~ ~ e s s for the co_orioetric 
F a a r r chromatographic assay of Y-amnobut:rric acid obtained on 
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Table 8 .2 
Recoveries of GAEA added immediately before application to the paper 
Amount added Amount recovered R e ~ ~ r y y
------- ---------
~ ~ ~ ~ % 
50 48 96 
50 42 84 
100 93 93 
100 97 97 
150 144 96 
150 138 92 
Hean recovery 93% 
The first serious dra\,lback was the recovery Hhich a ppg,rently rose to 
as much as 174%. This i s inex plicable unless 1ve i nvoke the presence of a 
substance or substances in the brain which reacted 'Ili th the added GABA and 
thus yielded a compound which gave the apparent l y high recovery . This 
makes the assay less specific. Another serious disadvantage of t he method 
was that the same brain extract applied to the same paper in the same jar 
r eturned assay results that differed by as much as 30% fr om one another . 
The sensi ti vi ty of the assay vTas t oo 10v1 , vThich gave l arge scatter 
f or the readings; besides, t he assay procedure takes a long time and only 
a limited number of samples could be run through in the same time . 
For the above reasons 'I;Ie l ooked. f or another a ssay method for 
Y- aminobutyric acid . 
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8 .2 Enzymatic f luorometric determination of GABA in rat brain 
The enzymatic mea surement of GABA \Oras f irs t described by Jakoby and Scott 
(1959), v/ho isolated t he enzymes f or the GABA assay f rom Pseudominas 
fluorescens. The method 1-TaS then modif ied by Graham and Apt'ison (1 966) , 
to alle'"," measurement of suall amount s of GABA . 
'I'l e used the assay I:lethod of Graham and Apri s on but He made some 
modifications i n the volumes of the reagents used until we found that He 
had the most satisfa ctory procedure. 
Princi ple of the assay 
-----------
GABA-T Y-aminobutyric acid + a-ketoglutarate ) succinic secialdehyde 
+ glutamate 
2) succinic semia l dehyde + NADP+ SSADH ) succi nat e + NAD PH + H+ 
The excess N A A ~ + + is destroyed by weak alkali . The NAn HI ''1hich is stable 
in the ''leak alkali treatment is t he n converted t o a highly fluorescent 
+ product of NADP in one step by the addition of strong alkali containing 
hydrogen peroxide • The resultant fluorescence is a measure of the GAB! 
present . 
The composition of various buffers and reagents and the formulation 
of the enzyme reaction mixture are given in the f ormulary (Appendix I). 
8 .2(i) . Preparation of tissue extract 
------------------
Animals 'ITere killed by cervical dislocation and decapitation . the brains 
, 
were quickly removed and dropped into liquid nitro en . Five minutes later 
the brains VTere taken from t he liquid nitrogen. \veighed and homogeni zed 
for f ive minutes in 10 ml ice cold 7516 ethanol , using an HSE top drive 
homogenizer . 
Aft er centrifugation at 14000 rpm f or half an hour , 2 ml of the 
supernatant solution 'llere eva porated to dryness , using a Buchler rotary 
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evaporator under maximum vacuum at 60oC. The residue was then dissolved 
in 10 ml of distilled water and the resultant solution was centrifuged for 
half an hour at 25000 rpn, usin.:; an riSE ultra high s ~ e d d centrifuge. 
8.2(ii) Enzymatic conversion of GABA and fluoro phore formation 
----------------------------------.-
A 100 III of the clear sU:Fernatant solution '-Tas transferred to a conical 
glass tube. 1:Thile the tubes Here standing in a rack kept in an ice !(Tater 
ba th (oOe), 100 III of an enzyme' reaction mixture 'vas added to each tube . 
The tubes were capped YTith pn-afilm, mixed on a vortex mixer and incubated 
o 
at 38 C for forty-five minutes in a rotary evapomixer opera ted to shake at 
medium sp3ed. At the end of the incubation period . the tubes ,'lere returned 
to the ice 'tla ter bath and 250 III of phos pha te buffer \"lere added to each tube . 
They ''lere buzzed vigorously on a vortex mixer, recapped and transferred to 
a s h a k i i ~ ~ water bath at 60°C for fifteen minutes. 
At the end of the fifteen minutes, the tubes vTere removed from the 
water bath and 500 III of alkali peroxide 'lIas added to ea ch one , they vlere 
again buzzed vigorously, recap:Fed and returned to the water ba th for another 
ten minutes. ~ ' l o o millili tres of distilled water \'las then added to each 
tube and they ''lere mixed thoroughly until the very fine crystals 'ilhich 
'vere produced on the addition of ,-rater had completely dissolved . 
The fluorescence i-ras then measured at 460 ml! after a9tivat ion et 
365 mil, using a Farrand spectrophotofluorimeter . 
A number of 100 III portions of different concentrations of standard 
GABA soluticn in 75% ethanol were evaporated to dryness and 100 !ll of the 
reaction mixture ''las added to each. The tubes Here then treated in the 
same manner as that described for brain extracts to form a calibra tion curve, 
examples of i'Thich are given in figure 8 . 2 . 
FIGURE 8 .2 
Typical calibra tion curves for the enzymatic f orowe ric assay of 
Y-aminobutyric acid obtained on three separate occasions 
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Two blanks were carried through the whole procedure . One vTas 
an enzyme reagent blank, a 100 ul portion of e e ~ ~ ~ o l l evaporated to dryness 
to 1'lhich 1 00 ~ l l of the enzyme reaction mixture had been added and treat ed 
as described before. The other blank was the tissue blank i'lhich i'laS 
100 ~ l l of brain extract, obtained after the ultracentrifuga tion step , to 
which 100 ~ l l of enzyme free reaction mixture were added . The mixture 
l'las carried through the vrhole procedure . 
Table 8 .3 
Recoveries of standard GABA solution added to brain extracts by the 
enzymatic fluorometric method 
Amount added Amount recovered R e ~ ~ ~ ~
----- - - ----------
~ ~ ~ ~ % 
0 . 2 0 . 18 90 
0 .2 0.18 90 
0 .3 0 .28 93 
0 .3 0 . 27 90 
0 . 4 0.39 97 
0 .4 0.38 95 
Mean recovery 92 .5 % 
8 .2(iii) Recoveries of standard GABA solution added to an extract 
------------------------------------------------------------------
of E ~ ~ i n _ h o ~ ~ ~ ~ n n ! ~ ~
Different concentrat ions of standard GABA solutions in 100 ~ l l of 75% ethanol 
were evaporated to dryness . Another series of tubes, each containing only 
100 ~ l l of 75% ethanol was evaporated to dryness at the same time . To each 
tube , 100 III obtained from one brain extract were added and the tubes Here 
treated as described before for t he assay of GABA . 
Results are shoun in table 8 .3 . 
_.-" 
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8.3 Post mortem changes in bra in GABA levels 
Y-Aminobutyric acid is one of the biologically labile compounds \-Those con-
centrat ion in the brain was f ound to be increased post mortem ( ( e r r n a n n and 
Shellenberger, 1973). We therefore performed experiments to study the 
post mortem changes in GABA levels in rat brain, and to look as well for the 
best method of killing. 'I e used liquid nitrogen in our study as it i.s the 
quickest and cheapest vlay of freezing. 
8T;(i) Comp:3.ris on betTlleen whole body i mmersion, decapitation , 
--------------------------------------------
decaPitation and skin removal , brain r emoval and dropping in liquid nitrogen 
----------------------------------------------------------------------------
The post mortem increase in the l evels of GABA i n the brain i s believed to 
arise as a result of the conver sion of a l abile pool of glutamic acid . 
The question arose in our mind whether this pool becomes active from· the 
moment of killing or whether some time has to e l ~ p s e e before activation . 
This was tested for in four different ways . The first .-las the whole body 
immersion in liquid nitrogen; in this case compl ete prevention of the con-
version which might be activated by death. should occur. The second 
experiment was to decapita te the animal and to drop the head into liquid 
nitrogen. ST/laab (1971) has suggested t hat the skin of t he skull i s the most 
important temperature insulator for the c.ortex . This wa s examined by decap-
ita ting the animal, r emoving the skin over the skull and dropping the head 
into liquid ni trogen. The fourth test was done by decapitating the animal, 
r emoving t he brain and dropping the brain itself into liquid nitrogen . In 
all the last three tests, the dropping into l i ~ u i d d nitrogen of either the 
head or t he brain was done in less than t hirty seconds . The br ains Here 
t hen treated as described in section 8 . 2 f or the assay of GABA . 
Result s are given in t able 8 .4. 
+ Mean -
S.E . 
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Table 8.4 
Comparison b e ~ ~ e e n n different ways of freezing on brain G A A ~ ~ content 
( See t e x t 
142 139 
129 143 
157 156 
144 147 
+ 
14 ' -5.7 146 :!: 3.6 
for d eta i 1 s ) 
157 
123 
126 
149 
+ 138 - 8.4 
139 
153 
140 
146 
144 :!: 3.2 
It is clear t ha t no difference in brain concentration of GABA arises 
because of the four diff erent ways of freezing. Thi s means t ha t neither 
dea th itself nor deca pi.tation have an early effect on the labile glutamic 
acid pool . So we ' decided to use the easiest and quickest ~ ' l a y y of freezing , 
which i ~ ~ s s by removal of the brain aft er cervical dislocation and. decapit-
ation and then dropping the brain into l iquid nitrogen. 
8 .3(ii) Time course of the post mortem increase in GABA of rat brain 
---------------------------------------------------------------------
This experiment t ~ a s s designed to look f or the post mortem changes in GABA 
levels revealed by the brain freezing technique . 
Ash (!l istar ra t s 'tlere killed by cervical dislocation and decapitation. 
the brain .... ras quickly removed and pl aced on a glass plate and left for the 
time r equired a t the l aboratory temperature (200C) . It was then dropped 
into liquid nitrogen , left for five minutes , removed and homo enized in 
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10 ml ice cold 75% ethanol. The brains 'I'lere assayed for their GABA con-
tent by the method described in chapter 8, section 2 . 
Results are given in table 8.5 and figure 8.3. 
Table 8.5 
Time course of the post mortem changes in 'l-aminobutyric acid in r at brain 
Time Y - ~ ~ o b ~ ~ ~ : : ~ ~ ~ ~ C ~ ~ g ~ f r ~ ~ . 1 2 _ ~ £ ~ ~ s s
minutes ~ g m m % 
0.5 125 .5 + 3.8 (2 ) -
0.66 147 .8 + 6.4 (2 ) +17 -
1 162 .7 + 4.8 (2 ) + 29 .6 
-
2 162.5 + 2.0 (2 ) + 29 .4 -
3 182.9 + - 4.9 (2) + 45 .7 
4 162.6 + - 1.0 (2) + 29 .5 
6 171 .3 + - 5.0 (2 ) + 36 
7 174 .5 + - 6.0 (2 ) + 39 
Each value is the + mean - standard error from the number of animals shown 
in P'lXentheses . 
Results in the previous section ShOYI clearly t ha t death does not by 
itself produce any effect on GABA content of the brain , in contrast to 
some other substances such as acetylcholine , the concentration of which i s 
much affected by decapitation. 
On t he other hand , it is clear from the results presented in figure 
8.3 that post mortem changes do begin some t hirty seconds aft er death . 
These changes are apparently biphasic in nature . an early increase being 
follOiTed by a decrease and then a slight increase again i n the concentration 
of GABA . 
F G t ~ ~ 8 .3 
Time course o ~ ~ the post oorteo chan-es in 
Y - a m i n o b u ~ j T i c c acid c o n c e n t t a t i o ~ ~ in ra· bra on 
• 
T 
R 
... 
o 
N 
... 
M 
... 
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8 .3(iii) Comreent on t he enzymatic method. for the a s say of GAB.I\. 
--------------------------------------------------------------
The enzymatic fluorometric method in i ts final f orm. a s presented in section 
8 . 2 , has been found to be very s a t i s f a c t o ~ ~ . . I t i s less time consuming 
than p:1per chromatogra.phy . a large number of samples can be run a t the same 
time , it is v e ~ J J reproducible (samples carried out in triplicate gave a 
coefficient of variation of not more than 3%) but t he mos t i mportant p o o ~ t t
is that it is very sensitive . the Im'Tes t concentration u sed of s t andard 
GABA solution ( 100 ng!tube) had a fluorescence "Thieh '/las doubl e that of the 
enzyme or tissue blanks . Although t he sensitivity of the method coul d 
be increased a l ot more by decreasing the dilutions and t he volumes of t he 
solutions and reagents used , it is still , as it is nmv . very sensitive f or 
the assay of GABA in either 'Ilhole or Farts of the brain . 
r a t brain 
Female Ash ltlistar rats weighing bet''leen 140 and 160 gms i'ler e used . The 
animals 'l'Tere obtained one "Teek before the experi ment . They \'Tere caged 
i n sixes and alla,'led free access to food. and iva ter . 
One ''leek later , the rats were divided into groups of f our a nd each 
group received an intraperitonea l injection of phenobarbitone (1 00 me!kg) , 
phenytoin (75 mg/kg) or carbamazepine (50 mg/kg) . Control groups of r ats 
were injected ,oJ'i th the appropriate volume of the corresponding vehi cle . 
The animals were killed by cervical dislocation and decapitation at 
certa in times af t er injection. Tneir brains vTere qui cldy removed a ne. dropr;ed 
into liquid nitrogen , ,.,her e they i'lere left f or five minute s . They ' .. ,ere 
then homogenized in 10 ml of ice cold 7 7 ~ ~ V/ V ethanol a nd assayed for their 
GABA content by the method described in section 8 . 2 . 
Results are given in tables 8 . 6 a nd 8 .7. 
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Phenobarbitone increased the total brain levels of GABA thirty and 
sixty minutes after its injection; thereafter the levels of GABA returned 
to their normal values . On the other hand, neither phenytoin nor carbam-
azepine had any effect either thirty or sixty minutes after t heir injection. 
Table 8 .6 
Effect of single doses of phenobarbitone on the levels of GABA 
Time ~ t e r r i n j e c t i ~ ~
minutes 
o 
30 
60 
90 
120 
in rat brain 
GABA 
~ g m m
152.6 ! 1.9 (4) . 
171.2 ! 1.88 (4) 
163.6 ~ ~ 4.8 (4) 
144.9 ~ ~ 7.7 (4) 
145 .4 :!: 10.4 (4) 
~ h a ~ e _ f r £ ~ ~ £ _ ! ! ~ ~
% 
+ 12.17 
+ 7.20 
- 5.07 
- 4.73 
P 
t test 
< 0.C01 
< 0 .05 
N.S. 
N.S. 
Each value is the mean ! standard error from the number of animals shown 
in pu-entheses 
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Table 8 .7 
Effect of single doses of phenytoin and carbamaz e pine 
on GABA levels in r a t brain 
Treatnent TiIUe after GABA Change from p 
------ ------
-controI--~ ~ j j ~ t i ~ ~ ~
-----
minutes f!g/gm ~ ~ ~ t test 
Saline + + 1% ~ i T e e n n 80 30 and 60 130 .4 - 7 .1 (4 ) 
Pnenytoin 30 + 138.3 - 2.7 (4 ) + 6 .1 N.S. 
60 + 136.2 - 3 . 2 (4 ) + 4 . 5 N. S. 
Prow-lene + (4 ) glycol 30 and 60 151.4-3.2 
Carbamaz e pine 30 + 155.4 - 5 .2 (4) + 2 .6 N.S. 
60 + 146 . 2 - 5.4 (4) - 3.4 ' N.S. 
+ Each value is the IUean - standard error from the number of animal s shmrn 
in J:E!,rentheses 
PAR T III 
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PAR T III 
CHAPl'ER 9 
PRODUCTION OF EPILEPTIC LESIONS IN THE RAT 
After 'tTe had studied the actions of antiepileptic drugs on normal 
animals, the question naturally arose as to whether the neurotransmitter 
agents in the brains of healthy r ats would behave in the same manner as 
those in the brains of animals producing epileptic discharges. and simil-
arl y whether an anticonvulsant drug would have the same effect on a part 
of the brain exhibiting focal activity as on the rest of the brain . 
A search through the literature revealed that the best method of 
producing chronic epileptic focus in r a ts (which are r esistant to other 
possible techniques ~ c h h as local freezing and alumina) \'las that first 
described by K"qel.off (1 960) , Tllho appiied cobalt pmTder to the cerebral 
cortex. The advantages of this method were discussed by Emson and Jos eph 
(1 975), ,.,rho pointed out that it gives a secondary focus in the homotopi c 
area of the contralateral cortex free from the direct effect of the cobalt . 
Furthermore, the model is chronic and shows epileptiform activity for a 
long t ime. 
The first step i:l t ~ i s s experiment 'tTas to find a ltlay of measuring 
the brain acti vi ty i n altTake , unrestrained rats in order to follmv the 
progress of epileptic activity after cobalt i mplantation . 
9.1 ~ ~ e a a u r e I ! l l n t t of the brain activity of unrestrained , nonanaesthetized rats 
De Vos and Bonta (1964) developed an electrode set i'lhich permits the electro-
ence phalographic measurement of the unrestrained nonanaestheti zed rat . ' .. fe 
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have adopted their technique , ivi th some modif ications , to use in our s t udy . 
The electrode set consisted of five stainless steel screv! electrodes, 
mounted on a common plastic pl ate the size of ltImch ivas 12 x 8 mm and vli t h 
a thickness of 1 mm (see figure 9 .1 (A)) . The electrodes Here 4 mm in 
length but only 2 mm protruded from the lO'tler surface of the plat e . Four 
-
of t he electrodes which were used for recording were mounted 6 mm apart 
from each other, the fifth electrode in the front point of the plate serv-
ing to provide an indifferent earth connection. 
Stainless steel washers , soldered to shprt lengths of insulated wire . 
were fixed under the head of the electrodes . The short lengt hs of "lire 
terminated in a common socket for connection to the recording apparatus 
(Figure 9.1 (B)). The total weight of the electrode set was 1 gm. 
A guide plate (Figure 9 .1 (C)). equipped ,.,ith a small handle and 
made the same size and shape as the plastic plate on which the electrodes 
were mounted, was used for marking t he holes i n the skull of the rat in 
which t he electrodes were to be implanted. 
I I p ~ ~ n n ~ ! i o ~ ~ p r ~ ~ ~ ~ ~
Female Ash 'listar r ats ,.,eighing between 150 and 160 gInS 'Il'ere used . 
The rat vTas anaesthetiz ed with an intraperitoneal injection of 
50 mg/kg pentobarbitone , the skin of t he head vTas shaved and the scalp 
was then cut along the midline from the level of the eyes to that of the 
ears . The skin wa s then reflected laterally as far as possible and t he 
exposed bone \'las cleaned of muscle and f sci a until it appeared t o be dry 
and the bone sutures vlere clearly visible . The guide pla t e i'laS t hen 
placed on t he skull . ensuring that t he front point of t he pl a te VIa s in 
FIGURE 9 . 1 
(A) Electrode set component 
(B) Assembled electrode set 
(C) Guide pIa te 
(See text for details) 
(A) 
iB) (C) 
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the midline of t he head a nd t hat the rea r end "Tas in line ',lith t he occip-
ital suture . The holes required f or the int roduction of t he elect rodes 
i'1ere drilled through the pref ormed hole s of t he gui de pl a t e l'1 i th a denta l 
drill . The diameter of the holes \Vas s lightly smaller than t ha t of t he 
electrodes. Thereafter the guide Fia t e 'ITa s t aken off and the electrode s 
plate placed on the skull a nd t he electrodes ,Tere s cre".'/'ed gently. into t he 
holes . The screwed electrodes fitted firmly in the skul l and needed no 
other means of fixation. 
The top of the electrodes pl ate \1as then cover ed vii t h denta l cement 
to ensure complete insulation and vias left to dry. Ther ea fter , a n a nt i-
biotic was sprayed on to the skull and the skin ,<la s sutured usi ng a steril-
ized cotton thread, so that only the connecting termina l socket, which was 
extended to the back of the head, remained exposed. 
After operation, rats i-lere placed in individual cage s . 
The electrodes 'tlere located in the brain a s follows : hT O bilatera lly 
in the frontal cortex and t he other tivo in the par 1etu cortex . 
A cable coupler, i1hich l'las first described by Sutton and Hi ller 
(1963), was obtained from a comnercial source. This cabl e coupl er , vThich 
was connected bet 'tTeen the animal and a connection s elector. a l l oHed the 
recording cable to turn freely as t he animal moved and a t t he same time 
maintained electrical continuity . 
A connection selector. l<lhich vTas pl a ced be t i'Teen t he cable cou_ler 
and the r:ecording app3.ra tus , allo\'Ted us to se l ect and var y t he pairs of 
electrodes f rom 'IThicb the recording for ea ch channe l "Toul d be t a ken . 
The r ecording a "'Omr a tus 'lias a Devices four channel physiologi cal 
r ecorder I'Thich ',,;as conne cted to t he connect i on s e l ector an to a n 
FIGURE 9.2 
Diagram used for the measurement of br ain activity 
of unrestrained n o o n a e s t h e t i z e d d rats 
(1) Cable coupler 
(2 ) Connection selector 
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oscillOSCOF€ 'tlhich gave a visual tracing of the brain IS activity . Figure 
9 . 2 indicates the general arrangement of the recording and other apparatus. 
Bipolar records ivere t aken as follo',1S: 
1. Left a nd right frontal 2 . Left and right parieta l 
3. Left frontal. left parietal 4. Right fronta l. right parietal. 
A typical record taken i mmedia tely after the electrode impl ant a tion 
i s give!) i n figure 9.3. Figure 9.4(A) Has t aken t-,venty-four hours aft er 
the implantation and figure 9.4(B) was t aken one month after the implant-
ation. 
Immediately after the opera tion, the EEG traces f r o ~ ~ the four channels 
vlere characterized by sharp high voltage single spikes. These spikes dis-
appeared twenty-four hours later and our immediate explanation of this was 
tha tit ioTaS due to a n injury to some brain cells inflicted during implant-
ation of the electrodes. Thereafter, the tra ces appeared normal a nd the 
rattern rerr.ained unchanged throughout the four ',leeks over ,oJ'hich the r ecording 
iias made . In addition, the behaviour of the animal vii th impl a nted ele ctrodes 
was entirely normal and no sign of stress or infection waS seen . 'if e I-rere 
satisfied , therefore, ",ith the technique and 'l1e used it in our subsequent 
experiments . 
The second step in the eXF€riment , .. as the product ion of an epileptic 
lesion . Cobalt poI'lder , cobalt gelatine sticks and cobalt 'Hire have a ll 
been used by different vlorkers in this field . In preliminary ex periments , 
we found that the use of the cobalt pOvTder ,vas not sa ti sfactory , since the 
amount of the poHder applied to the cortex could not be sta ndardized, a nd 
this, vie thought. might give lesions of varying acti vi t y ',vhich !:light , in 
turn, affect our results. , 
FIGUrtE 9.3 
Traces of normal brain activity taken imnediately after electrode 
implantation 
1. Left and right frontal 2. Left and right :p3.rietal 
3. Left frontal , left parietal 4 . Right frontal , right IErietal 
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FIGURE 9.4 
Traces of normal brain activity taken tiventy-four hours (A) and 
one month (B) after electrode implantation 
1. Left and right frontal 2 . Left and right parietal 
3. Left ~ r o n t a a , , left parietal 4 . Right frontal , right parietal 
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B 
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The use of cobalt gelatin sticks ioras f irnt descr i bed by Fische::- , 
Holubar and ~ ~ l f k k (1967) and thi s overcame the disadvanta e of cobalt 
povlder \'lhich we have already mentioned . Other advantages , to o, i-!ere 
described by the authors in their p::l.per . The cobalt ilire and pm.,rcier ',Ter e 
obta ined commercially from Gooofell ou metals . 
~ l e r e e prerared i n our de:r:a,rtment . 
The cobalt ela tin sti cks 
P r ~ ~ £ ~ t i £ £ ~ ! _ ~ ~ ~ ~ ~ ~ _ ~ ~ ~ _ ~ ~ ~ ~ ~ _ ~ ~ ~ ~ ! ~ ~ _ ~ ! ~ ~ ~ ~ ~
The method used \'las tha t des cribed by Fi s cher , Holubar and -!alfk (1 967 ) . 
Five grams of either metallic cobalt po\'Tder ( (esh 200) or fine lass 
pO\'lder and 5 t o 7 ml of vTarm (about 56°C) 5% gelatin solution -Tere stiITed 
in a mixture using a glass rod . and kept at 56°C in a test tube . After 
p::l.rtia l ~ e d i m e n t a t i o n n of the suspended pO\'Tder and decanta tion of the super-
natant gelatin solution , the mixture vTas poured. on to a horiz onta l i·mrm 
slide to form a layer of about 1 mm t hick . ~ ~ t e r r cooling . the solidif ied 
cobalt gelatin film was dehydrated for three hours in acetone and kept for 
tyr o hours in a desiccator in formaldehyde vapour . The sli d.e ITas then 
,'lashed rep3atedly in distilled wa t er a nd kept i n 80% alcohol. 
Before use , tile a lcohol ~ . , a s s evapora ted to drynes s in a n oven a t 56oC. 
9 . 2 Behavioura l studies and t he measureme nt of locorr. otor activit" in r a ts 
i mplanted ~ i i h h cobalt gelntin stick . cobalt wire o ~ ~ glass ~ e e a a i n n stick 
Female Ash ':lista r r a t s weighing be tt'leen 140 and 160 gIllS iJere housed in 
individual cages a ~ ~ ~ kept in reverse daylight condition . the dar k cycle 
starting at 10 . 15 a . m. and the light cycle a t 10 . 15 p.m. The ra ts -,'/er e 
tes ted for their sensitivity tmlards s ound s timula tion . Irone of the r a ts 
to be used exhibited any convulsions in r esponse to t he one mi nute perioc 
of s o u ~ d d stimulation described in chapter 3. 
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One ''leek later the rats ,ver e divided into four groups of four and 
each '"as anaesthetized vTi th 50 mg/kg pentobarbitone given by i ntra FBri toneal 
injection. The skin was shaved and the scalp was cut along the mi iline . 
The skin was reflected end the exposed bone was cleaned fr om fascia and 
muscle so tha t the bone sutures Here clearly visible. 
Using a dental drill, a hole vTas bored in the skull at a point 2 mm 
to the right of the midline and 2 mm posterior to the bregma . The dura 
was cut by means of a fine needle and a cobalt gelatin stick , a glass 
gelatin stick (1 x 1 x 2 mm) or cobalt wire (1 x 2 mm) was impl anted i nto 
the cortex at right angles to its s u r f ~ c c . .
The skin was then sutured using sterilized cotton thread a ~ ~ ~ the 
animal was left to recover in its cage . The fourth group of animals vTaS 
operated on as described but received no implant . 
control group. 
This group served as a 
The plate in figure 9.5 shows the position of the hole in the skul l . 
Body weight, body temperature (measured rectally by using electrical 
thermometers equipped l'lith rectal thermistors). food. and '-Ta ter intakes were 
monitored daily at 9 .30 a . m. One hour after starting the dark cycle 
(11.15 a .m. ), the motor activity of three r a t s from each group'tTaS measured 
for fifteen minutes each hour f or four hours using an Animex apparatus . 
Starting ''lith a different group each day. the ra t s '!Tere left for five 
minutes on the apparatus before the actual counting of the motor activity 
started . 
The Animex was set at a sensi tivi ty of 25 r.ticroampere and it 'tTaS 
tunecl..; every time at 40 microampere. 
FIGURE 9.5 
Plate of skull s showing the position of the h ole through 
which i mplanta tion of cobalt stick , cobalt ,'fire or gl a ss 
gelatin stick ivas made 
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After f inishing measuring the motor activity (around 4 . 0 p. m. ) , 
each rat \vas assessed behaviourally for at least five minutes in order 
to detect and f ollovr any behavioural changes tha t Inight be taking place . 
Results 
Twenty- four hours after the operation , the motor a ctivity of r a ts implanted 
wi th either cobal t sticks or vrire \.,a s depressed , but only the group impl anted 
Hith cobalt sticks shmved a significantly 10lver activity ( p < 0 .02) than 
control animals (Figure 9.6) . 
Rats implanted with cobalt '(Tire ate l ess during the first nine day s 
after the opera tion, but ap:1rt fr om that all grou ps ate and drank the same 
amount during t he \,Thole period of the experiment (Figure 9.7) . They 
gained ,'reight a t the same rate, and a lthough there were slight fluctua tions 
in their body temperature , there ~ . , a s s no s i gni f icant difference i n r ectal 
temperature among the four groups , except on ,the fifteenth day , when t he 
three implanted uroups all shm-red s ,1ightly higher temper a tures than the 
sham operated group (Figure 9 .S) . 
Behaviourally , rats in the four groups wer e indi stingui shable f rom 
each other t 1renty- four hours after the operation . 
Three days after the operation , r ats implanted ~ i i h , c o b a l t t sticks 
started t o lift their contra l a teral hind limb on walking and by the fifth 
day both cobalt groups started to shm., noli tches of the contra lateral h ind-
limb . These twitches Io{ere stronger when the rats ';ler e at rest . Some 
r ats inclined towards t he side of the implantation "Then they ,-rere di spl aying 
povrerful t\vi tches . 
FIGURE 9 . 6 
Locomotor activity of r ats implanted i-rith cobalt vT ire (left hatched 
columns) , cobalt gelatin sticks (right hatched colunns) , lass 
ge l atin sticks (dot t ed columns) or sflam oper a ted r ats (open columns) • 
Significant ly different by the t test (* P < 0 .05 ; +* p < 0 .02) 
f r r ~ ~ the va lues obtained f r o ~ ~ the sham opera ted group . 
Each bar is the mean:!: standarc. error cf four observations , taken OVer a 
four- hour period , of three rats (see text for details) . 
III 
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FIGVLtE 9.7 
Changes i n food and water intakes of r ats im planted Hith cobalt It/ire 
(left hatched columns), cobalt ge latin sticks (right hatcr-.ed .:::ohu::ns) , 
glass gelatin sticks (dotted columns ) or sh8.o operated rats (o pen COlumns). 
Significantly different by the t test (* p < 0 . 05 ; ** ** p < 0 . 001 ) from 
the values obtained ~ r o m m t he .sham operated grou p_ 
+ Each ba r indica tes the mean - standard error for four r a ts . 
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FIGURE 9 .8 
Changes of body ,..,ei ghts and body temperatures of rats 
i mplanted with cobalt wire (left hatched columns) , cobalt gelatin 
sti cks (right hatched oolumns) . glass gelatin sticks (dotted 
columns) or sham operated r ats (open columns ) • 
+ iach bar i ndicates the mean - standard error for four r ats . 
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On the seventh day , each r a t i.,ra s subje ct ed to the s Olmd of t11e bel l 
for one mi nute (as described i n chapter 3) . None of the r a t s exhibi ted 
any form of con-TUlsion . H o,.,r ever , s ome of the r ats i r:lpl anted -,dth cobalt 
exhibi ted an incre2.se in the fre quer.cy of hii tches during t he sound stin:-
ula tion. 
By the eighth day after the operation , hritches of the contralatere.l 
fr ont limb sta rted to appear in both t ypes of cobalt i mplanted r a ts . In 
cobal t stick rats , t ';ri t ches in the con tra l a teral hind li:nb ' / l e e e e a ccom:;:ani ed 
someti mes by a violent i'li t hdra'tTa l of t he Tilhole limb, ~ ' l l i c h h occasionally 
s pread t o involve the "Thole body i n a f orm of strong body j er k r emi ni scent 
of the ' wet dog shake ' seen in anirne.ls 11i thdr a,m fr om mor p iine . Hats in 
a standing position shoi'led a s tereoty ped movement in which they rr:.oved the 
head and the body trunk from the midline of the body to the s i de of the 
implant ati on in cont i nuous r hythm . The musculature of the cont r alat er e.l 
hind limb ',las weak, as i s shmm by the fact t hat the r at a ppea:ed to move 
the leg only "Ti th difficulty i"hen progressing f orward . 
On le. ter days , the t i'litches of the contra l ateral limbs in r :l t s 
implanted '\-li th cobal t ~ ' T i r e e became nore frequent and they -.. rere e.cconp:3.ni ed 
by some jerks of the ':Thol e body . These hli tche s came s ometi mes as a 
strong burst of continuous hTi tches f ollmred by a period of r est i'lhich w:..s 
f ollovred by another burst of bTi tches . I n r e. t s impl a!1tecl 'd i c:h cOb:3.ft 
sticks . the ti'Ti tches "Tere even stronger and mo:'e f r eq,uent and vrere a ccolfl?ln-
i ed by violent ·:Titr..dr ai'ial jerks of t he limb 1·rhich sprec.d. to i nvolve mo:'e 
proximal musculature . 
time . 
'rhese r at s became irri t t ~ l e e to touch <iurin3' this 
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On the thirteenth day after the operation, a movie film was made 
(a cORr of this film has been deposited in the department) . It shows 
the peak effects described above in rats given cobalt . 
The motor activity of r ats with cobalt stick impl ant s started to 
increa se from t he tenth day after the opera tion so that by the tuelfth 
to the fifteenth day after operation it Has significantly higher than tha t 
of control aninals (figure 9.6 ). 
After tae sixteenth day, jerks became less fre quent and less violent 
and by t he end of the third 'I'I'eek only ti<Ti tcnes could be seen in both groups 
of cobalt implanted rats . 
None of the rats sho'lted any convulsions in response t o sound stimu-
l ation hTO or three weeks after operation . 
9.3 The appearance of lesions produced by cobalt impl a nta tion 
One, t 'lTO or three \Teeks after t he implantation of cobalt wire , cobalt 
-gelatin sticks or glass gelatin sticks , r a ts i'lere a naesthetized i'l'i th 
50 mg/kg pentobarbitone by intrap3ri toneal injection . The chest l'TaS 
opened and cardiac perfusion of about 20 ml of 1570 formalin "Tas performed 
into one of the ventricles after making a cut in t he OPPOSite ventricle . 
Ten minutes later the brain i'TaS removed and kept in f ormalin solution . 
The plate in figure 9.9 sho'\vs the .position and t he extent of t he 
l esions produced one 'ITeek a fter implanta tion of cobalt wire a nd stick. 
The lesions were about 1 mm in diameter around t he i mpl a nta tion site and they 
extended through the depth of the cortex . In animals given either cobalt 
'ITire or cobalt stick t he contra lateral cortex appe <> r ed normal . Picture 
no . 3 of the same figure ShOi'IS the response three ,veeks . ~ ~ fter the impl a n-
t ation of glass gelatin sticks ; there ,'las a very sli G'ht su per f icial 
FIGURE 9.9 
Plate shm-ring the appearance of the brain lesions produced by implan_ 
tation of cobalt gelatin sticks, cobalt wire or gl ass gelatin sticks 
".) One vreek after implantation of cobalt gelatin stick 
1, ) One \'reek after implantation of cobalt ,.ire 
3) Tr..ree I'reeks after implantation of glass gelatin stick 
4) Brain of sham opernted r a t 

FIGU3E 9 . 10 
Plate s h h ~ ~ r i n g g the appearance of the brain lesions produced by the 
implantation of either cobalt gelatin stick or cobalt ,'rire 
, ) Two "leeks after the implantation of cobalt ..,elatin stick 
5) Tvro ,'leeks after the implantation of cobalt wire 
S ) Three ,'leeks after the implantation of cobalt gelatin s t i c ~ ( (
l ) Three ,'Teeks after the i mplanta tion of cob3.lt vire 
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lesion \'/'hich did not extend i nto dee fe r cortical areas . Picture no. 4 
shm'/'s the bra in of a sham operated r at three \v eeks a fter operation. 
By the second ,.;eek after t he iI::lpl ant ation of either coba lt \'Tire or 
sticks ( plate shO'iTn in figu.re 9. 10) , t he le sions ',,,ere larGe and i n the 
ca se of the cobalt gelatin sticks, dark ne crot ic tissue i n the centra l 
area around the implantation site ",as seen . 
By the t!1ird ';veek after impl anta tion, an increased vascularity ',Tas 
obvious in t he brains of aniID9.1s given cobalt "Tire or sticks (figure 9. 10) . 
Although t he contralateral cortex seemed to be u u ~ f f e e t e d d sUfer-
ficially , hlO or three \'Teeks a fter t he impl antation of either cobalt ',,,ire 
or coba lt stick, inspect ion of the deeper l ayers (revea l ed aft er henisec-
tion of the bra in ) shmTed that the lesions spread to the contr a l ater:l l cor-
tex by the second ,,,eek after il!l9lanta tion (figure 9 .1 0 (5) , (6) , (7 ) ane. 
(8» • 
9 . 4 Bra in a ctivity of rats i!!lDl a nted t'li"th cobalt gelatin stick , cobalt 
tdre or glass gelatin stick 
The follot"ing ex periment t'las carried out in order to f ollow the chancies 
in the brain activity of rats implanted \'Tith cobalt gela tin s ticks , cobalt 
trire or glass gelatin sticks . 
Female Ash ':Jistar r a ts :'reighing bebreen 140 and 160 gms \ver e used . 
The rats lvere housed in individual ca ues on reverse daylight . One I'reek 
after housing , each rat \'ras anaesthetized 1,-lith 50 r:lg/kg pentobar bitone by 
intraperitoneal injection and a cobalt gelatin sti ck . cobalt I'Ti re or gl ass 
gelatin stick 'Iras impla.'1ted as described i n chapt er 9 , section 2 . Each 
rat received a set of electrodes as described in chapter 9, s e e t i o ~ ~ 1 • 
The rats vlere then left t o recover in t heir cages ' : T ~ ~ r e e their br .9.in a cti vi t ~ , ,
''las monitored t ,\,lenty- four hours l a ter, as described in section 9.1 . 
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In order t o follo',,; the progressive change in brain a cti v i t y , a 
scoring system \'l!:ich involved countine the nunber of burs t s of s pike dis-
charge for a certa in ~ ~ i i d d of time \'1as devi sed . The br a in a ctivity 
re cor ded by ea ch of the f our channels for each rat vias f ollo',1ed vi sue..lly 
using the oscilloscope for five minutes , and the tota l number of discharges 
f or each rat over a ~ r i o d d of brenty minutes was t aken . Only continuous 
burst s of spikes conta ining no fevrer than five high voltage spi kes fer 
burst 'Viere counted , so t ha t isolated single spikes , .. ere not counted . The 
t otal number of the continuous bursts of spikes in the four cb.annels iJaS 
t hen plotted against the time in days t hat had ela psed since the operation . 
Results are shown in figure 9 . 11 . 
The results Shovl that the tota l number of spikes \.as maximum be 'breen 
day ei ght and day fifteen after implanta tion of either cobalt stick or cobalt 
wire . Glass gelatin sticks gave spikes a s 'ITell but they Vler e very fel'T. 
They, t oo , rea ched a maximum eight days aft er i mplanta tion and thereafter 
declined . 
Fi gures 9 . 12 , 9 . 13 and 9 .1 4 S S O ~ l l traces of brain act i vi t y t aken 
f ive days after i mplantation of glass gela tin sticks , cobalt gel a tin sticks 
and cobalt wire respectively . The br a in a ctivity of the r a ts im pl ant ed 
ltTi th cobalt gelatin sticks sho'lled a hi gher voltage background acti vi 'bJ than 
those implanted 'I'lith cobalt wire or glass gelatin sticks . The burst of 
spikes recorded in channels one and four f rom r a t s i mplanted with cobalt 
wire vlere of a higher frequency and voltage t han those from r aL that had 
received cobal t gelatin sticks . 
Fourteen days after t he i mpl ant a tion , cobalt 'Jela t i n sticks produced 
a higher background activity than di d cobalt ,'Tire in channels 1. 3 and 4 ; 
beside the burst of high voltage spikes . the b[lck.:,ar ound activity ':Tas char -
acterised by a large number of high voltage single spikes (fi gure 9 . 16) . 
FIGURE 9 . 11 
Develo}ment of abnormal s pike a ctivi ty i n rat s implanted Hith gl ass 
gelatin stick (A) , cobalt gelatin stick (3) ana. cobalt 'dire (C) 
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FIGURE 9.12 
Traces of brain activity of rat. implanted \ ~ t h h glass gelatin stick 
into the right cortex taken five days after implantation 
1 . left and right frontal 2 . left and right parietal 
3. left frontal . left parietal 4. right frontal . right Farietal 
1 
3 . ".,,""" 
4 
~ . . 100AJV 
1 Sa:. 
FIGURE 9. 13 
Tra ces of brain activity of rat i mplanted with cobal t gelatin stick 
into the right cortex taken five d&ys after the implantation 
1 . left and right frontal 2 . l eft a nd right parietal 
3. left frontal . left parietal 4 . right frontal , right parietal 
1 
2 
3 
~ ~ 100.uv 
1 Sec. 
FIGURE 9.1 4 
Traces of brain activity of rat implanted with cobalt wire 
into the right cortex taken f ive days after the implantation 
1. left and right frontal 2. left and right parietal 
3. left frontal , left parietal 4 . right frontal, right parietal 
1 
2 
3 
~ ~ 100AJV 
1Sec. 
FIGURE 9.15 
Traces of brain a c t t v i ~ J J of ra t implanted with glass gelatin stick 
into the right cortex taken fourteen days after the implantation 
1. left and right frontal 2 . l eft and right parietal 
3. left frontal , left parietal 4 . right frontal , right rarietal 
2 
3 
4 
1 
---.! 100,uv 
1Sec. 
f 
FIGURE 9. 16 
Traces of brain a ctivity of rat i mplanted w i ~ h h cobalt gela tin 
stick into the right cortex t aken fourteen days after the implantation 
1 . left and right frontal 2 . left and r i ght parietal 
3. left fronta l , left parietal 4. right frontal , right parietal 
2 
3 
4 
~ ~ 100,Uv. 
1 Sec. 
FIGURE 9 . 17 
Traces of brain acti vi ty of r at implanted ,'lith cobalt ,'lire 
into the right cortex taken fourteen days after the implantation 
1 . left and right frontal 2 . left and right parietal 
3. left frontal, left parietal 4 . right f rontal, right parietal 
1 
2 
4 .'IrYU'1 ... ".,. ..... 1 
. ~ ~ 100,Uv 
1 Sec. 
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On the other hand , cobalt vIire :;;roduced chara cteristic bursts of very fast 
high voltage spikes (figure 9 . 17) but the background activity r esembled 
that produced by glass gelatin sticks (figure 9 . 15 ) . 
;:[e noticed during the course of these experiments t ba t the outbursts 
of spike activity usually took place only when the r at ,vas at res t. Even 
when the rat had been moving around carrying on it s normal activi ty, it 
would stop and stand in a characteristic position a second befor e there was 
an outburst of spike activity . After the burst. the animal r e turned to 
its normal activity so that for most of the tiDe 'Ire could predict the onset 
of a burst of EEG acti vi ty by noting ltThen that r a t had taken u p the char -
acteristic position. 
Furthermore , we found little correlation b e ~ i e e e . t h e e time of occur-
rence of the burst of spikes and the limb jerks and '1ve only r arely not iced 
the occurrence of both events s i m u l l a ~ e o u s l l . .
9,5 The effect of cobalt epileptic lesions on the l evels of netrrotra ns-
mitters in r a t brain 
Til e have seen in the previous sections of this chapter t lw. t the maximu:n 
epileptogenic effect produced by either cobalt stick or Hire occurred 
between the seventh and fifteenth day after the impl antation. \{e there-
fore performed ex periments in vThich Ive mea sured t he levels of t he neuro-
transrni tters vie previously studied. during three times : one 1'Teek ~ f t e r r
implantation (the start of the maximum e pileptogenic effect). 17 .. ro i-reeks 
after implanta tion (the time of reak epile pto enic ef fect) and three \'leeks 
after implantation (i·rhen the epi leptogenic effe ct started to fade ) . in 
order to see l"het!ler t here ' .. lere any changes in t he levels of any of t he 
neU!'otransl!'.i tters 'Ire studied and ",hether any of the change s observed 
correIa ted in any 'ITay id th chanzes observed i!1 the motor and cr3.in a cti vi ty . 
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Female Ash ':listar rats \-lei ghing be"b'leen 140 and 160 gros \-lere used . 
Cobalt gel a tin sticks, cobalt ,-Tire or glass gelatin sticks I'Tere im9l anted 
into the right cortex by the method described in secti on 9.2 . The rats 
i-lere killed a t va rious time s thereafter and their brains \'Tere reooved and 
cut longitudinally along t he midline i nto two halves. Each 'half ',Tas then 
assayed f or its dopamine and noradrenaline content by the method described 
in chapter 1 or for its 5-hydroxytryptamine and 5- hydroxyindoleacetic a cid 
by the methods des cribed in chapter 5 or for its GABA content by the me thod 
described in section 8 .2 . 
Results are given in tables 9.1 to 9.7. 
Cobal t sticks and vTire produced a significant decrease in t he levels 
of both noradrenaline and Y-aminobutyric acid in t he implanted half of the 
brain one week after t he implanta tion. At the same time. cobalt sticks 
produced a significant decrease in the levels of noradr ena l ine in t he contra -
lateral half of the brain as \-Tell. DOfami ne and 5-hydroxytr'Jptamine content 
were not changed by either cobalt sticks or wire but 5 - h y d r o o J i n d o l l a c e t i c c
acid was significantly increased by both cob3.lt \dre and sticks in the 
implanted half of the brain . Cobal t i.; ire produced a significant i ncrease 
in the levels of the indole in t he con trala teral half as "Tell . 
1\110 'fTeeks a fter the im pl antation . t he effect on GA.B!" levels dis-
appeared . On t he other hand . t he levels of noradrenaline in r a t s impl anted 
i'1i th cobalt sticks Ivere still depressed . At this time. too . t te levels of 
5-ilydroxyindoleacetic a cid vTere significantly increased in both halves of 
brains t hat had been implanted ivi th cobalt stick . "Thile cobalt 'dire pro-
duced a significant increase i n t he levels of this indole in t he implanted 
side only . 
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Table 9.1 
3ffect of one week implantation of cobalt gelatin sticks , cobalt wire or gl ass 
gelatin sticks on the l evels of dopamine and noradrenaline i n rat brain 
Treatment R i g h h _ h h ~ f f Left half R i ~ ~ ~ ~ ~ f f Left half 
---- ------ --------
D O ~ i : : : ~ ~ Noradrenaline 
-----------
ng/gm ng/gm 
Cobalt gel atin 
893 ~ ~ 29 .3(4) 912 ~ ~ 17.7(4) + ** 366! 13.7**(4) sticks 348 - 6.2**(4) 
922 ~ ~ 16 .4(4) ~ ~ 23 .1(4) + ** . + (4 ) Cobalt wire 921 352 - 3.5**(4) 432- 16.3 
Glass gelatin 
933 ~ ~ 19.0(4) 897 ~ ~ 32 . 1 (4 ) + (4) 48i!: 22 .0 (4) sticks 467 - 12 .0 
929:!: 17.8(4) 899 ! .19.3(4 ) + (4) 453= 27 .0 (4) Sham operated 493 - 12.3 
+ Each value is the mean - standard error from t he number of animals shown in 
parentheses. 
Significantly different by the t test (** p < 0.02 ; 
values obtained from the sham opera ted group. 
** 
** p < 0.005) f rom the 
Table 9.2 
Effect of two ,.,reeks implantation of cobalt gelatin sticks , cobalt idre or 
glass gelatin sticks on t he levels of dopamine and noradrenaline in rat brain 
Treatment 
Cobalt gelatin 
sticks 913 ! 68(4) 
Glass gelatin 
sticks 925 :: 32 (4) 
Sham o:r;erated 933::: 28(4) 
Left half 
909 ! 41 (4) 
890 ! 57(4) 
899 :: 26(4) 
885 ! 19(4) 
Left half 
Noradrenaline 
ng/gm 
473 :: 27.0 (4 ) 
486 :: 12 .0(4) 
479 :: 11. 6 (4 ) 
491 ::: 8.4(4 ) 
+ Each value is the mean - standard error from t he nUI:1ber of animals shmm 
in p3.rentheses . 
** Si gnif icantly different by t he t t est (** p < 0.001) from the va lues 
obta ined f rom the sham operated group. 
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Table 9 .3 
~ f f e c t t of three weeks impl antation of cobalt gelatin sticks . cobalt wire or 
gl ass gelatin sticks on the l e'Tels of dOp3.mine and noradrenaline in rat brain 
Treatment ~ ~ g ~ ! . . ~ l f f Left half R R g h h _ ~ ! f f Left half 
----- ----- -----
D O F 8 - ~ ~ ! : : Noradrenaline 
-------
ng/gm ne/gm 
Cobalt gelatin 
949 ! 4(4) + 3(4) 398 ! 10(4) 478 ! 12(4 ) sticks 937 -
Cobalt wire 898 :: 28(4) 963 :: 17(4) 483 :: 20(4) + 488 - 18(4 ) 
Glass gelatin 
936 ! 56(4) 946 :: 35 (4) + 5(4) 473 :!: 19(4) sticks 485 -
Sham 0 p3ra t ed 961 ! 18(4) 897 :: 34(4) 458 :: 37(4) 474 :!: 17(4) 
Each value i s the mean :!: standard error f rom the number of animals shown 
in p:u'entheses . 
Table 9 .4 
Effect of one week implantation of cobalt gelatin sticks , cobalt vrire or 
glass gelatin sticks on the levels of 5-hydroxytryptamine and 5- hydroxy-
indoleacetic acid in rat brain 
Treatment left half Left half 
5-Hydroxytryptamine 
- - - - - - - ; g 7 ~ - - - - - - -
5-Hydroxyindoleacetic acid 
------;-7--------
ng;gm 
Cobalt gelatin 
sticks 512 ! 38 . 4(4) 511:!: 19.7(4) 372:!: 13**(4) 31 3 :: 13 (4) 
Cobalt wire 548 ! 27 .7(4) 498:: 9 . 1(4) 371:: 13**(4) 391 ~ ~ 5::(4) 
Glass gelatin 
sticks 503 ! 20 .8(4 ) 500:: 19.3(4) 341 ! 10 (4) 333:: 15 (4) 
Sham operated 499 ! 17. 3(4) 492 :: 13.8(4) 323:: 11 (4) 321:: 12 (4) 
+ Each value is the mean - standard error from the number of anirn l s shmm 
in p:u'entheses . 
Signif icantly different by the t test (** p < 0. 02 j 
the values obtained from the sham operated group. 
** ** p < 0.001) f rom 
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Table 9.5 
Effect of tuo weeks implantation of cobalt gelatin sticks , cobalt '!Tire or 
glass gelatin sticks on the levels of 5-hydroxytryptamine and 5- hydroxy-
indoleacetic acid in rat brain 
Treatment 
Cobalt gel atin 
sticks 
Cobal t vTire 
Glass gelatin 
sticks 
Sham o ~ ~ a t e d d
Left half 
5 - - y d r r y t r y y : E a m i : ! ~ ~
TlfY'gm 
549 ~ ~ 21 .6(4) 500 : 20.5(4) 
+ 516 - 4 .8(4) 519 ~ ~ 17 .0(4) 
521 ! 6.38(4) 528 ! 10 .9(4) 
531 ~ ~ 18.5(4) 503 ! 14. 1(4) 
Left half 
5 - - y y ! . : £ ~ ~ ~ ~ ~ e t i ~ ~ i d d
. ndgm 
365 ! 17.1**(4) 36 1 ~ ~ 14.9**(4) 
346 ! 13 .6* (4) 339 ! ,12. 4(4) 
330 ! 7.0 (4) + 330 - 4 . 2(4 ) 
313 ! 3.5(4) + 311 - 8 .1 (4) 
+ Each value is the mean - standard error from the number of animals shown in 
tar en theses . 
Significantly different by the t test (* P < 0.05; ** p < 0 .02) from the 
values obtained from the sham operated group. 
Table 9.6 
Effect of three weeks implantation of cobalt gelatin sticks. cobalt wire or 
glass gelatin sticks on the levels of 5-hydroxytry ptamine and 5- hydroxyindole-
acetic acid in rat brain 
Treatment 
Cobalt gelatin 
sticks 
Co bal t 'flire 
Glass gelatin 
sticks 
Sham o ~ r a t e d d
Left h9.lf 
5 - ~ r ~ ~ r r p t ~ ~ ~ ~
ng/gm 
533 :!: 18 . 1 (4) 521 ! 16 .0(4) 
503 ! 19.0(4) 499 ~ ~ 11 .9(4) 
. + 
511 - 7 .8 (4) 512! 18 .1(4) 
513 ~ ~ 16 . 2(4) 506 ! 14.1 (4 ) 
+ 
Left half 
5-Hydroxyindoleacetic acid 
----------------
ng/gm 
31 6 ~ ~ 15.1(4) 303 ! 11.7(4) 
317 ! 18 .0(4) 293 ! 11 .0(4) 
J 
313 :!: 18 . 2(4) 315 ~ ~ 15.9(4) 
319 ~ ~ 18 .7(4) + 311 - 5.6(4) 
Each value is the mean - standard error f rom the number of animals shol.m in 
}:arentheses . 
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Table 9.7 
Effect of one I I e e k , , tloJo weeks and three vTeeks implantation of cobalt gelatin 
sticks , cobalt wire or glass gelatin sticks on the levels of GABA in r a t brain 
Treatment 
ONE i'lEEK 
Cobalt gelatin sticks 
Cobalt wire 
Glass gelatin sticks 
Sham operated 
'r.-lO vlEEKS 
Cobalt gelatin sticks 
Cobalt wire 
Glass gelatin sticks 
Sham 0 pera ted 
Cobalt gelatin sticks 
Cobalt ',Tire 
Glass gelatin stick 
Sham 0 fera ted 
+ 
left half 
Y - A ~ ~ ~ u t ~ 2 : c i ~ ~
fJ,g/gm 
128.8 ! 3.08**(4) 
139.3 ! 2.79* (4) 
152.6 ~ ~ 6.3 (4) 
156 .9 : 7.3 (4) 
149.1 ~ ~ 2.6 (4) 
162.8 ! 8 .1 (4) 
+ 165.8 - 6.3 (4) 
161.9! 7.08(4) 
155 ."16 ! 4.2(4) 
164.2 ! 6.6 (4) 
165.0 :! 16.3(4) 
168 .3 ! 5.7(4) 
139 ! 6 (4) 
159 :! 8 .1 (4) 
156.6 ~ ~ 7 .7 (4) 
155 . 2 ~ ~ 6.06 (4) 
161.6 ~ ~ 3.7 (4) 
165.6! 11 (4) 
163.9 ! 2 .4 (4) 
167.78 ~ ~ 11.4(4) 
166 .0 ! 2.9 (4) 
166 .2 ! 13.3(4) 
159.7 ! 12 .8(4) 
164. 1 ! 2.5(4) 
Each value is the mean - standard error from the number of animals shown 
in p:u-entheses . 
Significantly different by the t test (* P < 0. 05; ** P < 0 .02) from the 
values obtained from the sham operated group. 
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Neither cobalt sticks nor cobalt Hire had any effect on the levels 
of any of the transmitter s and of 5-hydroxyindoleaceti c acid three ,'leeks 
after implantation. 
Glass gelatin sticks did not produce any change at any of the times 
studied . 
9 .6 Revieyr of t he results presented in chapter 9 
The production of model epilepsies in animals 'tlhich resemble those found 
in hunan subjects would be a very useful tool f or penetration into the 
unlmo .. m mysterious world of epile psy . 
Cobalt i i p l a n ~ a t i o n s s into rat brain produced some central changes 
which resembled those occurring in grand mal epile psy in the human being 
and at the same time it did not produce any major neurological defects i n 
the rat which might have complicated the results obtained by this mode l . 
Rats implanted with either cobalt sticks or cobalt wire looked healthy at 
all times and although at the peak of the response they showed very strong 
jerks and twitches , t hese did not affect in any way their normal pattern 
of behaviour and t he rats still ate , drank and gained "leight as vIe 11 , 
and l ooked a s healthy as those with glass implant ation or simply ~ ~ hole 
only in their skull . Cobalt sticks proved to be a better agent t han 
cobalt wire. since the jerks they produced were stronger. and more frequent . 
The changes produced by cobalt sticks i n the motor activity were noticeable 
at the peak of their effect and they produced the most profound c:tB.n.::;es in 
the brain activity . 
Neurochemica lly, only a few changes could be seen : GAB. ... content ;vas 
decreased by both cobalt sticks and ,'lire , but this occurred only in the 
impl anted half of the brain and only f or one \veek after implantation . 
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Noradrenaline was decreased in both brain halves by cobalt sticks and only 
in the implanted half by cobalt "Tire, one week after implantation. How-
ever, only cobalt sticks produced changes in noradrenaline two weeks after 
the implantation (i'lhen the maximum epileptogenic effect was observed) and 
this only in the implanted half of the brain . This might i ndi cate an 
increased utilization of the amine in response t o the increased activity 
of the brain . 
A surprising result Has obtained \vi th 5-hydroxyindolea cetic acid , 
which was increased in the implanted half by both cobalt sticks and T,Tire and 
this persisted for t ~ o o weeks after implantation. The wire increased the 
indole in the contralateral brain half one weelc after implantation and the 
sticK did so for hTO ''leeks after implantation. 
5-Hydroxytryptamine itself did not change at any time during the 
experiment and the increased concentration of metabolite mi ht indicate an 
increase in the rate of synthesis and at the same time a correspondingly 
increased utilization of 5- hydroxytryptamine . 
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CHAPl'3L 10 
IEV2:LS OF ANTICOJVULSANT DRUGS AFTEr? ACUTE AND CHRONIC 
Adequate drug t heraP,y of epilepsy in human beings requires that a 
constant serum concentration of the antiepileptic drug be maintained, 
high enough to prevent seizures but not so high as to give toxic effects . 
This can only be achieved by continuous determination of the drug serum 
concentration . The importance of ensuring a steady concentration of the 
drug has only recently been fully apprecia ted. 
In our field of research , the idea of developing a technique for 
the measurement of serum levels of anticonvulsant drugs i n animal s came 
from our idsh to see '({hat serum levels .. Tere being developed in response to 
our treatment regimen and 1'lhether the times at i'Thich ",e measured the effect 
of the anticonvulsant drugs on the various neurotransmitter agents coincided 
"Tith the drug's peak serum and brain levels. 
Severa l methoQs of analysis are available for the estimation of 
anticonvulsant drugs. Fluorometric assays for phenytoin ,'ler e described 
by Dill and Glazko (1972) and by Dill, Leuny, Kinkel and Glazko (1976) . 
A colorimetric method of assay for phenobarbitone was described by Bush (1 96 1) 
and for carbamazepine by Norselli, Gerna and Gara ttini (1 971). In ad:i. tion 
a considerable number of gas chromatographic analyses f or anticonvulsant 
drugs, using either f 'lame ionization or nitrogen detectors , have been 
developed. 
Gas liquid chromatography is considered to be one of the best 
available methods for the determinat ion of anticonvulsant drugs in bio-
logical fluids. The method is more sensitive , gives much more a ccurate 
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results and requires smaller sample volumes than does any other. The 
most important advantage is that several anticonvulsant drugs can be assayed 
simultaneously i n the same specimen . 
10.1 Gas chromatograPhic analysis of anticonvulsant drugs 
Of the several methods vie tried for t he gas chromatographic analysi s , vT e 
found that t he method described by Dorrity and Linnoila (1976) gave the 
best results in terms of sensitivity and recover y , l'Tithout any need f or 
solvent eva poration . 
l2.!.lli) l i i . e t h o ~ ~ ~ ~ c t ~ ! : :
Half a millilitre of serum was placed in a 15 ml round bott omed glass 
stoppered centrifuge tube, to which 1 ml of 3M sodium dihydrogen phos phate , 
dissolved in methanol water mixture (1/9 V/V) was added . Ten millilitres 
of a mixture of ether-toluene (3/7 V/ V) containing 25 IJ. of 5(.4- methyl 
phenyl)-5 phenyl hydantoin as internal standard vlere added and the mixture 
was then shaken in a rest hand shaker f or ten minutes and centrifuged a t 
2000 rpn for another ten minutes . Nine millilitr es of the upper organic 
layer were transferred to a n o t h e ~ ~ glass stoppered conical cent rifuge tube 
containing 75 III of 0 .2 H tetramethylammonium hydroxide in methanol. The 
tube was then shaken and centrifuged as before . 
After centrifugation , the upper ether-toluene layer was aspir ated off 
by suction and the last traces of the sol vent were carefully aspira ted from 
the interface. The remainder of t he tetrame thylammonium hydroxide (i n 
the conical bot tom of the tube by then i t d e v e l o ~ d d a slioht broimish colour) 
was transferred to a microsampl e vial. The tube ."as then washed Hi th 
50 III methanol and the 'tlashing vlas incorporated iii th the tetramethylammon-
ium hydroxide i n the microsampl e vial . 
One rni croli t re of the mixture was t hen injected into the chromato-
graph . 
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10 . 1(ii) Condi tions for ga s chromatogrephy 
--------------- -------
A IYe 104 \d th dual flame- ionize tion detector ',vas used . The chroma to-
gra ph wa s connected to an Infotronics CRS 309 automatic i ntegrator set at 
1 0 1'0' noise and to measure peak areas resolved 1·Ti thin 8 s econds . 
The columns used were made of ' Chromatoglass ' and were 180 cm long 
and 2 mm internal diameter . They were Jacked iii th 3% OV 17 on ' Chromosorb ' 
\-lHP of mesh size 80- 100. 
The columns were conditioned before the f irst use for f orty- ei ght 
hours at 280°C vTi th nitr ogen flow of 40 ml J:er minute . The columns ,'rere 
condi tioned every time the pacld.ng IDS. terial ,,,as partly or complete ly 
changed . 
'fe found during the course of the experiments t hat an overni rrht 
condi tioning of t he columns \OIas necessary before use . This conditi oning 
gave a steady 101'1 base line and better resolution. . Bleeding of the columns 
occurred only rarely under these conditions . The tempera ture dial of t he 
injection port -;Tas set at maximum _ .. /hich at oven temp3r a ture of 250°C vTas 
Calibra tion of the inje ction tempera ture i s given in t able 10 . 1. 
Phenobarbi t one and carbamazepine was chromatogra phed by using a 
t emp3ra ture pro:,rramning . The column temp3r a ture ,'ras held ° t 160 C for 
one minute a ft er injection and progr meed at 160C per winu te u p to 280°C 
(7 . 5 minutes ) and t he temperature IoTas held at 280°C for anothe r five 
minutes . 
Fhenytoin ',·r s chromatographed at constant temp3rature (280°C ) . Gas 
flow rates i'lere nitrogen 40 ml p3r minute , air and hydrooen ' , ' J J ~ e e 10 pot:nds 
fer square inch . 
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Table 10.1 
Calibration of in jection temperature of the RJe Unicam 104 chromatogr aph 
(A) Constant temnerature 
Scale 
o 
5 
l-Iaximum 
Maximum 
150 
150 
150 
250 
138 
168 
21 0 
286 
(B) Programed temrerature (from 150°C to 260°C at maximum dial) 
150 
250 
250 
250 
(A) Phenobarbitone 
Time after the start 
- ~ ~ t ! ! ~ ~ p r o i E a ~ ~ ~
(minutes) 
o 
6* 
10 
16 
* End of programme 
208 
232 
250 
280 
The 'ITorting standards used for the construction of a calibration curve for 
phenobarbitone were 10, 20, 30 and 40 mg/litre . 
To 0 . 5 ml of drug- free serum , 1 0 0 · ~ 1 1 of different c o n c e n t r ~ ~ i o n s s of 
phenobarbitone standard and 0 . 9 ml of 3 . 3 H sodium dihydrogen phosphate 
\'lere added and extraction \'laS done as described earlier . Each concentra tion 
was carried out in duplicate . 
:'ve found that the use of tem:;:era ture p r o g r a . m . r n i i . ~ ~ gave better 
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resolution of the p3aks and 10\'1 base line t han usi ng constant t emp3rature . 
Examples of the calibration curve ar e given in figure 10 .1. Chromatograms 
obtained after the column i n j e c t i o ~ ~ of 1 ul reagents blank extract (A ) 
and reagents blank plus int ernal standard extra ct (B) ar e shmm in figure 
10.2. 
Chromatograms obtai ned after the column injection of 1 ~ l l of dif f -
erent extr act of d i i f e r e n ~ ~ concentra tions of phenobarbitone plus the 
internal standard are given in figure 10.3. 
The retention time for phenobarbitone was six and a half minutes 
and of t he internal standard eleven minutes. 
The reliability of the method was tested by studyin the recovery 
of phenobarbitone. 
The recovery '.>ras carried out by adding different concentra tions of 
phenobarbitone solution in me t hanol to a half millilitre drug- fre e serum 
to which 0 .9 01 of 3.3 M sodium dihydrogenphos phate was added . The tubes 
were t hen trea ted in t he manner described before. 
t abl e 10 .2. 
(B) _ F h h n y y ~ ~ : ; ;
Results ur e given in 
The working standards and the construction of the calibra tion curve for 
phenytoin was carried out i n the same manner a s t t ~ t t described for pheno-
barbit one. 
Examples of the calibration curve are given in figure 10.4 . 
Chromatograms obtained after the injection of 1 ~ l l r eagent bl ank (A ) . 
reagent b l a ~ ~ ~ plus internal standard (B ) , 2.5 mg/litre phenytOin (C and E) 
and 5 mg/litr e phenytoin (D and F) are given in figure 10. 5. 
Fhenytoin added to blood serum ioTa s r ecovered in the r ange of 9(ffb. 
Results are given in table 10.3 
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Table 10 .2 
Recoveries of phenobarbitone added to ra t serum 
Amount added 
-----
mg/Htre 
10 
10 
20 
20 
30 
30 
Amount recovered 
mg/litre 
8 .8 
8 . 2 
17.8 
18 . 6 
29 
28 . 5 
Mean recovery: 90.6% 
Table 10.3 
88 
82 
89 
93 
96 .6 
95 
Recoveries of phenytoin added to the serum of r at blood 
Amount added Amount r ecovered R e c ~ e E l l
--------- -------
mg/litre m g / l i t r ~ ~ % 
5 4.2 84 
5 4.6 92 
10 8 .7 87 
10 9 .0 90 
20 1 9 95 
20 18 .7 93 .5 
Mean r ecovery : 90% 
FIGURE 10 . 1 
Typical c a l i ~ r a t i o n n curves for the gas chromatographic 
anal ysis of phenobarbitone obtained on three separate occasions 
2-0 / j 
• 
1·5 
~ ~
H 
-CJ) 
0 
+-' 
2 
2 1-0 
a 
~ ~
2 
a. 
0-5 
10 20 30 40 50 
Phenobarbitone (mg/l) 
FIGURZ 10 . 2 
Chromatograms obtained after the column injection of 1 ~ 1 1 of 
reagent blank extract ( ~ ) ) ~ ~ d d reagent blank plus internal 
standard (B) 
IS = internal standard 
I 
I 
' .- ~ ~
.-_. 
I 
VT 
: I I 
.- .. 
: ~ ~ -I 
4 I 4 
, 
i ~ ~I 
I 
- --I 
-
-' - ~ ~
-"--- . 
I 
........ 1 
--
0 
I ~ ~ -, , ,.. 
I , 
\ 
, 
, : 
I i , ~ ~! i I , N , 
I I 
,.. 
:;) 
I I I I I ! ~ ~
I . I . I ' I . ~ ~ %: I I : I : , 
I I 
-
_1-_ , ~ ~
i _ "O N'" 
,.-. 
-
! 
, , 
-
.... 
i 11 , 
, I ~ ~ l..U , 
. : I I I I ! i ! I: , ; ~ ~. i I I , , I I ! .... 
--
: I ~ . , ,~ - - . . ~ ~ --- +-- ._-- I , 
-
, --_ .. 
: J I· 
' rr 
I 
I 
~ ~_ .. -. 
--- ~ ~
: ri -- ... .. ~ ~
: en I , I ... . ~ ~ I 
~ ~ S 1 I ,1 I I I 
i : C\I 
..,... 
I 
i 
I 
I 
I 
_. 
FIGURE 10 . 3 
Chromatograms obtained after the column i njecti on of 1 ~ l l of 
different concentr a tions of phenobar bitone extra cts 
( . ) 10 mg/litre phenobarbitonE (B) and (C ) 20 mg/litrc phenobarbi t one 
Ph = phenobarbitone IS = interna l standard 
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FIGURE 10.4 
Typical calibration curves for the gas-chromatographic 
analysis of phenytoin, obtained on two separate occasions 
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F I G U : ~ E E 10 . 5 
Chromatograms obtained after the column injection of 
reagent blank extract (A),. reagent blank extract plus internal standard 
(B) f 2.5 mg/l phenytoin (C and E), 5 mg/l phenytoin (D and F). 
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i £ L L a r r ~ ~ P i n ~ ~
'lfhen carbamazepine 'vas chrom:ltographed under t he same conditions as those 
described for phenobarbitone , ''Ie found t hat it yielded bro adjacent peaks 
Hhich vler e not reagent bl anks . The f irst peak ',las resolved half a minute 
befo:-e the second one and the hei ght of each feak ,\-las not the same aft er 
different inje ct i ons , although He f ound t hat the sum of the heights of the 
VllO r.eaks ,.;as a l ,,,ays the same (Fi gure 1 0 .6) • 
The only possible explanat i on tha t could be given f or thi s pheno-
menon at t hat time 'lras that carbamaz e pine undeI"tlent an erra tic decomposition 
which yielded n 'l O different compounds, the sum of '''hich corres ponds to that 
of the original carbamazepine. 
later ,'Ie found a report tha t confirmed our conclusion . It tr:!ns-
pires that carbamazepine decomposes partially to iminostilbene at the 
elevated temrerature of the gas chromatography and that this decomposi hon 
is not reproducible (Kupfer berg , 1972) . Kupferberg developed a different 
method f or the gas chromatographic analysis of ca rbamazepine which depends 
on the formation of the trimethylsilyl derivative of the drug, using 
cyhe ptamide as internal standard . 
A calibration curve obta i ned from the ratio of t he heights of the 
ti'lO F€a.ks of carbamaz e pine a 5 ainst internal standard i s given in figure 10 . 7 . 
10 .2 Leyels of phenobarbitone a fter acu te a nd chronic trea tment 
In the followi ng experir.lents , we a re reporting r esults obtained by using 
different routes of admini s tra tion i n order to see "That levels ',Ie a r e a chiev-
i ng by our method of injection and to comp3.r e it "lith the levels obt a ined 
after using a di fferent route of a d m i ~ s t t a t i o o . .
FIGURE 10.6 
Chromatograms obtained after the column injection 
of 1 ~ l l of 7.5 mg/litr e carbamazepine (A) and (B) and 10 mg/litre 
carbamazepine (C) and (D) 
car . = carbamazepine IS = internal standard 
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FIGURE 10 . 7 
A calibration curve for the gas cr.romatographl c analysis of 
car ba:naz e Pi ne 
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10.2(i) Serum levels of phenobar bitone aft er ora l and int r aperit onea l 
---------------------------------------------
administration 
Female Ash )'listar r a ts ,veigr.ing be-t,veen 150 and 160 gIllS )·Ter e used. The 
rats ',lIare divided into hlo groups . One group r eceived an i ntr aperitoneal 
injection of phenobarbitone (100 mg/kg) in 0 .5 ml sa line . 'rne other group 
received the same dose of phenobarbitone by t he ora l intuba t ion t echni que 
in 1 ml tap IVa ter . 
At various' times thereafter, two millili tres of blood ",Ier e drawn from 
each rat by cardiac ~ c t u r e e and placed into tubes ,oTashed previousl y :vi th 
heparinized saline . The tubes ,'Tere then centrifuged at 2000rpm and 0 . 5 
m1 of the serum was extracted preparatory to determining its phenobar bi-
tone content by the method described in section 10 .1(i ) . One mi cro li tre 
of the extract vIas then chromatographed , using the conc. itions described in 
Solutions of different concentration of phenobarbitone in m e t i ~ n o l l
added to 0 .5 ml, of serum ,vere treated in the same manner as t he serum of 
treated rats to construct the calibration curve . Results , given in 
figu:-e 10.8, ShO\Ol that different levels v/ere achieved by the two different 
methods of administration . Intraperitoneal i njection produced a higher 
serum level of phenobarbitone than did the oral intuba tion met hod . Hor e-
over, maximum serum levels were reached VdO hours after t he i ntr aperi tonea l 
injection, but only one hour after the ora l i ntubation . This i ndi cates 
that absorption of the drug -Vlas oore cO!I4plete : ~ r r m m t he ~ r r t o n e a l l site 
than it I·Tas from t he s tomach. 
Figure 10.9 sho:vs chromatograms obt ained aft er t he in jection i nt o 
the column of 1 ~ l l extracts of seruc collected thirty minutes (A) and 
sixty oinutes (B) and (C ) after i ntraperitonea l i n ject i on of 100 m g / l ~ ~
phenobarbi t one. 
~ I G U R 3 3 10 . 8 
Serum levels of phenobarbitone obt · ined aft er the a ministr e tion 
of 100 mg/kg of the dr ug by intra peritoneal i njection (A ) and 
oral i . t u u ~ t i o n n (3) 
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Chromatograms obtained after t ~ e e c o l W L ~ ~ i r.je ction of 
' 1 extracts of serum collected from r a t s thirty minutes (A) 
and sixty m i n u ~ e s s (B ) and (C ) after intr f f r i t t n e e l l injection 
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10 .2(ii) ~ n e e effect of a - m e e h h l - ~ ~ J T o s i i e e on s er UE and br a i n l evels 
--------------------------------------------------------------------
~ ~ J ~ ~ ~ ~ ~ 8 i ! ~ = =
In cha pter 2 , section 4 of this thesis ':le sm.,r t hat a - r n n t ! 1 Y Y - ~ t y r o o i n e e
r educed si gnificantly t t e induction time and prolonged t he s lee pi nG t i me 
caused by phenobarbitone .' 'ole saw s ~ , ' e l l l that the c c m m i n ~ d d t reat ment ':lith 
the ~ d O O drugs pro ' uced a progressive and c o n t t ~ u o o s s fa ll i n body temper a ture 
vlhich neither of the t;vo drugs proc.uced T:lhen iven on i t s a.m . '1\,0 pos"'-
i bili ties arose from these results . Ei ther a - m e t t y l - ~ ~ y y o s i n e e ~ o t e n n i a t t 3 3
the effect of phenobarbitone at a c e n t t ~ l l level ( ( y n e r g i s ~ ) ) or a l t e ~ n a a i v e e J J
a- methyl-lrtyrosine competes with phenobarbitone or inhi bi ts t he micro-
somal enzymes in the liver on 'tThich the metabolism of phenobarbi t one dep.mds . 
These possibilities Here test ed by mea suring serurc and br ain levels 
of phenobarbitone after a a m e t h y y - ~ t y r o s i n n . .
Female sh \. istar r a t s Neighing be 'b.'Teen 150 and 160 grams Her e u.:.>ed . 
The rats were divided i nto ~ T O O maj or groups . One grou p vTas divided int o 
several subgroups and each received an intra peritonea l injection of pheno-
barbi t one (1 00 rag/kg) . The other group ':las a. lso divided i nto sevey 1 sub-
groups and each received the cOr.'lbined trea tment by a - m e t h h l - ~ ~ ' y y o s i n e e
(250 mg/kg) and phenobarbitone (1 00 m Ike ). 
Each subgroup in the h/o major grou fS \'Ta S killed a t ' c o o r e s s o n n i n ~ ~
and predeteroined times thereafter by decapitation . Blood ~ a a colle ted 
directly from the decapi ta ted body into tube s ~ r e v i o o s l y y Via hed ',dth he}lir-
inized saline . The brain wa s removed a.nd homo",enized ',vi th 5 d di stilled 
ivater . ~ n e e blood a a ~ ~ brain homooenate \'Iere t hen centrifu€ed at 2COO .pm 
for ten minutes and 0 .5 w ~ ~ of the serum and 1 ~ l l 0: the s u p e . p ~ t a a t t soluti on 
from the brain homogenate had t l eir phenobar bit one ex t r:lcted by the rr.etho:l 
described in section 10 . 1(i ) . One r.li croli tre of the e;c tr:.l ct c'(O s then 
- 207 -
injected into t he gas chromatogr aphy column under the conditions des-
cribed in section 10.1(ii ) . 
Resul:s are presented in figures 10 .1 0 and 10 . 11. 
The results ShO'11 that C C - m e t h y y - ~ ~ y r o s i i e e reta r ded the elinination 
of phenobarbitone from both serum and bra in . 
Table 10 . 4 ShO'iIS t he ~ r c e n t t g e e changes in the levels a nd elimna tion 
r a tes of phenobarbitone . Although the table s hOivs t hat phenobar bi tone 
concentra tion in the brai n dropped at a faster rate than tha t in the serum , 
·the elimination rate per hour, calculated from the amount of phenobarbitone 
left after certain times, '\'I'as sloHer in the brain than it Ivas f or the serum . 
For the purposes of these calculations, zero time 'tTa s taken as three hours . 
In both serum and brai n the elimination r a tes decrea sed \'li th time . 
o : : ~ ! e t l l l - ~ t y r o s i n e , , on the other hand , seeelS to revers e the Plttern COel-
pletely . In the presence of this drug , t he phenobarbitone concentra tion 
in the brain fell off much more slowly than it did in the serum . t;!hile 
elielination r a tes I-Tere very 10\'1 in the brain, they seemed to increase ."li th 
time. The opposite state of affairs obtained in the serum . 
Although vIe could not find any statistical correlation ar:long these 
numbers , the results indicate tha t a a m e t h y y - ~ t y r o s s n e e changed the ;'laY by 
which phenobarbitone Ivas me tabolized in the bra in or serum. Although it 
i s only speculative , it is tempting to "T onder ItThether the increas ed elir.l-
i nation rate of phenobarbi t one by the brain might be an indication that the 
brain ".vas r eacting in an adaptive ;vay to the persisting high concent r a tion 
of the drug . H01"ever , our main concern was to f ind i'lhether a-methyl- j2-
tyrosine pot entiated the effect of phenobarbitone through a synergistic 
effect or through effecting a delay of its metabolism . Our results i ndicate 
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clearly t hat it doe s decrease t he me t abolism of the drug . probably by 
in..lU. bi tio!1 of the mi crosornal enzyme . On t he ot!1er hand , some synergistic 
effe ct could not be ruled out completely . Ho,';ever, CX- methyl-1!-t yrosine 
has been reported to be toxic for the ld..dney (Hoore . "fright and Bert . 1967 ) 
and '1lhen ';1e remember that 27% of phenobar bitone is excreted unchanged in 
the urine (Glasson and Benald..s , 1973) . along with its other metaboli tes , 
it i s t empting to suggest t hat a decreased elimina tion of phenobar bitone 
by the' kidneys may be in part a supplementary factor i n elova ting the 
levels of the drug ~ 1 e e s a a ' l l in serum and bra.in after a- methyl-]!-tyrosine . 
Correlation of brain and serum levels of phenobarbitone a t diff erent 
times after injection are given in figure 10. 12; t hese show a high corre-
l ation (r = 0.927) b e ~ N e e n n brain and serum l evels . 
Table 10.4 
Percentage change and elimination rates of phenobarbitone lvith or \'Tithout 
a a m m t h y y - - t y r o s i n e e trea tment 
Hours after Phenobarbi- Elimination Fhenob,9.r bi- Elimina tion 
adminIstration ~ o i i e e c r u : n g ~ ~ - rate--- t o ! ! ~ ~ +-ampt.!, -rate--
--------
(3 hrs as zero t i me ) t ~ ~ rng/hr % mg/hr 
SIX HOURS Serum 
- 12.9 3.98 - 7.63 2.32 
Brain 
- 36 .1 0 3. 16 - 1 .09 0.09 
T','lELVE HOURS Serum 
- 30 .30 3. 11 - 11.78 1.1 9 
Brain - 42 .29 1.23 - 5.87 0 . 16 
Tl,'lENTY -FOUR Serum - 52 .89 2.32 - 25.85 1.1 2 
HOURS Brain - 69 .20 0 .865 18 .8 0 .22 
-
F I ~ E E 10 .1 0 
Serum levels of phenobarbitone, for ra ts treated vnth Fheno-
barbitone only (100 m e l k g ~ ~ continuous line; and r ats treated 
with phenobarbitone plus ~ ~ m m t h y y - ~ ~ y r o s i n e e (250 mg/ko) , 
dotted line 
+ ~ ~ c h h point indicates the mean - standard error for three rats. 
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FIGURE 10 . 11 
Brain levels of phenobarbitone , for rats t rea ted with 
phenobarbitone only (100 mg/kg) , continuous line ; and 
rats treated ~ i t h h phenobarbitone plus a - m e t h h l - ~ ~ y r o o i n e e
(250 m g / y ~ ~ , , dotted l ine 
+ Each poi nt indicates mean - standard error for three r a ts 
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FIGUR:r; 10 . 12 
Correlations bet\.leen serum and brain levels of phenobarbitone obtained 
at different times after t he i ntraperitoneal injection of 100 mg/kg. 
Closed circle s : 3 hours after injection 
Closed triangles: 6 hours after injection 
Open circles : 12 hours a fter injection 
Open triangles : 24 hours a.fter injection 
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10 . 2(iii ) Serum and br ain levels of phenobarbit one after I on term 
----.-------------------.------------------
adr:ri.nistra t i on and vIi thdra':Tal 
In chapter 3 of t his thesis , we re ported behavioura l changes after t he long 
term administration vIi th phenobarbitone , and "Te observed that ,-1i thdraHal 
sympt oms developed rapidl y upon removal of the drug . In the f ollO'tring 
eX]:eriments :-le studied brain and blood l evels of phenobarbitone at the end 
of each dose level we used and as Nell aft er the '-1i thdrawa l of the drug . 
P.nenobarbi tone was administered to ra t s in their drinking -,-la ter by 
the same s chedule described in chapter 3 . The r a ts vTere ei ther killed a t 
the end of the second week of administr ation (50 mg/kg/day ), the fourth 
week of administr a tion (100 mg/kg/day fr om the beginning of the thi rd ''leek). 
the sixth week of administr a tion (1 50 mg/kg/day fr om the beginning of the 
fifth "Teek) or at va rious times after ,'li thdra''lal from the drug . 
The rats ,.;ere decapitated and the blood "Tas co llected directly from 
the decapita ted body i nto tubes previously r insed with he parinized saline . 
The brains ''lere removed and homogenized ''li th 5 ml distilled vTa ter . The 
brain homogenates and the blood "lere then centrifuged a t 2000 r pn and 1 ml 
of t he supernatant solution from the brain homogenate a nd 0 . 5 ml of the 
serum had their phenobarbi t one extracted by the me thod described in section 
One microli tre of the extra ct I-TaS then injected into the gas chrOlIa t -
ography column under t he conditions described in section 10 .1(ii ) . Results 
are gi ven in f i gure 10 . 13 . 
The results ShOH t hat t\-IO ~ ' T e e e s s after t he administr a tion of pheno-
barbitone at a dose level of 50 mg/ kg/day . the serun levels 1'lere 38/'; Dore 
than that in the brain . ~ ' l h e n n t he dose level ltIas incre-:l sed to 100 rng/kfrj day , 
FIGURE 10.13 
Serun and brain concentra tion of phenobarbitone during its 
habi tua Hon and wi thdra,.al 
Continuous line - serum; broken line - brain 
See text f or dosage 
+ Each point indicates mean - s tandard error for three rat s . 
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the levels in both brain and. serum increased sharply af t er the f ourth 
vTeek , ",hen t he serum levels ~ l e r e e 2 0 0 ~ b b more than that in the brain . 
HOT:rever , ~ ' l l e n n the dose ,'las i ncreased to 150 mg/kg/day , there ;'lere 
slight increases in the levels of t he drug in both serum a nd brain 
after the sixth ,'leek of administ r ation , ,·Then t he serum levels Iver e 
225% of thEe of the brain . 
Forty- eight hours after the ,d thdravTal of the drug , serum and 
brain levels dropped sharply . At tha t s t t ~ e , , less than 3f; 'flas l eft in 
the serum and less than 10/; in the brain . Thus t he ' severe Hi thdra\'Tal 
symptoms observed on the removal of phenobarbitone after its longtero 
administration Here associated i'li th the sbar p f all in brain and serum 
levels . 
10 . 3 Seruo levels of phenytoin after its lon t e r ~ ~ admini str a tion 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - ~ - - - - - - - - - - - - - - - - - - - -
and vTi thdrawal 
------
In our deps..rtment , S. Cooke (1979) had demonstrated that the Ivithdra\·Ta l of 
phenytoin after its long term administration to rats caused no abstinence 
syndrome . So ive decided to look for the levels of phenytoin i n the serum 
after its long term administration and ivi thdralval in order to see i'Thet her 
the absence of vri thdra;'ral symptoms might be due to a lack of ability O.l the 
drug to produce dependence or to the drugs r r m a i p ~ ~ g g in the body at suff ic-
iently high levels to protect against any si3TIs of Ivi thdravral . 
Female Ash \'Ji star rats ~ ~ e i g h h n g g bet-ireen 150 and 160 31llS liere used . 
The rats Here injected ';Tith phenytoin suspended i n saline conta ininb 1) 
TI·reen 80 in an increasing dose s chedule for three i,reeks , as described in 
cha pter 4 . Thereafter , blood sampl es , .. Tere collected by cardiac punct"..l:'e 
ei ther one hour , h renty- four hours or f orty- eight hours a fte:- the l a st 
injection into tubes previously rinsed Hi t h hep::.rinized saline . The tubes 
~ T e r e e centrifuged at 20CO rpm and 0 . 5 ml of the serun h.:l<i i ts phenytoin 
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Table 10 . 5 
Serum levels of phenytoin after its l o o ~ ~ term administra tion and 
wi thdrai"al 
Time after last injection '1umber of animals 
--------.--.-----
hours 
5 
24 4 
48 4 
29 .65 
F h ~ n y t o i n n
mg/litre 
+ 
- 2 .01 
+ 3.28 - 0 . 1 
+ 3.069 - 0 .09 
+ Each value is the mean standard error 
extr acted by the method described in section 10 .1 (i) . One microlitre of 
the extract Has then injected into the gas chromatography column under the 
conditions desdribed in section 10 . 1 (i1) . Results are given in table 10 .5 . 
The results shO'.'l that phenytoin levels dropped sharply h lenty-four 
hours after the last i njection and only 1 1 ~ ~ of the original concentra tion 
remained . From these results , ,\'e can conclude that phenytoin is a !X)or 
drug to produce dependence and the sharp fall in the serun levels did not 
produce any i'Ti thdrai'Tal symptoms . 
Figure 10 . 14 S h O O · l S S chromatograms obtained after the colunn injecti on 
of 1 III of diff erent serum extracts of rats treated ",i th phenytoin . 
FIGURE 10 .1 4 
Chromatograms obtained after column injection of different serum 
extracts from rats that had been injected for three vleeks with 
phenytoin 
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GENERAL DISCUSSION 
Epilepsy 'tTas defined by Hughlings Jackson as ' a state produced 
by an abnormal excessive neuronal discharge Nithin t he central nervous 
system' • 
It is nON an acce pt ed fact that the transmission of impulses 
across syna pses in the vertebrate central nervous system i s mediated 
for the most part by t he intervention of speci fic chemical transmitter 
substances, some inhibitory and others excitatory . Thus it i s tempting 
to speculate that epilepsy might be accompanied or preceded by a distur-
bance of the pre- or post-synaptic mechanisms involved in neurotransmission . 
resulting i n disorganized neuronal activity in the f orm of an epileptic 
dischar ge . The spread of this epileptic activity to norrral neighbouring 
neurons a l so i nvolves synaptic transmission . thus further underlinine the 
i mportance of t he study of central synaptic transmission in the epileptic 
state. 
It is reasonable to believe t hat t he concentration of the neuro-
transmit ter in the synaptic cleft should be t he paramet er most directly 
r el ated to the l evel of functioning of the transmitter , but since the 
determir..a tion of . this concentration i s beyond the s:::ope of current techno-
logical methods , only indirect estimation of t he par ameter can be obtaine . 
For exampl e , cp..anges in Nhole brain concentration of a neurotransmit ter 
or i n its turnover r ates may reflect changes in the neurotransmitter 
concentra tion i n the synapti C cleft . On the other hand , they 0 y not . 
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There are , of course , factors other than the neurot r ansmitters 
themselves ,!Thich mey affect neurotransmission in epilepsy. KnOim 
influences include electrolyte concentration, the ionic pumps and hormones . 
A study of these factors is outside t he scope of our s tUdy . 
In our effort to study the mode by which an anticonvulsant drug 
exerts an inhibitory effect on epilepsy , ,ve examined the effec t of some 
anti-epileptic drugs of kIlol'Tn efficacy on some chemical subst ances (and 
their metabolites) present in the brain and generally accepted as trans-
mi tters . 
Because of the large amount of data reported in our e e p e e i m e n n a l l
studies , we shall first discuss the results in the sequence in , ... hich t hey 
are presented in the experimental chapter . Ie ter vTe a t t empt to r ela te the 
resul ts i'li th each other . 
I. Catecholamines and anticonvulsant drugs 
The possible role of brain biogenic amines in experimental seizures and 
the mode of action of anticonvulsant drugs has been a subject of consider able 
interest ever since Chen , Ensor and Bohner ( 1954 ) demonstrated in mice that 
reserpine 10 'Tered maximum electroshock sei zure and chemoshock s eizure 
thresholds and antagonized the anticonvulsant effect of phenytoin. .u zi k 
and lennear (1965) suggested t hat the antagonism of r e s e r ~ n e e to t he anti-
convulsant effect of phenytoin was not the result of amine de pl etion . si nce 
other amine de pletors (a- methyl dopa , a - m e t h y l - ~ ~ t y r o s i n e e and a a m e t h y y - ~ ~
tyrosine) '!Tere b.effective in this respect . Although t hey found no 
correlation between the brain amine concentra tions and t he incidence of 
minimal electroshock seizures , Azzaro , "denger , Craig and Stitzel (1971 ) 
came to a conclusion vThich supported the original one of Chen and his 
- 219 -
colleagues t hat brai n amines (noradrenaline , dopamine and 5- hydroxy-
tryptamine) are all intimatel y involved in the effect of r eser pine on 
electrically induced sei zures . They based their conclusion on the 
finding that the administration of amine precurs ors to animals trea ted 
I·rith r eser pine resulted in both an increase in bra in amine concentra tion 
and an ant agonism of the effect of r eser pine on sei zure incidence . 
Similarly , they found t hat the administration of i nhibitors of catechol-
amine and/or 5- hydroxytrypt amine synthesis to r eserpine-treated mice 
prevented brain ar.lines from returning to\,Tards their control l evels and 
prol onged the effect of reserpine on the mini mum electroshock seizure 
threshold . Noreover , A z z a r o o . . show'ed t hat the action of r eser pine 
can be approximated i n control oice by the concomi t ant inhibiti on of 
catecholaoine and 5- hydroxytryptamine . In a l a ter study . this same 
group of research ~ T o r k e r s s (l!l enger , Stitzel and Crai g , 1973) provided 
data ilThich suggested t hat noradrenaline and 5- hydroxytryptamine , but 
not dOp:l.mine , are important in r egul ating mini mal electroshock sei zure 
susceptibility . They suggested t hat the total amine concentra tions 
are less important than the restora tion of the abili ty of the tissue to 
synthesize and store t he transmit ters , since inhibitor s of noradrenaline 
and 5- hydroxytryptamine synthesis in reserpine-treated animals prevented 
t he minimal electroshock seizures f rom re turning to their control intensity . 
Kilian and Frey (1 973) and Neyer and Fr ey (1 973 ) demonstr at ed t ha t inhi b-
i tion of noradrenaline synt hesi s in the brain \'Tould decr ease the convul sive 
threshold and antagonize the anticonvulsant effect of phenytoin and pheno-
barbit one agains t electrically and chemically in uced convulsi ons in nice 
and !'ats . This aug ested a role f or noradrenali ne in t hese ef_ scts . 
- 220 -
Destruction of catecholamine neurons i n the brain by the int r a-
ventricular i njection of 6- hydroxydof8 r:line increased the severity of 
audiogenic seizures in susce ptible rats (Bourne , Chin and ~ c c h i o n i , ,
1972 ) , increased the susceptibility to both ele ctroshock and chemically 
induced seizures (Bro','ning and !'1aynert, 1970 ; Quattrone , Cru..Tlelli and 
Samanin, 1978) and antagonized the anticonvulsant effect of phenytoin , 
phenobarbitone , carbamaze pine and acetazolamine against electrically 
induced convulsions (Browning and Simonton , 1978; Quattrone and Samanin . 
1977; Quattrone , Crunelli and Samanin, 1978 ). 
Studies in ex:r;erimental animals of a genet ic strain highly 
susceptible to audiogenic seizures have likewise proVided data i ndicating 
a rela tionshi p of brain monoamines to seizure phenomena . Schlesin er , 
Boggan and Freedman (1 965) and Kellogg (1976) found t hat the DBA/2 strain 
of mice (three weeks old) exhibited a high degree of sensitivity to 
audiogenic seizures together ,'lith lOltT levels of brain noradrenaline and 
5-hydroxytryptamine, indicating a possible role for these amines in 
seizure mechanisms. HovTever . in a more recent report, Lints , :" illott, 
Sze and Nenja (1980) re ported no change in the concentration of either of 
the n ~ o o acines measured in the same strain of mice at the same time as 
that re ported by Schlesinger and his c o - \ ~ o r k e e s . . It must be added , 
hOliever, t hat Anlezark , Horton and I·1e ldrum (1 978) had found that doIaIDine 
agonists reduced the susceptibility of t he DBA strain of wice to audio-
genie seizures . This effect i ~ a s s blocked by haloperi dol , a dora-mine 
antagonist, t hus suggesting a role for dopamine in audiogenic sei zure 
susce pti bili 'bJ • 
In another strain of mice (EL) susceptible to convulsions produced 
by postural sti mul ation, Kohsaka , Hirama t su and I-iori (1 978) derllonstra ted 
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that postural stimulation produced 50% de pletion of brain dopamine . 
A further decrease was observed in the levels of dop:unine "'hich "Tas 
accompanied by a fall in noradrenaline levels at the preconvulsive 
stage . The concentration returned during the convulsions to the 
levels seen at the resting position . 
Vi e began our investigation into the relationshi p between anti- I 
convulsant drugs and catecholamines (noradrenaline and d o ~ ~ e ) ) by 
simply looking at the effects of single doses of some of these drugs 
on the whole brain levels of the catecholamines . 
Before discussing these results , how'ever , vTe have to refer to 
the fact, mentioned briefly in an earlier section of this thesis , 
that resting brain levels of dopamine in untreated animals varied from 
one experiment to another . 
During the course of our studies , different batches of alumina 
were used . 'Ne noticed that some batches are more effective in adsorbing 
q.o}8mine than others . Even in the same batch , alumina preFaI'ed on 
different days gave different degrees of adsorption . This should not 
give ri se to the large differences l.;e observed in our animals. since a 
cal ibration curve was constructed for each experiment and any effects 
on the degree of adsorbtion should happen equally to Qoth the brain 
extract and to the external dopamine . It can only be concluded (and 
this sonewhat lamely) that some components of the brain extract affected 
the adsgr ption or elution of brain dopamine and that the extent of thi s 
effect ,.;as dependent on subtle differences a a o o ~ ~ different batches of 
the alumina . 
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Single doses of phenytoin, phenobarbitone , carbamazepine and 
sodium bromide had no effect on the Nhole brain levels of either ca te-
cholamine, thirty ~ ~ u u e s s and one hour after injection . Tt·;ice daily 
doses of the same drugs , given for one week , also failed to influence 
the amount of dopamine or noradrenaline in the rat brain . 
The f a ct that the levels of dopamine and noradrenaline vary 
among the different brain regions might result in changes in the concen-
tration of either catecholamine in a small area of the brain ' s being 
masked in assays of the \oThole brains . \'1i th this in mind, we turned 
our attention to the effect of these drugs on the regional dis tribution 
of the catecholamines , and some interesting results emerged . Single 
doses of phenytoin increased the concentration of dopamine in the striata 
and of noradrenaline in the midbrain, the area s of the brain which contain 
the greatest concentrations of dopamine and noradrenaline r espectively . 
Carbamazepine increased significantly the amount of noradrenaline in the 
midbrain and the cerebral hemispheres , but it did not affect the dopamine 
levels in any part studied. Phenobarbitone did not change the concen-
tration of either catecholamine in any part of the brain . Phenytoin 
would seem to decrease the utilization, increase t he synthesi s or inhibit 
the breakdo'lm of dopamine in the striata and to have a similar effect on 
the noradrenaline in the mid brain. 
Azzaro , Gutrecht and Smith (1973) re ported t hat 10'11 concentr ti ons 
of phenytoin (10- 5 to 10-4) facilitated, and higher concentration's (10-3 ) 
bad no effect on the ~ N e n t y y oinute accumulation of radio-active noradrenaline . 
The higher concentration (10-3) proQuced a severe r eduction in the five 
oinute accumulation of DR) noradrenaline . Furtheroore . phenytOin 
produced an inhibition of the oxidative catabolisI:l of the r adio labelled 
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amine i ~ ~ cerebral cortex slices and in whole and l ysed synaptosomal 
fractions of the cer ebral cortex . The authors concluded that the 
facilitating action of phenytoin on the ~ w e n t y y minut e accumulation 
of [ 3H] noradrenaline uas due to an inhibitory effect of phenytoin on 
the oxidative catabolism of the radio labelled amine and not t o an 
effect on the uptake which 'Ilas inhibited, at least by the higher con-
centrations of phenytoin , at the five minute s t age . I n another r eport . 
Azzaro and Gutrecht (1975 ) have identified the characteri s tics of the 
inhibitory action of phenytoin on monoamine oxidase to be of a com-
peti tive nature. They also found that phenytoin reduced the activity 
of tyFe A monoamine oxidase to 20 Fer cent of its control values , v1hile 
type B .,las inhi bi ted to the extent of 50 per cent . 
Thus phenytOin seems t o increase the level s of noradrenali ne in 
the midbrain and of dopamine in the stria t a by inhibiting their ca tabolism . 
Chang , Okerholm and Glazko (1 972) provided data t hat shmled that phenytoin 
is metabolized to a corresponding catechol which is ext ensively methyla t ed 
to the 3 ~ m e t h y l l catechol . Thus the possibility exists that the f r ee 
catechol metabolite of phenytoin may compete 'i'ri th ca t echolamine s f or the 
3 ~ ~ m m t h y l a t i o n , , t hereby exerting a sparing effect and prolonging the 
life time of t he catecholamines at their r eceptor sites . \'lhether the 
ability of carbamazepine to increase the noradrenaline cont ent in the 
midbrain and t he cerebral hemis pheres can be ex plained by a simil ar 
mechanism must remain a sFeculation, but it may not be irrelevant to 
recall that carbaoazepine has antidepressant p p o ~ r r i e s s so t h<:t t it i s 
not unreasonable to predict that it might i ntervene in some vlay in the 
noradrenaline system. This point i s t aken up again later . 
'any ,vri ters suggest t hat t he absolute concentra tion of a trans-
mitter in the brain may bear little relationshi p t o the actual activity 
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of the system under study . It may be that the es timati on of turnover 
rates of the catecholamines in central neurons can be used as a better 
index of t he functional state of these neurons . f/lany t echniques , 
isotopic and nonisotopic , are being utilized for the measurement of 
catecholamine turnover in the central nervous system. One of the 
simplest 'tlays involves following the disappearance rate of the endogenous 
catecholamine after inhibition of its biosynthesis by a - m m t h y y - - t y r r s i n n . .
In our study on the effect of anticonvulsant drugs on t he turnover 
ra tes of ca techolamines , "T e found t hat only phe!1obarbi tone influenced the 
rate at 'I'lhich t he catecholamines "rere depleted by a- methyl-J?:-tyrosine . 
The results, presented in chapter 2.3, show that phenobar bitone r educed 
the rate at vThich doFallline ,'las depleted a t all times studied . On t he 
other hand , the effe ct on noradrenaline depletion ltTaS seen only during the 
first six hours of a - m e t h y l - ~ t y r o s i n e e treatment . Thereafter, pheno-
barbitone no longer inhibited noradrenaline turnover . Indeed , eighteen 
hours after a- I:!ethyl-J?:-tyrosine Nas given there 'tTas a slight but signif-
i ~ n t t stimulation of turnover . Our results support t hose of Corradi . 
Fuxe and Hokfelt (1966) , who re ported resul t s similar to ours in r e ~ a a d d
to dore-mine . On the other hand , these vT orkers found t ha t phenobar bit one 
produced no change in noradrenaline de pletion by a-methyl-J?:-tyr osine . 
It is reasonable to suppose t hat foHm'1ing the a ministration of 
a- methyl-J?:-tyrosine , the rate of depletion of cat echolamines ,'lill be 
proportional to their ra te of release and subsequent removal from the 
rece ptor sites , and this will depend on t he activity of t he neurons in 
question. Thus , the higher the impulse f l ~ d d a long neuronal fibres , 
the faster 1dll be t he r ate of de pletion of ca t echolamines f roI:! those 
fibres and vice versa (Cooper, Bloom and oth, 1978 ; nebron , 1977) . 
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In our experiments, phenobarbi t one decreased the rate of depletion of j 
do pamine at all times studi ed, and those of noradr enaline at the early 
hours after administration of a - m e t h y l - ~ ~ y r r s i n e . . If the above 
supposition is valid in our case, we can suggest that phenobarbitone 
inhibited the neuronal activity of dopaminergic neurons at all times 
studied and t hat of noradrenergic neurons only for the fir st few hours 
after its administration . 
~ l h e n n we looked for the region in which phenobarbitone resisted 
. 
the de pletion, we found it to be in the cerebral hemis pher es . 
Our behavioural studies on the interaction bet 'l'1een phenobar bi tone 
and a-methyl-Jrtyrosine proved to be very interesting . Both a- methyl-Jr 
tyrosine and phenobarbitone given a lone produced sedati on and hypothermia . 
The hy pothermia produced by phenobarbitone was rapid in onset and shOl'Ted 
recovery aft er five hours, vlhereas that produced by a-methyl-ktyrosine 
was 910\'1 in onset, but continued to the end of the time of measurement 
(tvlenty-four hours - see Fig'.lI'e 2.4, rage 23) . Sedation i'lent in the same 
''lay as hypothermia. \'lhen both drugs wer e injected simultaneousl y t he 
hypothermic and sedative effects vlere greatly PJtentia t ed . a-Methyl-j!-
tyrosine reduced significantly the induction time and prolonged the sleeping 
time caused by phenobarbitone. We supposed a t the time that a - m e t h y y - ~ ~
tyrosine either potentiated the effect of phenobar bi t one by central 
synergistic mechanisms or by inhibiting the microsomal enzymes in the liver . 
The results presented in chapter 10.2 show t hat a - m e t h y y - - t y r o s i n e e delayed 
the metabolism of phenobarbitone in both the serum and the brain . T:/ e 
could not rule out completely t he existence of some synergistic elfect 
bet-.ieen the tao drugs , and VTe di scussed i n addition the possi bili t y that 
a a m e e h y y - ~ ~ y r o s i n e e might affect the elimination of phenobarbitone . 
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Papeschi and Randrup (1973) suggested that t he hypothermia produced by 
a - - e t h y y - - t t r r s i i e e was the r esult of blockade of the synthesi s of do pa-
mine and noradrenaline i n fer i pher al organs and of do pamine centra lly. 
since loading of catecholamine stores by L-DO PA antagonized the hypo-
thermia induced by a a m e t h h l - ~ ~ y r o s i n e e IVith a lesser degree of effect -
iveness after peri pheral decarboxylase inhibition. Nhether phenobar-
bitone ~ o t e n t i a t e d d the hypothermic effect of a - m e e h y y - - t y r o s s n e e through 
an effect on the catecholamine sys tem remains an open quest ion f or further 
research in this field. 
One of the major means of studying neuronal f unction i n a rarti c-
ular organ or system has been the observation of functional impairment 
after r emova l of the neuronal input. 6-Hydroxydops.mine , a neurotoxin \.hich 
causes destruction of neurons containing catecholamines , i s one of t he drugs 
"'Thich are useful for this p.u-pose. He there fore used 6- hydroxydop:l.Inine as 
a further means of studying the effect of anticonvulsant drugs on the 
catecholamine system. 
In our e x p e r i ~ e n t s , , a single dose of 250 ~ g g of 6- hydroxydopamine 
injected intraventricularly effectively depleted only noradrenaline stores . 
dopamine being depleted by only 14 per oent t Vle lve days after t he injection . 
~ ' 1 h e n n pargyline preceded 6-bydroxydo:tamine trea tment , t he de pletinG action 
on dopamine was grea tly potentiated tvhi le noradr enaline depl etion stayed 
the same . Pargyline inhi bi ts monoamine oxi dase , ther e by increasing t he 
amount and the dura tion of the effec t of 6 6 h y d r o ~ J d o p a m i i e e in the brai n , 
so producing a greater degree of destruction of dopaminergic neurons 
(Breese and Traylor, 1970). 
I.'The n tve looked a t the effect of sinol e doses of anticonvulsant 
drugs on the levels of catecholamines in t he brains of rat s treat ed vrith 
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6- hydroxydopamine tI·relve days earlier , we found that phenytoin and 
phenobarbi tone increa sed significantly the amount of both amines , ''lhi le 
carbamaze pine increased only that of noradrenaline . These resul ts 
recall those in animals that had not received 6-hydroxydopamine . 
It is known that 6- hydroxydopamine treatment lowers sei zure 
thresholes and antagonises the anticonvulsant effect of phenytoin , 
phenobarbitone and carbamazepine against electroshock sei zures (Quattrone , 
Crunelli and Samanin , 1978) . In our experiments , the se drugs increased 
the amount of the amines present in the stores , which might have been 
expected to exert an effect against the electrically- induced seizures . 
However , this ''las not so . 
After 6- hydroxydopamine treatment . there is a r eduction in the 
number of catecholamine- containing neurons , ,.,hich is a ccompanied by a 
decrease in tyrosine hydroxylast activity and a loss of noradrenaline 
uptake sites (Bell , Iverson and Uretsky , 1970) . Because of this r educ-
tion i n the number of neurons and the activity of tyrosine hydroxyl ase , 
the total turnover r a tes of catecholamines in the brain would be expe cted 
to decrease , and this iias found to be so (for r eferences see Kostrzewa. 
and Jacobowitz , 1974) . Thus , although in our experiments the anti-
convulsant agents ~ o d u c e d d an increase in the levels of the amines in 
the surviving neurons , the total size of the catecholamine s tores 'lIaS 
reduced and smaller amounts of the amine could be released . This might 
not be sufficient to antagonize the electrically induced seizures , unlike , 
perha ps , the state of affairs in the experiments descri bed by uattrone 
~ . . If this assumption i s true , we would expect that the reloadin 
of the catecholamine stores would r everse the enhanced effect of 6- hydroX'J-
dopamine towa.rds t he electrically induced se izure . The work of Stull , 
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Jobe and Gei ger (1 977) showed t hat t his is indeed so. These aut hors 
found t hat the enhenced e l ectroshock seizure int ensi ty produced by the 
de pletion of noradrena line and dopamine in and near the vent ricular a r ea 
by the intracerebroventricula r administra tion of benzoquinolizine Has 
antagonized by the sy stemic administration of L-DO :A. . 
The behavioural changes (described in cha pt er 2 .7) produced by 
combined treatment ,OTi t h an intraventricular inje ction of 6-hydroxydofamine 
and an intra peri tonea l injection of J8,I'gyline ',ler e uni que in t heir fea tures . 
Vetulani, Reichenberg and 'liszniowska (1972) re ported s ome early behavi oural 
changes in rats treated with 6- h,ydroxydop:unine given, by unilater al i ntra-
ventricular i njection and a monoamine oxida se inhibitor (nia l amide ) given 
intraperitoneally. They descri bed the behavioural changes a s strong 
sti mulation , postural changes and circling behaviour . They clai ned that 
these changes '1Tere completely absent when treatment was effected und er 
ether anaesthesia and if the rats were not separated . Fighting behaviour 
d e v e l o ~ d d if the rats i-rere PIt together in one cage two hours aft er t r eat-
' ment , but failed to do so if they Ivere rut together i lIlllled iately after t he 
injections. Our experimental results are entirely differ ent f rom t hose 
described by Vetulani et ale , although vTe adhered to the same protocol 
they used. Giving 6-hydroxydopamine unilatera lly before the monoamine 
oxidase inhibitor, we observed some behavioural changes in rats after the 
recovery from the short ether anaesthesia , but this occurred ~ h e t h h r r the 
animals \'1ere caged singly or together ( see Figures 2 .8 . 2 .9 and 2 . 10). 
!,fe did not observe any circling behaviour . No fi ghtin behaviour devel -
oped any time after the injection, either in the s i ngl y caged or the 
grouped rats . Vetulani a nd hi s co-\"orkers detected a n increase i n 
dopamine concentration in the i n j e cted half of the br ain i n t hei r a n i i l s s
.and the behavioura l changes ,,,er e prevent ed compl etely \.,i th spir operidole . 
a dopamine receptor blocker . In vievr of t ' .e Circling behavi our di splayed 
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by the treated animals and the increase in dopamine concentration in the 
injected half of the brain , these authors suggested that the damage 
produced by 6- hydroxydopamine was not symmetrical . 
Fi biger, Lonsbury and CooIEr ( 1972) described early behavioural 
changes similar to some of the ones we noticed . They reported that 
animals treated with pu-gyline and 6- hydroxydop:l.mine became aphagic and 
adi psic , that they did not groom , assumed a hunched back posture and 
showed increased irritability . HO\vever , they also re ported that their 
animals exhibited a pronounced state of hyperactivity throughout the 
first "ttITelve hours after administration. Although VIe did not measure 
the spontaneous activity , it was obvious , even by casual observation , 
t hat rats exposed to the combined treatment were less active than rats 
t reated with either pargyline or 6- hydroxydopamine alone . 
In cats, displayed rage and occasional convulsions have been 
r eported after combined treatment with pargyline and 6- hydroxydopamine 
(Howard and Breese , 1974). Rats injected intraventricularly vlith 
6-hydroxydopamine on the right but not the left side of the brain , 
exhibited hlo and a half hours later short periods of violent activity 
t o the extent of convulsions (Laverty and Taylor . 1970) . Similar 
r esults were reported in rats hTenty- four hours after intracisternal 
injection of 6-hydroxydopamine . ·Scotti De Carolis , Ziegler , Dell Bass 
and Longo (1971) have examined the electroencephalographic and behavioura l 
alterations and reported motor depr-ession intermingled yTi th spells of 
hyperirritability and seizures . In our experiments \'l e observed the 
motor depression together \u th continuous hy:p3rirri t abili ty . but ,,,e sa',; 
no convulsions during the IEriod of our observation , or \·rhen the treated 
rats ~ e r e e subjected to auditory stimulation at various times ,ther eaf t er . 
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The behavioural changes observed in our experiments may FOss i bly 
be s u b s e ~ v e d d by a dopaminergic mechanism , since neither pargyline nor 
6-hydroxydo IBmine alone can bring about all of the observed changes iTe 
noticed. Jonsson and Sacks (1971), demonstrated that monoamine oxidase 
inhibition increases the accumulation of 6- hydroxydopamine in sympathetically 
innervated tissue. Thus pargyline, by increasi ng both the duration of 
the effect of and the uptake of, 6-hydroxydopamine by the dopaminergic 
neurons might be expected to increase the release of d o ~ m i n e e by displace-
ment mechanisms and so make more dopamine available at the rece ptor site . 
The question arises as to whether the results presented and dis-
cussed so far enable us to say that the activity of an anticonvulsant drug 
depends in part on the catecholamine systems in the brain . T'ms is 
difficul t to answer as yet , but vTe can say that some promising results 
emer ed from our preliminary exp=riments, in which 'ile saw that single 
doses of phenytoin increased the levels of dopamine in the striata and of 
noradrenaline in the'midbrain and increased the levels of both amines in 
the brains of ra ts treated ~ d t h h 6-hydroxydop?mine. We discussed the 
possibility that these effects of phenytoin might have been the result of 
inhibition of the oxidative catabolism of the catecholamines . lbeno-
barbitone reduced the depletion of both dopamine and noradrenaline in 
the early hours after a - m e t h y l - ~ t y r o s i n e e and did so also after 6-hydroxy-
dopa.!Iline and i'le discussed the possibility that phenobarbitone produced 
these changes by inhibiting neuronal activity . Carbamazepine , on the 
other hand , seems to have an effect on noradrenaline, where single doses 
increased the amount of amine in the midbrain and cerebra l hemispheres 
and did so for the ;'1ho1e brain after 6-hydroxydo}B.mine . 
So far the results \'lere prOmising , and because Dos t of the dr ugs 
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used for the treatment of epi le psy are given over a long period of t t ~ ~ , ,
we extended our study to inspect the effect of anticonvulsant druos on 
the levels and turnover rates of catecholamines after long term admin-
istration. 
Chapter 3 desdribes results obtained after long term administrat ion 
and wi thdra,,,al of phenobarbitone . The method of habituation we used ',las 
very successful in producing dependence on p h e n o b a r b ~ ~ tone , since \fl th-
dra'..;al of the drug produced severe abstinence symptoms , charact erized 
by irritabili ty , aggressiveness , a decrease in food intake, loss of body 
\"eight and Gonvulsions. 
A tolerance to the lOi-:er doses of phenobarbitone developed about 
ten days after treatment at each dose level of the drug , Nhere a slight 
aggressiveness and biting behaviour were noticed and rat s conducted 
themselves in a completely different manner from that seen during the 
first days of treatment at each dose l evel. i'l e called this phenomenon 
self ,\,1i thdrawal, since phenooorbi tone stimulates its own metabolism as 
well as that of other barbiturates (Conney, Davidson , Gastel and Burns , 
1960; Kato and Chiesara , 1962; Frey and Kampnann, 1965 ) . It i s ,,,ell 
known as 1'lell that tolerance to the sedative and hypnotic action of 
phenobarbitone develops after a few days of treatment and then di sappears 
(Frey and Kampmann , 1965 ) . So phenobarbitone acting by stimulati its , 
O1'l'n metabolism might decrease the levels of phenooorbi t one in serum 
giving ri se to the mild withdrai.;al symptoms described ear li er . 
The first dose of pheno'barbi tone \'l e used (50 mg/k daily) pro-
duced an increase in food and \'later intakes . These perSi sted f or nlo 
days , but t hen fell so that on the fourth day and ther eafter both t r ea ted 
and control groups ate and drank t he same amount . The same thing 
happened again ~ ' l i i th food intake \'1hen the dose ,'las incr eased u p t o 
- 232 -
1 00 mg/kg daily . Crossland and Turnbull (1 971) related the increase 
in food intake on the lon", term treatment i'iith sodium barbitone to the 
stimula tion of the g r m ~ t h h rate of young rapidly grOTtTing r ats , as 
indica ted by the increase in the body ';Teight and skeletal length . 
In our eXp3riments . there ioTas evidence that r a ts on phenobar bitone 
gre'tT at a faster rate than did control rats , but thi s '\,as seen only at 
the 1011T dose levels and i t 'tras reversed when the daily dose .. Tas increased 
t o 150 mg per kilo . It is possible that the observed increase in food 
intake was caused by an action of ' phenobarbitone on the hypothalamus •. 
Feldberg (1960) noticed that i njection of barbiturate into the lateral 
ventricles often resulted in hyperphagia before the induction and during 
recovery from anaesthesia . 
\ \ h e n n \'le studied t he effect of long term administration of 
phenobarbitone on the catecholamine content of rat brain , "Te found that 
habituation to phenobarbitone had no effect on the total content of 
either dopamine .or noradrenaline . H01'leVer, it \oras associa ted 'Id th an 
increase in the dopamine content of the striata and midbrain and an 
e ~ u i v a l e n t t decrease in that of the cerebra l hemispheres , so that the 
t otal amount of dopamine remained u n c ~ ~ n g e e . .
The dopaminergic nigrostriatal system is believed to be concerned 
with the integration of incoming sensory stimuli and the fine control of 
movement . It 'flaS clear theta t the end of the p3ri od of ha bitua ti on to 
phenobarbitone , the rats ,'lere ataxic , their response to external stimuli 
was depressed and movement ,vas imP3-ired . ~ ~ i h e t h e r r vTe can attribute t he 
changes in dopamine content of the striata and the midbrain to a decr eased 
acti vi ty of the nigrostriatal system (among others) , and l'lhether . if so , 
these changes are also related to the behavioural changes , :lfe ",Ti ll leave 
as an open question . 
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The decreased dopamine concentration in the cerebral hemis pheres could 
conceivably be the result of an increased release and utilization of this 
amine in habituated r a ts . It might be"relevant to note this point since 
the motor centres are located in the cortex . 
Before considering any explanation f or the above reported resul ts . 
let us go a little further in order to try and see the i.,hole picture. 
The catecholamine system in the brain of r ats "lhich ·had been 
habi tooted to phenobarbitone ioTaS studied after the withdrmval of the drug . 
'1\10 days after the '1ri thdraiial of phenobarbitone . the amounts of dopamine 
and noradrenaline were de creased in the brains of the previously habituated 
rats. 'ilhen we looked at the regional distribution of the catecholamines 
in the brains of this group of rats, we found that the changes took place 
in the striata for dopamine and in the cerebral hemispheres for both 
amines . The loss of dOp3.mine in the cerebr a l hemispher es of \·r i thdrawn 
rat s iias greater than that in habitua ted rats . HOi.,ever , wi thdra'lral of 
phenobarbi tone 'IlaS not associated '1Ti th any decrease in d o ~ n e e l evel s in 
the midbrain iVhich had been elevated by the previous long term admini s-
tration of the drug . 
mine in the midbrain . 
This might indi cate a slow turnover ra ts of dopa.-
The experiments of Morgan, Pfeil and Gonzale s (1 977 ) to some extent 
pre-dated ours . These worlrers reported an increase in d o p a ~ i n e e concen-
tration in the striata of r a ts de pendent on sodium barbi t one . 'l".-renty-f our 
hours after wi thdrai'lal of the drug , dopamine concentrat ion Nas l O'dered to 
tha t of control value and forty- eight hours af t er VIi t hdrawal t here Has a 
further depletion . ':Ii thdraiia l of sodium harbi tone decreased the concen-
tration of noradrep.aline in the cerebr al cortex and the thalamus t\·rent y- four 
hours after t he removal of the drug . Habituation in ~ o o g a a ' s s experioent s 
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had no effect on the l evels of noradrenaline. The results re ported by 
Horgan and his CO- I-1orkers a r e in good agreement iii th the r esults .·re 
reported ,,,i th respect to t he elevation of dops.mine in the stria t a after 
habituation to phenobar bitone and the decrease of d o p a ~ n e e in the striata 
and of noradrenaline in the cerebral hemispheres after ,. i thdra\oJ"a l of the 
drug . Unfortunately, ·lorgan and his co-,.orkers did not report "1hat had 
happened to dOp:l.mine in the cerebral hemispheres during habituation to 
avd l"1i thdra,ial from sodium barbitone . 
To summarize the results so far, habituation decreased the levels 
of dopamine in the cerebral hemispheres and increased it in the stria ta 
and midbrain , i<Thi le "'1i thdra\"ral brought about a decrea se in dops.mine l eve l 
in the striata and a further decrease in the cerebral hemis pheres . 
Noradrenaline content decreased only in the cerebral hemispheres . 
In order to investigate our results further , we examined the 
effect of habituation to. and "1i thdravTal of phenobarbitone on the turnover 
rate of the catecholamines after a - m e e h h l - ~ t y r o s i n e . .
i'ie found t hat habituation to phenobarbitone decreased the depleti on 
of both catecholamines, normally brought about in the striata for d o p a ~ n e e
and in the cerebral hemispheres for both amines . 
We should draw attention at this point to an apparent discrepancy 
beti"-reen the results we obtained for \'Thole brain and those rela ting to the 
regional distribution vlhen we 'rTere considering the noradrenaline content 
in habituated rats treated with a - m e t h y y - - t y r o s i n n . . :lhereas habituation 
to phenobarbi tone } " l ~ d d no apparent effect on the depletion of \'Thol e br a in 
noradrenaline brought about by a - m e t h y y - - t y r o s i n n . . ,.;hen 'lTe conducted our 
regional studies ~ ' T e e found that habituation reduced t he depleting effec t of 
a - ~ e t h y y - - t y r o s i n n . . This d i fference , of course , arose f rom the difference 
- 235 -
in the tiffie of killing a fter a - m e t h y y - - t y r o s i n n . . In the 1-Thole br ain 
assays the killings :·;ere made eighteen hours after a- methyl-.:e-tyrosine , 
while in the regional studies the anims.ls Her e killed only four hours 
after a-metrijl-.:e-tyrosine . This i s in good agreement Hi th the results 
obtained on the effect of single doses of phenobarbitone on the disapp-
earance rate of noradrenaline after a-methyl-.:e-tyrosine, where a d e e a y i i ~ ~
effect was seen only during the early hours after a- methyl-.:e-tyrosine . 
Our results after a-methyl-k"tyrosine are consistent Tili th thos e 
obtained for the effect of habituation on the unimpaired ca t e cholamine 
system exce pt for the results for dopamine in the cerebral hemispheres . 
For this catecholamine in the unimpaired system, there 'tlaS an increased 
turnover w'hieh changed to a decreased turnover ,,,,hen the system 'Nas 
impaired by the administration of q - m e t h y l - ~ t y r o s i n n . . On the other 
hand , ,'li thdra,.,al of phenobarbi tone increased the depletion of both 
dOplmine and noradrenaline in I'Thole brain, an effect that was found to 
be localized in the striata and cerebral hemispheres f or dopamine and in 
the cerebral hemispheres and midbrain for noradrenaline. The se obser-
vations, too, are consistent with those reported after ,\'7i thdrawal of the 
drug in an unimpa.ired system. 
Norgan, Pfeil, Huffman and Gonzales (1978) reported that "lith-
dravTal increa sed t he rate of de pletion of both dOpamine a nd noradrenaline 
in the brains of b ~ b i t o n e e dependent rats , suggesting a role for 
ca techol amines in the manifestation of barbi tura te vli thdral·ra l symptoms . 
These result s again are consistent "Tith the results vie r eported after 
wi thdralial of Iile..'lObar bi tone . 
'. 
It is now clear that habituation decreased a nd "li thdr m'la l increased 
the turnover r a te of dOpamine and noradrenaline . The e f fec t of habi t uation 
vIaS more pronounced on the doramine system. \'[ e i dentified t he ar eas at 
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vlhich t hese changes took place and as i>/' ell confirmed the effect s i n 
animals given a - m e t h y l - ~ ~ y r o s i n e . .
Let us consider now the possible explanations of the results 
"lv e reported above. 
The reduced turnover of dopamine during habituation may be 
theoretically due to inhibition of monoamine oxidase , to a direct 
stimulation of dopamine rece ptors, to a reduced dopamine r el ease f rom 
. 
its nerve terminals or finally a decreased flevl of nerve imprl ses i n 
dopamine neurons (Corrodi, Fuxe, Lidbrink and Olson, 1971). 
Lidbrink, Corrodi, Fuxe and Olson (1972) also reported t hat 
single doses of phenobarbitone (100 mg/kg) had no effect on the tota l 
amount of noradrenaline and dopamine in rat brain, a result '11hich was 
confirmed by our preliminary '11 ork. On the other hand , the same dose 
of phenobarbitone decreased the depletion of dopamine brou ht ' about by 
a - m e t h y l - ~ t y r o s i n e e in the striatum and of noradrenaline in the cere-
bral hemispheres . These results, too, are in good agreement with 
our findings . In this same fG.per, Lidbrink and his cO-\'Torker s found 
that phenobarbitone was no different in its effect on monoamine oxidase 
than '1TaS C(-methyl-,l2-tyrosine . This finding applied to the cer ebral 
cortex, the neostriatum and the hypothalamus and it excludes the idea 
that inhibition of monoamine oxidase might be responsible f or the r educed 
dopamine or noradrenaline turnover. The second possibility \-las te s ted 
by the same authors , by the injection of phenobarbitone into r ats vlith 
a unilateral lesion of the nigrostriatal doFamine path\>/'ays . They found 
no asymmetry or rotation in those rats,thus excluding the possibility 
that a direct stimulation of dopamine receptors i'laS r esponsible for t he 
observed reduction in dOpamine turnover . 
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Cooper, Bloom and Roth (1 978) proposed that an alteration in 
the ~ ~ r n o v e r r rate of a n e ~ o t r a n s m i t t e r r is not necessarily a clear 
indication tha t there has been a change in impulse f low in a given 
neuronal J;a thl.,ay • Al thoug:!J. these authors ':lere speaking about the 
catecholamine system , their statement seems to be contradictor,y to 
the ~ . . o o k k of Anden , Corrodi, F'uxe and Ungerstedt (1 971) and of Nyback 
(1 972 ), ,.,ho -reported that the turnover of doramine and noradrenaline 
"Tas media ted by changes in nervous activity a nd vTe . conclude tenta-
tively that the reduced dopamine turnover seen after phenobarbitone 
habi tuation was caused by a decreased impulse flmoJ' in dOJ;aminergic 
neurons. 
For the observed decrease in the degree of depletion of nor-
adrenaline in the cerebral hemispheres of habituated rats treated 
with a a m e t h y l - ~ ~ x o s i n e , , similar mechanisms to that described for 
dopamine can be suggested. Lidbrink and Farnebo (1 973) found that 
phenobarbitone , in a wide range of concentrations , did not interfere 
with the uptake, retention and the spontaneous or evoked release of 
(3H] noradrenaline in rat cerebral cortex. This again supports the 
concept that a decrease in neuronal activity is responsible for the 
reduced turnover of noradrenaline observed in the cerebral hemispheres 
of the habituated rats seen during the early hours after giving a- methyl-
~ t y r o s i n e . .
It may be relevant to point to the reports that drugs which block 
impulse flO.T in nigrostriatal dOJ;aminergic neurons increase instead of 
decreasing doJ;amine biosynthesis (for references see Roth, NOltrJ cky, 
';/al ters and Horgenroth , 1977) . Thus in conclusion ",e can assume tha t 
phenobarbitone produced a decrease in the turnover of catecholamines by 
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decreasing the impul se flmT in neurons . 
After '1l i thdravTal the picture ,'Tas reversed and there 'lias an 
increase in the turnover of both ca techolamines . 
Crossland (1 971) has put for'lTard a hypothesis that a ptation 
of the central nervous system to a depressant dru mi ht stem from an 
increase i n the liberation of an excita tory transmit ter or a decrease 
in the liberation of inhibitory transmitter sufficient to overcome the 
dePressed condition of the nerve cell. Barbi turates ar e knO'/m f or 
- . 
their depressant effect on neuronal firing and the catecholamines for 
their inhibitory role in neurotransmission . The theory of Cross land 
fits in well with our conclusion that phenobarbi t one decreased the impulse 
flow in inhibitory neurons . 
After withdrawal , the inhibitory effect of phenobarbitone on 
catecholamine neurons would be removed and t he neurons would presumably 
fire at a faster rate. resulting in an increased turnover of the amine . 
This i s w'hat we have found. to happen . It is interesting to note t hat 
the concentration of phenobarbitone in the brain I'las very low forty-ei ht 
hours after wi thdrawal . It was at this time that our measurements of 
the catecholamines l'lere made (Chapter 10.2(iii).) 
1 1 ~ e e extended our investi gation much further by studying the 
catecholamine systems during the onset of convulsions produced in the 
withdra\m rats by audiogenic stimulation , in order to see to '"hat extent 
the ca t echolamine systems ',lould r eact in convulsions . 
I,ihen r ats wi thdravm f rom phenobarbitone f orty-eioht hours earlier 
'" ere subje cted to auditory stimulation and tilled a t the time of convul-
sions , l'le f ound that t heir total br ain levels of doramine vrere unchan e 
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from those of untreated animals also subjected to stimul ation . H C\'l -
ever, t hey snOlved significantly higher amounts of dO}amine in t he stri ata 
and lO'irer amounts in the cerebra l hemis pheres , ' .... hi ch i s exactly the same 
situation we found in the brains of habituated r a ts. The br ai ns of 
convulsed rats shOi ... ed higher levels of dOp3.mine than the br ains of 
wi thdrawn r at s tlThich bad not been stressed by audiogenic stimulation . 
Noradrenaline levels ';lere lm'ler i n this group of r ats than in the cor-
responding untrea ted rats subjected to stimula tion, but contained sig-
. 
nificantly higher amounts of noradrenaline than did the brains of \.,i thdra\m 
rats which had not been stressed by audiogenic stimulation . 
It is obvious that ,'Ii thdra,.,al convulsions changed the activity 
of the catecholaminergic system. The mechanisms by '"hich the brain 
reacted during convqlsions are difficult to expl ain on the basi s of a 
single effect of a neurohumoral agent , although an explanation i s a most 
desirable goal . The convulsion state itself coul bring about lot of 
changes in the activity of other putative neurotransmitter s . especially 
since it has been demonstrated already that other neurohumours , like 
acetylcholine and Y- aminobutyric acid. control the activity of do paoin-
ergic and noradrenergic neurons . However, He \iill try to explain our 
findings on the basis of results obtained by other researcher s in this 
field . 
Ca l derini, Carlsson and N o r d s t r ~ m m (1 978 ) r eported t hat rats 
with sustained epileptic seizures produced by intravenous i njection 0 
bicuculline showed a reduced l evel of noradr enaline a f t t ~ ~ t irty minute 
and that the catecholamine remained 10'" during the 'bT O hours of sus t a i ned 
epileptic activity . This is in agreement \"i th the 10i ... e:- values of 
noradrenaline ':1e observed in t he br ains of t,1i t hdr avTn r a t s during 
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The same authors reported that dopamine was increased one hour 
after the sustained seizure activity and remained so a further hour 
later. This again supports the results ' .. re obtained for dopamine in 
the striata, but does not confirm those observed in the cerebral hemi-
spheres in \'ihich "Ire found a decrea se during convulsions. Tyrosine '"as 
reported by the same researchers to be elevated by bieuculline and the 
accumulation of DOPA follmving inhibition of I-aromatic a cid decarboxylase 
V/'as f ound as \Vell to increase in the striatum, l l m b i c c forebrain and the 
hemispheres during the period of seizures . This i ncrease 'tras found to 
be most pronounced in the striatum and the hemis pher es , i'lhich indicates 
an increased hydroxylation of tyrosine during epileptic seizures . 
Therefore it seems reasonable to suppose that the 10\0( levels of 
dopamine in the cerebral hemispheres seen in withdra'trn rats dur ' 
audiogenic convulsions are best explained by an extraordinarily high 
I! functional activity in the dopaminergic neurons exceeding the r ats of 
transmitter synthesis . The same can be applied to noradrenaline . 
The increased levels of dopamine in the striata can be simply explained 
on the basis of decreased functional activity . 
Catalepsy always fo11O\o(s convulsions . Catale psy i s thou ht t o 
be caused by a depression of dopaminergic mechani sms in the stria tum 
( Papeschi , 1977 ). Therefore the decreased dopaminer gic function in 
the striatum during convulsions would decrease the amount of dopamine 
at the rece ptor site, "rhieh in turn might result in catalepsy . This 
might give further support to our findings . Furthermore . Farjo and 
Hcqueen (1979 ) have suggested that a reduction in t he activity of 
striatal dopamine neurons might release the cortical neurons rom 
striatal inhibition and perha ps potentiate epileptic charges in the 
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cortex . Thus , i f this mechanism t akes pl ace in audio enic eonvulsions . 
we would expect t hat the decreased striatal activity during s ound stim-
ulation vlould release the cerebral cortex from its inhibition and. may 
contribute in part to t he convulsions . 
In conclusion, .d thdravlal r el a ted convulsions seem to increase 
the activity of noradrenergic neurons. The tone in dopaminergic neurons . 
on the other hand , ,yas increased in the cerebral hemis phere s a nd decreased 
in the striatum. ivhen com}:er.ed to withdrawn rats ~ d d thout soun sti mula-
tion , witbdrawn convulsed rats had higher l evels of do pamine ' and noradrena-
line which might reflect an increase i n the rate of synthesis of these 
amines during convulsions . A support for this suggestion comes f rom the 
findings of Calderini and his cO-Norkers (1978 ) that sus tai ned seizures 
increased the rate of uptake and hydroxylation of tyrosine . 
I 
When we extended our study on the mechanisms of convulsions by 
studying the turnover of catecholamines after a-me thy l -.I!-tyrosine , \-le 
found tha t a- methyl--..:Q-tyrosine protected most wi thdralm rats from sound 
convulsions , although the r a ts '"hich did not convulse showed vlild running . 
This group of r a ts sti ll sho\lTed less dO}:emine in their striata and 
cerebra l hemis pheres than the corres pondi ng control group treated vTith 
a - m e t h y y - ~ t y r o s i n e e and subjected to audiogenic sti mulation , but t hese 
values \oJ'ere higher than those of ' In thdrawn r ats In t h de pleted cat echolamine 
stores that had not been stressed by audiogenic stimulation . Horeove , 
noradrenaline ''las also reduced in amount in the midbrain of thi s group 0 
rats , Nhen comrared ,vi th those of control group treate ,'lith CX- methyl -
~ t y r o s i i e e and subjected t o audiogenic stimulat ion. The total moun s 
of de pleted dopamine and noradrenaline i!1. the brains of loTi thdralm r a ts 
~ · · h i c h h had been stressed by audiogenic sti !:lulation .ier e lightly hi her tr-an 
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in the brain of Ifi thdrat-Tn rats ,'lith depleted ca techolamines and -,Thich had 
not been stressed by audiogenic sti mulat ion. 
This indicates that catecholamine systems after a - m e t h y y - ~ ~ y r r s i n e e
in sound stimulated w i t h d r r ~ n n rats reacted i n a manner be nveen t hat seen 
during vlithdr a\.,ral and that in convulsions and may indicate that stimulatio!1 
in protected rats activated in f8.rt the me chanisms ,ve described as taking 
place during convulsions . 
The protective effect of a - m m t h y l - ~ t y r o s s n e e on audiogenic seizures 
in rats withdrawn from phenobarbitone i s surprising , s ince it i s knOlffi that 
disruption of catecholaoine systems either by inhibition of stora e (Cht n , 
Ensor and Boh.'1.er , 1954; Azzaro, \venger, Craig and Stitzel , 1972 ; 'len er , 
Stitzel and Craig , 1973 , and many others ) or the destruction of cat echol-
aminergic neurons by 6-hydroxydo pamine ( Brmming and Haynert . 1970 ; Bourn . 
Chin and Picchioni, 1972; BrmTning and Simonton , 1978 . and many other ) 
usually results in an increased susceptibility of animals to chemically , 
electrically and sound induced convulsions . Hmlever . the r esults r eported 
with the effect of a-methyl-lrtyrosine have been inconsi stent . For Hherea s 
Chin. Ensor and Bohner (1968) reported t hat a-methyl-lrtyrosine lower ed 
the extensor electroshock seizure threshold in mice , Jobe , 'cchioni and 
Chen (1 973) observed no change in susceptibility to audiogenic seizures 
in ra ts treated ,'lith this drug. Furthermore , the anticonvulsant effact 
of phenytOin against supramaximal electroshock "Tas not modifi ed by pre-
treatment with a - m e t h h l - ~ t y r r s i n e e (Bhattacharya . neddy and Das , 1976) . 
On the other hand , ~ i l k i s o n n and Halpern (1 979 ) re ported t hat a- ethyl-_ 
tyrosine administered t o r ats tvTelve hours before oupe trial sessions 
significantly depressed t he amygdalar aft er-discharge . Reserpine 
significantly augmented the amygdalar after-di scharge , I'Thich i s in line 
with other findings that disruption of catecholamine s torage system 
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increasES seizure activity . Our result s 'tiere supported by those eFOrted 
by Horgan , Pfeil and Gonzales (1978), '"lho re ported a protective effect of 
cx-methyl- .Q-tyrosine a gai ns t vTithdr m'Tal rela t ed convul s ions in barbitone 
dependent r ats . 
These conflicting results make the protective effect of CX- methyl-lr 
tyrosine against audi ogenic induced ,.,i thdra'tlal convulsions more difficult 
to explain . HOT'iever, there are severa l possi bilities I.;hich mioht con-
tribute to the observed effect . a- Nethyl-j2-tyrosine produces hypothermia 
and hypothermia below 2SoC provides complete protection against chemically . 
electrically and sound induced seizures (Essman and Sudak , 1964) . Hypo-
thermia as Nell '1laS reported to produce a rwrked decrease in the concen-
tration of glutamate (,.,hich is believed to act as an excitatory neurotra ns-
mi tter) in rat cerebral cortex (ToNer , 1959) . 
The other possibility is that e e - m e t h h l - ~ t y r r s i n e e itself mi ht be 
metabolized to t he corresponding ca techoles (ex-methyl noradrenaline and 
ex- methyl dopamine) and that these might be r e l eased and act as false 
neurotransmitters a t the catecholamine rece ptors and so provide a prot ec-
tion effect a gains t audiogenic seizure . This viel'; is supported by the 
finding of ~ 1 a i t r e e (1 965) 'iho reported tha t a ft er trea tment ... dth a- me thyl-ll-
tyrOSine , a-methyl noradrenaline and "cx- methyl dopamine could be et ecte 
in the brain tissue of guinea pigs in amounts averaging 2 0 and 355 per 
cent respectively of that of the remaining noradrenaline . 
these suppositions demand further investigation . 
Hmlever , all 
';Ii th the above arguments in mi nd , iie should try to el ci a te the 
functi ons of catecholaminergic systems durin habitua tion to and "lith 
from phenobar bi t one and during Tid thdra\"Tal convulsions . T' e simples t 
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hypothesi s that can be given at this stage i s t hat habituation to pheno-
barbitone decreases the turnover of catecholamines , most probably by 
decreasing flow in nerve impulses . ltlhen the drug is wi t hdral-Tn . the 
depressant eff ect is removed and the neurons return t o firing at a faster 
rate, resulti ng in increased turnover of transmitter s . Hithdrawal 
related convuls ions would bring about an increase i n the rate of synt hesis 
and an increase in the activity of dopaminer gic neurons in the cerebr 1 
hemis pher es and noradrenergic ones in the ''1hole br ain • At the same 
. 
time they evidently also produce a decrease i n the activi ty of dopamin-
ergic neurons in the stria ta . 
Exper iments in chapter 4 describe r esults obtained after 10 
term administration of phenytoin, carbamazepine and sodi um bromide on the 
cont ent and turnover of catecholamines in rat brain . The most stri !d ng 
changes observed in rats treated l'1i th phenytoin and car bam.s.z e pine ,'rere 
the high increase in \-ta ter intake and t he i ncreased urination produced 
by both drugs . Pnenytoin is knO'l-Tn to inhibit the centra l release of 
antidiuretic hormone in the human being (Fitchman and Kleeman . 1970) 
and probably acts by t he same mechanism in rats leadino to an inc ease 
in water intake to balance the wa ter lost by the increased urination . 
The effect of carbamazepine , on the other hand , perhaps cannot e so 
easily ex plained . It seems probable t hat the effect of carbamaze ne 
arises f rom its toxic effect on the lddneys of t he treated rato. HmT-
ever, tnis is only a matter of speculation and a proper explanation is a 
yet i mpossible . 
Neurochemically , long term administr ation of p p e ~ ~ toin an 
carbarnaze pine resulted in increased levels of noradrenaline in t ' c cer ebral 
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hemispheres and midbrain . while phenytoin also slightly increased t he 
levels of the amine in t he pons and medulla . :ihile phenytoin i ncr eased 
the levels of dopamine in striata and midbr ain and decreased it in t he 
cerebral hemis pheres . carbamazepine increased the l evels of t he amine in 
the striata anci the cerebral hemispheres . The effect of phenytoin on 
the dopacine concentration in different parts of the br ain is exactly 
the same as t hat obta ined after long term adcinistration ~ i i h h pheno-
barbitone. It is tempting to specula te, therefore: that phenytoin mi ·ht 
have exerted its effect on dopami'nergic systems by mechanisms similar to 
those described for phenobarbitone . The effect of phenytOin on noradr ena-
line levels, on the other hand, is different from that of Phenobarbi t one . 
which had no effect on noradrenaline levels but did delay the disa ppeara nce 
of noradrenaline from the cerebral hemispheres after a - m e t h y l - ~ ~ y r o o i i e . .
Phenytoin was r epor t ed by Azzaro , Gutrecht and Smith (1 973) t o 
inhibit monoamine oxidase. It produced a greater inhibi t ion of m o n n ~ ~ e e
oxidase typ3 A, i'lmch prefers noradrenaline and serotonin as ub ~ r a t e s s
(Yang and Neff , 1974) than it did ~ d d th monoamine oxidase type B (Azzaro 
and Gutrecht, 1975). Phenytoin ,'las reported as 'flell to inhi bi t the 
calcium dep3ndent potassium stimulated release of [3H] noradrenaline 
from rat brain slices (?incus and Lee, 1973) and to block the upt ake of 
radioactively labelled noradrenaline by rat bra in synaptosomes under 
physiological conditions (Hadfi eld , 1972; Azzaro and Gutrecht , 1973) . 
Phenytoin, therefore, seems to have different effects on n o o a a r e r ~ ~ i n e e
neurones. It i ~ ~ b i t s s the intraneuronal degradation of noradrenali ne , 
decreases its release and blocks the upt ake of t he release amine . The 
other possibility is that the ca techol metaboli te of _henytoi n may com-
p3te 'llith noradrenaline for 3-Q-methyla tion t hereby exerting a sp3.ri 
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effect and prolongins the life of noradrenaline in the synaptic clef t . 
The mechanisms we described above might explain our f i r.d i n , 5 ';ri -:;' 
regard to noradr enaline after long term a d m i n i s t t a t t o ~ ~ of p h e ~ ~ t o i i . .
Carbamazepine , on t he other hand, had s l l ~ h t t y y differ ent effect 
on the l evels of do::runine in the cerebral hemi spheres . This indi cat es 
t hat c2,r baI:l8.Zepine might have different mechani sms of action on d o ~ r . U n e e
activity in the cerebral , henispr.eres, especially '..,hen ~ ' l e e remember t hat 
carbamaze pine i s a diff erent c l l ~ s s of ant iconvulsant drug from those of 
phenytoin and phenobarbitone and resembles the tricyclic anti depressant 
agents . Furthermore , cs.rbame.zepine is more usually used i n t he treat ent 
of grand mal epilepsy associated ltTith depression . The difference i n i ts 
effect on do pg.mi ne from those observed 'ITi th phenytoin and phenobar bitone 
might be associated Ni th this difference in therap3utic use . 
The effect of c c r ~ m a z e p i n e e on noradrenaline l evels , on t he othe= 
hand , resembles that of phenytoin. In fact t ere is a reper Khich S. O'dS 
that carbamazepine shares some of the properti es described for phenytoin . 
Purdy, Julien , Faihurst and Terry (1 977) f ound that a concentra tion of 
10-4 of carbamaze pine significantly inhibited both the release and the 
upt ake of tritiated noradr enaline from rabbit brain synaptosomes , an effe t 
which ,';as described earlier for phenytoin ( see above ) . Since the ef ect 
occurred at a concentration that is higher than the t herapeutic dosage , 
the authors concluded that this effect ,-las i nsufficient to account for 
an anticonvulsant effect in this drug. Nevertheless , these r e ~ u l l 3 3 ~ ~ y y
a t least suogest a common effect of phenytOin nd car bar:18.z epine on the 
noradrenaline system . 
In support of the observed effect of caroamazepine on the 
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noradrenaline system , imipramine , "'hich is structurally r el t e to 
carbamaze pine , ,.,ras re ported to decrease the intensity of audiooenic 
seizures in genetically susceptible rats and strongly to anta onize 
the sei zure enhancing effect of a benzoquinolizine deriva tive . It 
also re s tored the fluorescence in the hypothalamus (Jobe , P1cchioni 
and Chin , 1973). This effect of imipramine was sug ested by Jobe ll..lU, . 
t o be caused by an accumulation of noradrenaline at the synapti c clef t . 
itself caused by blockade of uptake. This. it .. las proposed , would . 0 -
duce an anticonvulsant effect in ~ e s p o n s e e to central noradrenergic dis -
charge . Therefore it is possible that carbamazepine produces its 
anticonvulsant effect by mechani sms similar to those described by Jobs 
et a1. f or imipramine . 
Sodium bromide was tested for its effect on catecholamine systems 
just to compire the effect of modern antiepileptic dru s iti th an old 
fashioned one. Sodium bromide had virtually no eff ect on the ca t echo laclr.e 
systems . It only produced a slight increase in the concentra tion of 
dopamine in the midbrain after its long term administration , and e ye 
the disappearance of dopamine after a - m e t h y y - ~ t y r o s i n n . . It hll. no 
effect on noradrenaline levels or turnover. 
these results . 
Litt le can be ms.de rOm 
In order still further to investigat e our result s , i'le ex mine 
the effect of long term administration of p h e n y t o i ~ ~ an carbamaze pi ne o. 
t he turnover ra te of catecholamines after a- methyl- tyrosine . 
decreased the depletion of noradrenaline in t he midbr a i n nd (but only 
s lightly and ,'Ii th a low degree of si gnifi c nce ) in t he cer e br 1 hcci s .1 o r ~ ~ • 
This i s in good agreement Hi th the results obtaine i'li thout - met 1-_ 
tyrosine treatr:Jent \.,rhere the predominant effect of phenytOin on nor'" ' re aline 
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levels 'lTas observed in the midbrain . Carbamazepine decreased only the 
degree of de pletion of noradrenaline in the cerebr al hemi spher es . 
Both drugs resisted the depletion of dopamine in the stria ta and cerebr 1 
hem s phere s • The effect of phenytoin is similar t o that obtaine fter 
long term administr a tion of phenobarbitone . 'Iiher e the decr ea si effect 
on dopamine concentration in the cerebral hecispheres was not s een fter 
inhibition of ~ t h e s s s s by the administration of ~ - m e t h y y - - t y r r s i i e . .
In fact t here '\vas a r ever sal of the effect , the dru s resisti ('J' the 
depletion of dopamine caused by the synthesis inhibitor . These obser-
vations further underline the similarity b e ~ ' l e e n n the effects of r henytoin 
and those of phenobarbitone on the dops.mine system . Thi s i s perhaps 
not surprising in vie,,7 of the similarity in structure beti-7een the hlo 
drugs . 
Elliott, Jenner, Chad1'Tick , Reynolds and Harsden (1 977) faun 
that phenytoin produced a dose dependent inhibition of both apomo!' :.lhin 
and. amphetamine induced Circling behaviour in r a t s vIi th unil te £11 nigro-
striatal lesions, an effect ivhich ivas s een as well a fter L-DO tre tment 
( I1endez, Cotzias , Hena and r-apJ.vasilion. 1975), suggest i ng that phenytoin 
proQuced a functional blockade of striatal dopamine a ctivity . .:3uch a n 
effect ",ould be expected to cause a n increase in t he turnover r ates of 
d opar:ri.ne and as i'lell an increase in the concentrati on of do mine !'!let aboli te 
due to the feedback activat ion of dopaminergic neurons . !>rei t r.e_ coul be 
detected by these authors . I n fact , t hey re ported a decre se in do 
turnover and t his occurred only 'I7i th one dose and at one tioe interv 
(40 mg/kg after 2.5 hours ) . In our experi!'!lents single doses of phe oi n 
produced no change in the 'iThole brain turnover of 0 ~ m i n n . . he ... e i a 
pos s i bili ty that the catechol metabolite of phe!1ytoin re ported by " un , 
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Okerholm and Glazko (1 972 ) might have acted as a partial antawoni st at 
do pamine rece ptors i n the s triatum and t hat this might have accounte 
for the blockade effect observed by Elliott and his colleagu es . 
In conclusion . 'lie can say t hat phenytoin acted on do pg.minergic 
$Ystem by mechanisms similar t o those described for phenobar bitone . 
Carbamazepi ne . on the other hand . acted a little differently . but its 
major e f f e e t s s on dopami ne r r s e e b b e d d t hose of phenobarbitone . 
Phenytoin acted on noradrenergi c neurons by inhibiting mono-
amine oxidase . inhibiti ng release and as 'I'lell inhi bi ting the uptake of 
the released aoine . Its catechol metabolite would compete Id t h ca t echol-
amines f or 3 - ~ m e t h y l a t i o o . . thus prolonging the life of the catecholamines 
at thei r receptor sites . Carbamazepine shares some of the prop:!rties of 
phenytoin by inhibiting the r elease and as \'lell the uptake of nora r enaline 
and "d e suggested t hat they might have a common mechani sm of action on he 
noradrenergic neurons . 
II. Indoleamines and anticonvulsant drugs 
The finding by Bonnycastle, Giar man and Paa sonen (1 957) t hnt serie of 
anticonvulsant drugs significantly elevated the brai n 5- hydroxytry amine 
content . opened a neT era in the f ield of research i nto the m e c n a n i s ~ ~
of action of anticonvulsant drugs . Al thoubh the original \york by Bonn f _ 
castle ~ . . s h ~ T e d d t hat elevation of the brai n amine content by a 
monoamine oxi dase inhibitor or an amine precursor provided no protection 
against l e ptazol convulsions . l'lork carried out later by othe '.lor}:ers 
prOVided the opposite r esults . Thus treatments Nhic 1m'1er can r",l 
levels of 5-hydroxytryptamine (by inhibiting its synthesis ) ~ v e e Stin 
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reported to lo,'rer the threshold for maxim9.l ele ctroshock sei zures (Kilian an 
Frey, 1973) to intensify audiogenic sei zures in genetical ly suscepti ble 
rats (Jerliez , Kostovr sld. , Bi dzinsld. and Hau ptmann , 1978) and t o FOtentiate 
le ptazol convul sions in rats (Bhattacharya , Ghosh and Bose , 1978) . " ~ o r r ­
over , the anticonvulsant effect of phenobarbitone agains t e l ectroshock 
seizures Ivas inhibited by treatments that lmrered the cent r al 5- hydroX'j-
t ~ ~ p t a m i n e e content and potentiated by pre- treatment wi t h both 5- hydroxy-
tryptophan and L-DO PA (Neyer and Frey , 1973 ) . It 'vas a l so f ound that 
5-hydroX'jtry ptophan admini s tered 'to baboons with phot osensitive epi l epsy . 
completely prevented photica lly induced myoclonus s eizures ( ,Je l drum , 
Bal zamo , Tilada and Cacciuttolo, 1972). In human beings , 5- hydroX"j t ry ptophan 
in comb i na tion 'tli th a peripheral decarboxylase inhi bi tor vras found by 
Chadl>Tick . Harris , Jenner , Reynolds and !IIarsden (1 975) to be C8.Jabl e of 
bringing about a considerabl e improvement or a complete cessat i on of 
myoclonus . These patients had low levels of 5- hydroxyindoleace t ic a cid 
in their cerebrospinal fluid. That epilepsy might be associ ated i.,rith a 
deficiency in the aminergfC system was also su pported by severa l findin s 
that t he concentrations of 5- hydroxyindoleacetic acid and hornovapillic 
acid in the cerebrospinal fluid ,rere reduced in adults and children ·ri th 
epilepsy ( Pa peschi , Holina-Negro , Sourkes a nd J:Jrba , 1972 ; Shayi-l1tz , ohe 
and BOTiTers , 1975). Chadi.,rick , Jenner and Reynolds (1975 ) reported an 
increase i n the concentration of 5- hydroxyindolea cetic acid in the ce_ebro-
spinal fluid of epileptics receiving thera peutiC doses of phenytoi n a n" 
phenobarbitone. They also f ound a s light increase i n t he levels of 
homovanillic a cid , but this did not reach sta ti s t i cal si 'ficance . On 
t he other hand , Iro , Okuno , Nika\'I'a and Osumi (1 910) re po te a n in rease 
in the levels of homovanillic a cid in the cerebrospi 1 flui of chil ran 
with infantile spasm , status epile pticus or f ebri le convulsions . The 
first nro groups 'I'ler e receiving anticonvulsant drugs in v rious combi:18. tion • 
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but I to ~ . , , strangely enough , excluded the possibility that the 
increased l evels of homovanillic acid. "Tere a consequence of the anti -
convulsant drug theraPJ , because the patients with febrile convulsion 
shOl'led increased levels of homovanillic acid , a l though t hey had not 
been treated 'ITi th any of the anticonvulsant drugs . Another factor 
'Ilhich complicated this study is the fact that the cerebrospinal fluid 
sample s ''lere taken I·r ithin a short time of a convulsive at t ack . \'1 e 
can conclude that these results in humans, supported by those observed 
. 
i n animal s , provide some but not conclusive evidence that an ant i convulsant 
drug may exert its effect , in part at least , by modifying the serotoniner gic 
mechanisms in the brain. 
In our experiments on t he effect of s ingle doses of anticonvulsant 
drugs on the 5- hydroxytryptamine system , i'le found t hat only phenobarbitone 
i ncreased significantly the level s of 5- hydroxytryptamine (5-HT) in the 
brain and this was only seen 't1,T O and a half hours after its injection . 
Phenytoin , on the other hand , increased the amount of 5- hydroxyi doleacetic 
aci d (5- HlAA) at all times studied , the maximum effect bei observe half 
an hour after injection . Our results concerning the level of 5-HT after 
phenytOin are contradictory t o those reported by Bonnycastle , Bonnycas tle 
and Anderson (1962 ) and suppor ted by other i'f orkers (Jenner, Chadi.,rick , 
Reynolds and ~ r s d e e , , 1975 ; Chadwi ck , Gorro , Jenner , Mar sden and ey-
nolds , 1978) who found an incr ease in cerebral 5-HT and 5-HL levels 
in mice treated I·Ti th single doses of phenytOin . Hor,.,rever , our result 
confirm those r eported by Prokop , Shore and Brodie (1 959) and Green and 
Gr ahame- Smith (1975) , Tho found in rats that phenytoin in a si. 1e do e 
had no effect on t he steady state levels of 5-HT . 
The effect of phenytoin on the metaboli te suogests either that it 
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causes an increase in the turnover of the amine or that it inhibits the 
acid transport system in the brain thus decreasing the efflux of the 
metabolite from the brain. 
different ex periments . 
These possibilities ,lere examined in 
Phenytoin, phenobarbitone and carbamazepine, all r educed the 
depletion of 5-HlAA brought about by lrchlorophenylalanine ( PCPA) , 
phenytoin being the most effective in this respect . The pro portional 
change produced by phenytoin in the level of the amine metabolite 
after R;PA was greater than that produced by phenytoin alone . Thi s 
could suggest the possibility that phenytoin might have increased both 
the rate of synthesis and that of the breakdoim of 5-HT (an effect 
'!Thich \-las suggested by Green and Grahame-Smi th , 1975) , thus resulting 
in higher values for 5- HIAA seen after the synthesis inhibitor . If 
this assumption is true, vTe • ..... ould expect that phenytoin Hould elevate 
the levels of 5- HT if its degradation vTere blocked by a monoamine 
oxidase inhibitor . HOi'leVer , after pargyline , phenytoin did not pro-
duce any change on 5- HT levels, but still produced a decrease in the 
degree of depletion of 5- HIAA . It is difficult to explain this lack 
of effect of phenytoin after p:l.rgyline . There is a possibility that 
pargyline did not inhibit the monoamine oxidase completely and that the 
enzyme ioTas still capable of metabolizing the amine , or alternativel y 
that 5- HT might have been metabolized along other pathvrays . Houever , 
these are unlike l y possibilities , p:l.rticularly since phenytOin i tself 
was reported to have some ability to inhibit oonoamine oxidase ( zzaro , 
Gutrecht and Smi t h , 1973 ) . On the other hand , the el ev ting effect of 
phenytoin on 5-HIAA after pargyline indicates that the drug d o o ~ ~ inhibit 
the acid transport of the metabolite out of the brain . This is supper ad 
by the fact that the sane effect \las also demonstrated aft er probeneci 
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which is kno':Tn to block the acid transport syst em of the brain . These 
findings give support to the conclusion reached by Chase . Katz and I ~ p i n n
(1969 ) that phenytoin produces a restraining effect on the e f f l ~ { { of 
5-HlAA from the brain • 
. The r esults f or carremazepine ar e a ll consi s tent loTi th each other . 
for the drug reduced tne depletion of 5-HIAA aft er FCPA and par line 
and increased the accumulation of the metabolite after probenecit . 
These results all indicate tha t carbamazepine decreased the e f f l ~ ~ ~ of 
5-HIAA from t he brain . 
The results obtained 'fl th phenobarbitone are not as consistent 
as those for phenytoin and carbamazepine. A single dose of phenoba bitone 
i ncreased the 5- HT content of the brain 2 .5 hours after its injection . 
but produced no effect on 5-HlAA . . ' fter rargyline . phenobarbitone 
decreased the rate of accumulation of 5-HT , 1:lhi ch I'las in contr st I'li th 
the results obtained by the drug only , but we should point out here t hat 
the measurement was made at a time when phenobarbitone on its ~ ' 1 n n had no 
effect on the steady state levels of 5-HT. Phenobarbitone had no 
effect on the acid transport of the metabolite but decreased its de letion 
by FCPA. 
Phenobarbi tone '\-ras reported by Lidbrink, Corrodi and Fu..xe (1 97 ) 
not to change the steady state levels of 5-HT in either the cerebral cortex 
or the rest of the brain but to reduce significantly the degree 0 eple-
tion of 5- HT caused by n- propyldopacetamide (a tryptophan hyd oxylnse 
inhibitor) in both areas. These 'ilorker s claimed that this effect of 
phenobarbitone "\'Tas due to r educed nervous activity in the 5- -T neurons . 
The long term treatment !tlith phenobarbitone increase Signifi cantly 
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the brain levels of both 5- HT and 5-HIAA . The percentage i ncrease in 
the level of the amine Has much higher than t hat of its metaboli te . 
Several possibilities might be res ponsible f or the se eff ects . If tve 
consider the ei'fect on 5-HT f irst \ie can suggest t hat the l o o , ~ ~ term 
administration of phenobarbitone might increase the rate of synthesis , 
decrease the rate of release or inhibit the intraneuronal degradation 
of the amine . 
Among other neurotransmitters , serotonin is believed to be 
de pendent for its release on intracellular calcium ions and inhibition 
of t he efflux of calcium ions to the synaptic terminals i'lould be ex cted 
to reduce transmit t er release. A drug with this property \'(ould be 
expect ed to produce membrane stabilizat ion. 
Sohn and Ferrendelli (1976) provided data l'lhich shows that 
phenobarbitone and phenytoin, in concentrations similar to those used 
clinically for the treatment of epile psy , inhibited the uptake of 45 n++ 
into potaSSium depolarized synaptosomes from rabbit neocortex . Richter 
and ' Jackson (1 980) found that potassium s timulated r elease of (5H] - 5HT 
from rat midbrain slices l'l'aS calcium dependent and that the release IV s 
inhibited by addi ng phenobarbitone to the medium . Thus phenobarbi t one 
by decreasing t he calcium influx into neurons would stabilize its 
meobranes and reduce t he r elease of 5-HT. This is a very likely 
mechanism, since phenobarbitone was demonstrated by Lidbrink , Corradi , 
Fuxe and Olson (1 972) to have no effect on monoamine oxidase , maki i t 
less likel y t hat enzyme inhibition i s responsible for the el eva tion in 
the l evels of serotonin (S-HT) observed after habituation . The in ren sed 
concentration of the metabol i te might have been caused by an inhibitor 
effect of phenooorbi tone on its elimination . menooor bi t one ·.Ias foUl".d 
by Chase , Katz and Kopin (1 969) to retard the transfer of 14C_l a el led 
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5-HIAA out of the brain , a finding that supports our proposal . 
l:i e found t ha t withdrawal of phenobarbi tone brought dovrn the 
levels of both the amine and i ts metabolite, a f inding that c ~ ~ ~ be 
ex plained on the same basis as those described for the effect on 
catecho lamines , tha t is that ivithdra".ra l of the drug ".r ould reli eve the 
serotoninergic neurons from the drug depressant effect, resulting in 
the neurons f iring at a faster rate, thus reducing the levels of the 
amine in the stores . HQivever , the levels of s ero t onin di d not sink 
. 
belmv control values , unlike the catecholamines aft er phenobarbitone 
wi thdrawal . 
'iT i thdra"ral convulsions decreased the brain level s of serotonin 
and increased that of its metabolite. The percentage increase in the 
concentration of the metabolite i'Tas very much higher t han the ~ r c e n t a a e 
decrease in that of the amine itself , which indicates tha.t both the r te 
of synthesis and the rate of utilization of serotonin increased consid-
erably during convulsions . 
Calderini, Carlsson and N o r d s t r ~ n n (1 978) showed that sustained 
seizure activity induced in rats by the intravenous injection of bicuculline 
produced an increase in the levels and hydroxylation of trypto phan , 
decreased the levels of serotonin during the first thirty minutes of 
sustained seizure activity and substantially increased the levels of 
5 - H I ~ ~ ~ up to three hours after injection . These au thors concluded that 
seizures induced by bicuculline lead to an increased functional activity 
in serotonin neurons , ''lhich resembles t hat observed in our experioents 
after i'li t hdr aiVal-rela ted audiogenic sei zures . 
After the long term administration of phenytoin and carbamaz9. ~ ~ . .
t he levels of serotonin and of 5-HL'>A "Tere both increased . 
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Phenytoin produced i dentical percentage changes in the levels of 
both the amine end its metabolite. Phenytoin produced the same effect 
on the calcium efflux as did phenobar bitone (Sohn and Ferrendelli. 1976) , 
thus reducing t he release of 5- HT as a consequence of its s t a b b l i z i i ~ ~
effect on the meobrane . Phenytoin 'ITaS also reported to have a monoernine 
oxidase inhibitor activity (Az zaro . Gutrecht and Smith , 1973 ) , ',Thich m "ht 
in part contribute to the effect on 5- HT observed after its lon ter m 
a d m i r ~ s t r e t i o n . . The elevating effect on 5-nlAA comes froD the inhibitory 
effect of phenytoin on its elimination by the brain (Chase et al. , 1969 ) . 
The percentage changes produced by the long term administration of carbama-
zepine on the concentration of 5- HIAA was about double t hat produced in the 
levels of the p:u'ent amine , >vhich might indicate that the inhibitoI"J effect 
of carbamazepine on the acid transport of the metabolite i s greater t ~ e n n
t hat produced by phenytoin . The effect of carbamazepine on serotonin i s 
similar to that of phenytoin and could have been brought a out by similar 
mechanisms . 
It seems probable from the foregoing discuss ion that serotoniner 'c 
mechanisms may be involved in p3.rt in the mechani sms by 'tlhich anti convul-
sant drugs act in the brain. Our results a fter a cute doses re not us 
impressive as those seen after long term treatment with t he anticonvulsant 
drugs . These results indicate that they altered the 5 - h y d r o x x t r y ~ t a n i n e e
system and support the hypothesiS that the effect of anticonvuls nt dr s 
on 5- hydroxytry ptamine may be in part responsible f or their antiepile 'tic 
effect . 
III . y-Aminobutvric gcid and anticonvulsant drugs 
The biochemical factors that determine the amount of "1- minobut:rric ·' ci -:J. 
(GABA ) in the brain are the activity of the enzyme r r s ~ ~ ~ ~ i b l e e for i t 
synthesis ( g l u u ~ m i c c acid decarboxylase , GAD) and that re ~ o n s s b l e e for 
its meta boli sm (GA&- aminotransferase , GABA- T) . 
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In spite of many recent studies, the role of GABA in epile psy i s 
still a matter of controversy . Al thouoh agents that elevate brain GABA 
levels protect animals from convulsions , no clear cut r el a tionshi p 
exists b e e ' T e e n n the degree of elevation of the GAaA levels in the br a i n 
and the extent of the anticonvulsant effect . Indeed, some r ugs ',)'hich 
elevate centr al GABA levels have convulsant activity (for r evievT see 
i-i ood , 1975). This lack of relationship be'b,.reen GAM levels and the 
anticonvulsant effect was fir st demonstrated by Kuriyama, Roberts and 
RUbinstein (1966) , who shm'led tha't the anticonvulsant action attributable 
to amino- oxyacetic aci d was observed one and a half hours after its 
administr a tion , at i'lhich time GABA levels l-rere eleva ted, but no anti-
convulsant effect \'laS observed six hours after administra tion although 
the centra l GABA levels \'lere still elevated at tr-.at time . Similar 
findings l'lere reported by Crossland and 'lUrnbull (1 972) , vlho f ound that 
t he high dose of amino- oxyacetic acid (50 mg/kg) protected r a t s \'Ti t :dra'lm 
from sodium barbit one from audiogenic seizures and i ncreased the l eve l s 
of GABli by tvTofold ninety minutes after in jecti on. Smaller doses of 
amino-oxyacetic aci d (20 mg/kg) , which produced the same ri se i n " 
levels , produced no protection effect against audiogenic seizures . 
Crossland and Turnbull concluded that the amino-oxyacetic a cid effect 
was associated \'lith it s generally depressant effect on motor func t ion . 
Substances l'lhich depress centra l GABA l evels, by i n.'rri. bi t i ne; t!:'le 
enzyme required for its synthesis (GA:1)) lead to seizures ( r'ie l drur.l , 1975) 
but again no clear relationshi p exists bebTeen the degree of i nhi bition 
of GAD and the onset of seizures C;iood , 1975). 
It is an old observation t hat isoniazid causes convulsions a r ~ ~
a l so tha t it de pletes brain GABA levels and this i s the eta t ing point 
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of many later studies . Vernadakis and. '.Toodbury ( 1960) sho '..red that 
phenytoin increased the levels of GABA in the cerebral hemis pheres of 
rat br a i n and decreased that of glutamate, and several later r eForts on 
the effect of anticonvulsant drugs on t he l evel s of GABA in animal 
brain have appeared . The most s i gnifi cant report 'tTas probably that 
of Saad , El oasry and Scott (1 972) , \'lho f ound t he. t singl e doses of 
phenytOin , phenobarbitone , methyl phenobarbitone and mesontoin increased 
significantly the levels of GABA in the cerebral hemis pheres of mice . 
The most interesti!lg effect observed by the se authors Nas that the 
anticonyulsant drugs produced a significant elevation in t he amount of 
GABA in the cerebral hernis pheres of animals trea ted ~ . . i i t h i soniazid and 
that this elevat ion was accompanied by a disappearance of the characteristic 
isoniazid convulsions . This finding was later supported by LOscher and 
Frey (1977), ",Tho found that phenytoin and phenobarbitone prevented the 
decr ease of GABA levels in the brains of mice treated with isoniazid but 
did not effect the inhibition in GAD and GABA-T produced by the convulsant 
drug . However , LOscher and Frey (1977 ) excluded the possibility that the 
increase in GABA levels seen after phenytoin and phenobarbitone Tas res-
ponsible for their anticonvulsant effect , since phenytoin did not protect 
the animals against convulsions induced by picrotoxin, leptazol and 
bicuculline . On the other hand , these authors concluded that the 
anticonvulsant effect of diazepam , ethosuximide , trimethadone and 
sodium valproate may well be rela ted to their effect on the metabolism 
of GABA , since they reversed the inhibition of GAD activity and elevated 
above the control values the depressed GAB l evels in mice pretreated 
with isoniazid. 
Insulin \'Tas also reported to 10l';er cerebr al GABA levels and of 
course i t produces convulsions (Naynert and Kaji , 1962) . aad (1 970) 
found that phenobarbitone , methyl phenobarbi tone and primidone protected 
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mice from insulin convulsions and raised the l l f l e r e d d GABA content of the 
cerebral hemispheres . Tunnicliff (1976) found that si ngle oses of 
phenytoin did not change iihole brain levels of GADA in ra t s . 
In a more recent report, Patsalos and Lascell es (1 981) f oun t h h ~ ~
long term treatment with phenytoin (10 days) decreased brain l e v e e ~ ~ of 
GAM in the cerebellum, hypothalamus and stria tum . By contrast , pheno-
barbitone produced an elevation in GABA in all brain r egions and sodi um 
valproate ·had a similar effect ave!'Jiihere except in the stria tum . ',Ihen 
phenytoin \iaS administered iii th pheno barbi tone , eleva ted GAlli level '.lere 
found . Patsalos and Lascelles (1981) concluded that t hese anticonvulsant 
drugs had different actions on the GABA system. 
Abdul- Ghani , C o u t i n h o - ~ e t t o , , Druce and Bradford (1 981) have 
recently p.lt fo:r-;'Tard the suggestion that anticonvulsant drugs mi ht 
produce their effects partially or entirely by raising GABA content or 
by causing a rise in the concentration of this inhibitory a G ~ n t t in the 
extracellular fluid of the brain by inhibiting the upt ake of G BA 
folloiving its release. They tested the second possi bility by follold 
the in vivo and in vitro release of GABA and found t hat acute doses of 
phenobarbitone , phenytoin, carbamazepine and sodium val proate caused no 
detectable release of endogenous GABA in vivo or of exogenous ro . 
These authors suggested that there is no correlati on bet"reen anticonvulsant 
activity of these drugs and changes in GABA accumulation extracellularly . 
Vie should point out here that both phenytOin and pentobarbitone ',Tere 
re ported to increase the hioh affinity uptake of GABA in synaptosooes 
of the central nervous system of rats (:,'J einberger and '''richl s , 1976 and 
I'I einberger , Nichlas and Berl , 1976). These observations are not entirely 
consistent \'/i th the hypotheSis p..l.t fOri"rard by Abdul-Ghani and his colle' GU s . 
f or they imply that the drugs decrease , r a t her than i n c r r ~ s s , , An" l evels 
in the extracellular fluid of the brain . 
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In our experiments , single doses of phenobarbitone increased the 
total brain levels of GABA thirty and sixty minutes after its injection . 
Thereafter the levels of GABA returned to their normal values . On the 
other hand , neither phenytoin nor carbamaze pine had any efIect either 
thirty or sixty minutes after their injection . 
Our results Hith respect to phenobar bitone are in agreement i'/i th 
those of Saad et al e (1972) and of Patsalos and Lascelles (1 981) f or we 
could not observe any effect after phenytoin or carbemazepine . It i s 
,'I'orth noticing , hOvTever , that Saa.'d ll.,al. (1 972) found an effect of 
phenytoin on G A a ~ ~ levels three hours after its administration , a time 
at which we did not measure the effect of the drug . 
Unfortuna tely , 'ITe did not have time to extend our e x ~ r i i e n n s s
any further , and little can be concluded from our observation on the 
effect of phenobarbitone on GABA levels , but it may be r elevant to point 
out that pentobarbitone Ivas reported by \ ~ e e n n e r g e r r and Nichlas (1 976) 
to increase hlofold the active uptake of GABA ,into rat brain syna.tosomes . 
Whether phenobarbitone produced its elevation effect on ABA by a si milar 
mechanism remains only a speculation and i s offered as a aug astion for 
further r esearch in this topic. 
Before we end our discussion on the role of G BA in the anticon-
vulsant effect of antiepileptic drugs , ,'le ,vould like to point to the 'lork 
reported by :/l ood , Russel , Kurylo and Ne\'Tstead (1979), :,rho sugge t e that 
the synaptosomal-enriched fraction of rat br ain coul be use as a model 
to evaluate drug induced changes in GA&\ l evels in nerve en ines . hey 
concluded from in vivo experioents that hydrazine , isoni cotinic 
hydrazide and amino-oxyacetic a c c ~ ~ brought about i milar d e c r r c ~ e e in the 
G A R ~ ~ content of the syna ptosomal-enriche fractions pre f rom the 
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brains of rat s taken at the onset of seizure , despi te the fact that no 
correlation I'Tas observed bebeen seizure activity and whole brain GA 
l evels . Although the hypothesis that the l evels of GABA t nerve 
endings , and not whole brain GABA levels , determine seizure susce ptibilit 
was suggested a long time ago, no experimental evidence supporti ng this 
hy pothesis ''las available until the '''ork of ';:ood and hi s co-',rorkers . I t 
,';ould be interest i ng to note what this model 'ITill provide in the future 
as a key to a nffi'l' field of research into the mechani sm of action of 
anticonvulsant drugs . 
IV, Cobalt induced epile psy and neurotransmitters 
".t[e saw in Chapter 9 that the insertion of cobalt stick or cobalt "rir e 
into the motor cortex led to a reproducible seizure st at e charact erized 
by the s lO\'I onset and prolonged duration of an epileptic-like encephalo-
graph Plttern in the side of the implantation as "lell as in the co trala t r 1 
cerebral hemisphere . In addition , myocloni c jerks "lere obvi ou on the 
side contralateral to the implantation. ~ ' [ e e did not s ee any eneraliz 
convulsions even after strong sound stimulation . Cobalt in 'uced seizure 
in rat s might seem therefore to be a useful experimental model for deter-
mining t he aetiology of the seizure state . The i dea behind our ex riments 
.. ;i th cobalt ,,,as to see 'Io1hether the prolonged seizure activi ty produce by 
cobalt implantation 'Io1 ould bring about any change in the neurotransnitter 
levels 'Ire studied and to compare any that "Tere f ound with those obtai. c 
after the brief seizures provoked by audiogenic stimulation after ea sin 
the long term administra tion of phenobarbitone . 
Several reports in the literature indicate t hat cobalt im In t -
ation in the motor cortex produces changes in some neurotransmi ~ e r o o n 
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in the enzymes r elated to their synthesi s and degradation . Crai, and 
Hartman (1 973) re ported that cobalt vTire i mpla ntation in ra t s ' pari etal 
cortex decreased the levels of glutamic acid , as partatic acid and t aurine 
and increased that of lysine and alanine at the site of the lesion . 
Emson and J oseph (1975) demonstrated that cobalt ge latine sticks 
impl anted in the f r ontal cortex of rats produced a decrease in the 
levels of GABA , glutareate and aspartate in the l esion and pri mary focal 
areas f ive to ten days after implantation . These authors exclude the 
hypothesis that spike activity in the cortex is associated ,'lith selective 
elevation of excitatory amino acids or selective reduction of inhibitory 
amino acids since glutamate ancl' as:r::artate (1almoffi as excita tory amino 
acids) as ~ o o e l l l as GABA (an inhibitory amino acid) were all reduced in 
the primary f ocus. - Furthermore , no change 'tTas observed in these amino 
a cid levels in the secondary focus. On the other hand , it oust be note 
that Dodd , Bradford , Abdul-Ghani, Cox and Continho-Ne tto ( 1980) demon-
strated t hat superfusi on vrith an in vivo cannula system in the br ain of 
rats implanted '.-lith F9rforated discs of cobalt produced an increased 
release of glut amate , valine and glycine in the lesioned side \lThen 
compared \lri th unlesioned tissue. Unfortunately , they could not detect 
GABA in their samples . Bradford and his colleagues excluded the 
possibility that the increa sed release of glutamate ''las caused b tissue 
damage , since another metal (nickel ) produced an eqUivalent amount of 
tissue damage but l ittle e pileptic activity and little r elease of glutamate . 
Thus the glutamate released at the cobalt f ocu s could 'o1ell be re sponsible 
for the hyperactivity. 
Balcar, fumai n, I'ark , Borg and I.J3.ndel (1 978) re ported tha the hi h 
affinity u ptake of glutamate in t he epile ptogeni c focus of r a ts implanted 
,-li th cobalt I'O"Tder ei ght to ten days earlier i-ras unchanged , vThile t: t of 
GAB! vTaS significantly Imler than that i n t he non- implante controls or 1. 
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those that had received an i mpl ant on the contralatera l side . Cobalt 
itself had no effect on GABA or glutamate uptake . These observations 
are not. of course , entirely consi stent ,vi th those of Bradford and his 
cO-iT orkers . This effect of cobalt i mplantation on GABA high affinity 
uptake in the primary f ocal area vias confirmed in a recent re!X)rt by 
Ross ~ ~ d d Craig (1981) . 
\ \ h o l e e brain l evels of noradrenaline. dor;amine and 5- hydroxy-
try pt ami ne of rats at various times after implantation of cobalt !X)\'lder 
. 
;'Tere r e!X)rted to remain unchanged (Colasanti and Craig , 1973) . The 
turnover rates of noradrenaline and dopamine r emai ned unaltered in the 
e pileptic rats, vThile 5- hydroxytryptamine me taboli sm showed complicated 
changes . These authors concluded t hat the i nvolvement of brain biogeni c 
amines i n the deve lopment and maintenance of chronic epileptic states 
differs mar kedly from that which "Tould be exrected in vi e"T of their 
apparently \'Tel l es ta bli shed roles as neurotransmit t ers . 
The enzymes associated Ni th the synthesis and metaboli sm of 
neurotransmitters vTere a l so r eported to be cz,.anged by cobalt impl ant ation . 
Thus . the acti vi ty of t he enzyme re sponsible f or acetylchOline synthesi s 
(cholinacetyltr ansferase) and for its hydrolYSiS (cholinesterase) were 
both re ?Orted t o be depressed in t he pri mary f ocus area in the brain 0 
rats implanted one week earlier wi th cobalt gelatin sti cks (Gol ber , 
Pollock , Hartman and Craig, 1972). The same results "Tere re ported by 
Emson and Joseph (1975) , who f ound as well a decrease in the l evel 0 
glutamate decarboxylase and aromatic amino acid decarboxylase in the 
lesion area and p r i ~ r y y and secondary f oci produced four to eight ays 
after i mplantation of cobalt gelatin stick. The levels of these 
enzymes returned to noroal by r lTenty-four days aft er oper tion . The 
same 'das re :r:orted for Y- aminobutyrate aminotransferase (Clayt on 
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Emson, 1975 ) . In t hi s same paper , Clayton and Emson r eported t hat t he 
a c t i v v ~ J J of the enzyme responsible for the synthesis of catecholamines 
(tyrosine hydr oxylase ) vIas in.'1ibi ted , rea ching it s maximum by the six t h 
day aft er cobalt implantation i n both t he pri mary and secondary f oci 
and remaining so up to seventy- five days after implanta t i on. The same 
was seen f or the cetecho lamine degrading enzymes (monoamine oxidase and 
catechol-Q-met hyl transferase) , .. hich ,'lere inhibited t o the same de ee 
as tyrosine hydroxylase . Clayton and ~ m s o n n suggested t hat the long t erm 
inhibition of the enzy!:1es may reflect a SlO1'1 rate of r eI8ir of noradren-
ergic neurons . ~ m s o n n (1976) has reported that the acute trea t ment ;'li th 
a m i n n - o ~ ~ a c e t i c c acid of r a t s wi th cobal t impl anta tion produced a r eduction 
in the Spiking activity i n both the primary and secondary focus five to 
ten minutes after injection and perSisting for thirty to ninety ~ n u u e e . .
These dos es of aroino- oxyacetic acid (20 - 60 mg/kg) ,.·,hich produce - narked 
sedation and i nhi bition of motor activity . also produced an eleva tion of 
brain GAM , but the author found no correlation betvTeen GAM content and 
s pike activity . Sodium valproate had no effect on spike f r e ~ u e n c c . .
ChroniC treatment ,'lith ION doses of amino-oxyacetic acid (25 - 5 mg./ 
reduced t he epileptifor:n spike fre quency \vhich "Tas most s t r r ~ ~ i n 8 ' ' in t he 
secondary focus and i t produced an inverted dose effect r el a tionship . the 
lOvTer doses having the largest effect . On t he other hand , the compoun ' 
produced a dose de pendent i ncrease in the levels of GABA and a decrea se 
in t he acti vi ty of GAD and G A A ~ - T . . Sodium va l proate had no effect on 
the development or the numbers of spikes in t he cobal t f ocus deSpite the 
elevation in GABA levels . The author concluded that the anticonvulsant 
action of sodium valproate and probably of amino- oxyacetic aei i s not 
likely to be medi a ted through oechanisms i nvolving elevation of brail'l GA . 
It has been suggested that dopamine mi ght play an antiepile tic role 
in cobalt epile psy . Farjo an.d IVlequeen (1 979) f ound t ha t dOplmine . gOni et s 
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( a p o m o o p h i ~ ~ , , li suride and bromocri ptine ) inhibited spike activity in 
es tabli shed primary and secondary foci in a dose de pendent manner , '!Thile 
a dopamine antagonist (pimozide ) had the opposite ef f ect and blocked t he 
antiepile ptic effect induced by dopamine agonists . Because t he intra-
striatal i njection of do pamine or apomor phine suppressed epile pti f orm 
spikes i ~ ~ t he cortex and the destructi on of striatal catecholami ner gi c 
-
terminals by 6- hydroxydopamine increased the spike activity , Farjo and 
ikqueen c O I ' ' c l u d e d d t hat the stria tum may play an essentia l p!.rt in media ting 
the antie pile ptic effect of dopamine and i ts agonists in the cobal t model 
of epilepsy . 
In our experioents 'tf i th cobalt , GAB! l evels I'Tere decreased only in 
the impl anted side of the brain and only one vTeek after the impl antati on 
of either cobalt sticks or cobalt wire. These findings are in agreement 
, .. ith t hose re ported by i!:oson and Joseph (1975) , Nho r eported a decr e se 
i n GABA l evels in t he lesion and primary f ocal area five to t en days fter 
cobalt stick implantation . This decrease in GABA levels cQuld be t he 
result of neuronal damage caused by cobalt or to a decreased synthesis or 
increased utilization of the aminoacid . The lack of any effect on G. 
in the implanted side of the brain ~ ~ O O or three weeks after impl ant a t ion 
argues against the possibility that the neuronal damage was the cause of 
the decreased GABA levels . since at t hat time the tissue damage vras most 
marked . The possibility of decreased synthesis is support ed by the f ct 
that the activity of GAD vTas reported to be inhibited a t t he same time as 
we found t hat the GABA had reached its m i n i ~ u o o l evel . The GAD activity 
r ecovered to the control values by the third vTeek (Emson and Jose th , 195) . 
On the other hand . the decreased GABA l evels in the impl anted si e mibht 
possibly be due to an inability of the tissue surroundi ng t e lesion to 
take up the released GABA as reported by Baclar and hi s cO-;'[orkers ( 1978) . 
Hm-rever , this too depends on the notion tha t the decrease ''las att r i but ':il e 
to a l oss of neuronal tissues . 
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-I'fhile dopamine l evels remained unchanged i n the brains of r a t s 
one , t HO or t hree ~ l e e e s s af t er cobalt implantation , noradrenaline l eve l s 
were decreased in t he i mplantation s i de and. in the contra-l a t er a l half of 
the brain one ,. eek af ter t he impla...Yl.tation of cobalt s ticks . Cobalt 
\"lire decrea sed the levels i n the i mplanted s i de only . In the se cond 
I'leek the decreased noradxenaline content I'las seen only in r a t s im pl anted 
with cobalt sticks and only in the impl a nted hal f of the brain . 0 
change Ha s seen in the noradrenaline l.evels three '!leeks a fter the impl an-
ta tion of either cobalt ",ire or sticks . 
The c ~ ~ ~ g e e in noradrenaline leve l s i n the secondary focus s een 
one ',leek after cobalt stick implant ation is of rarti cular interest . as 
this area is free of the maj or necrotic changes caused by cobalt . The 
mechani sms by "Thich t his decrease took place are difficult to assess . 
since the enzyme s involved in the biosynthesi s and in the intra - and 
extracellular degradation of noradxenaline are all re ported to be inhi ite 
in the pri mary and secondary f ocus (Clayton and Emson, 1975) . Ther e i s 
a pos s i bility that increased r e lease with a decreased syntheSi S due to t e 
inhibition of tyrosine hydroxylase may be a contributing factor . 
i'lhile 5- hydroxytry ptamine l evel s did not change one , b ro or three 
vTeeks a.fter impl antation of either cobalt Ni re or s ti ck , i ts :najor me t a -
bali te (5- hydroxyi ndoleacetic a cid ) \ ... as increased by both cobal t \'T i r e a nd 
cobalt sticks in t he implanted ha l f of the brain one week aft er i mpl nt -
tion. Cobalt v ~ r e e produced a significant increase in the l eve l of t he 
i ndole i n t he contra.lateral half of the brain a s wel l . 
'1\ .... 0 ",'leeks after iP.l plantation . cobalt sticks produ ced s i sni f i C3n 
increase in t he concentr ation of t he indole in both halves 01 t e br in , 
while cobalt Hire did so in the implanted side only . 
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As monoacine cx i da se 'lias re ported to be inhibited by the cobalt 
i mplantation ~ l l y t o n n and Bmson , 1975) , this increase in 5-HIAA could not 
be ex pl ained s imply by an i ~ c c e a s e e in t he turnover r ate of 5- hydroxy-
try ptamine • On the other hand it may be so . However , there i s a 
possi bili t y tha t cobal t produced damage to the blood brain barrier "'mch 
in turn affected t he a cid t r ansport of the indole and contributed to t he 
observed rise i ~ ~ 5-HIhA . 
If vT e compare the results obta ined with the cobalt model just 
. 
di scussed vTi th those obtained after ivi thdrawal from phenobarbitone , .,Te 
can conclude tha t t he mechanisms involved in t he production of the chronic 
e pileptic state diffe r markedly from those operating in the production of 
the acute state . HQi.,ever , although the cobalt model produced peri pheral 
changes c ~ 2 r r c t e r i z e d d by myoclonic jerks on the contralateral s i de to the 
i mplantation and electroencephalograph manifestation resembling those 
obtained f rom pl.tients "Tith grand mal epilepsy , '<Te never saw the generalized 
convulsions of the clonic- tonic type (even after strong sound s i mulation) 
that Nere seen in rats ' .. lithdrai-Tn from phenobarbitone . The cobalt model , 
of course , carries the advantage of giving a chronic effect \'Thich i s not 
the case 'tTi th convulsions resulting from phenobarbitone wi thdrm1al but ' .. ;e 
believe that id thdrm';al convulsions the more closely resemble those s een 
in grand mal epilepsy . t· oreover , no interference id th brain structure 
took place ,as is the case ,vi th the cobalt model. 
V. Conclusion 
Neurotransmitters represent the chemical substances t hat medie te commun-
ication at syna pses . Therefore the elucidation of the effect of a nti -
convulsant ru s on these neurotra nsmitters "'ould probably ovic.e 
meaningful inSights into the biochemical mechanisms by Hhi ch a n .. i convu lsa .. t 
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drugs exert their effects on t ne central nervous system. The most 
significant resul ts in our research are those obtained for the effect 
of ~ ~ t i c o n n u l s a n t t drugs on monoamine systems . ':Ie saw that the long 
term administration of ~ ~ e n o b a a b i t o n n , , phenytoin and carbamazepine 
produced an increa se in he levels of monoamines i n certain areas of 
the brain . ',-,I e have proposed t!1at phenobarbitone produced these effects 
by i ~ b b t i i g g neuronal activity of the monoamine systems . Phenytoin , 
on the other hand , ~ ~ c c u c e d d its effect !JI'obabl? by inhibi tin the intra-
neuronal degradation of the monoamines and may also share some of the 
properties described for phenobarbi tone. Carbamazepine \.,as reported 
to share some of the effects exerted by phenytoin - inhibiting the 
release of noradrenaline and inDibiting the re-uptake of the released 
amine - and 'iTe have suggested a cornmon mechani sm of action bet-.... een 
phenytoin and carbamazepine . 
Thus it is evident that anticonvulsant drugs cause the accum-
ula tion of noradrenaline , dO}lil!line and 5-hydroxytryptamine in certain 
areas of the brain . These probably take place a t the nerve endin s 
and since the m o n o a m i ~ e s s are believed to act as inhibitory transmitter s 
it is possible that part of the effect of these anticonvulsant d s 
may be mediated through an effect on these monoarnines , first by accUQulatin 
the e.mine ' t the nerve endings of certain areas of the brain , Nhi ch u}:On 
stimulation i<Tould release this amine in sufficient quantity to eXhlbi t 
inhibition on excitated neurons and secondly by inhibiting the u pt ake of 
the r eleased amine thus prolonging its effect at the syna pse , as sug este 
for phenytoin and c a a ~ e p i n e . . Now, the' question that mioht be asked 
is Hhether these effects are genuinely an anticonvulsant effect 
' .. [hether it is possi:,le to re plicate these eff ects in b e n u i i e l ~ r r epile t i c 
animals . Thi s i s our proposal for further ~ ' l O r k k in this fi el d . A step 
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in this direction ,.,ras t a k e ~ ~ 1"1: e:1 we began to study a model of chronic 
epile psy in r ats using cobalt as the epileptogenic agent . The study of 
the effect of anticonvulsant drugs on the monoamine system in these 
animals (especially i n the secondary f ocus \'o'hich is free from the direct 
effect of cobalt ) should provide at least a part anffi'o'er to the questions 
we have posed . 
It certainly seems to be the fact that t hese monoamine s are 
i nvolved in the manifestation of the epilepti f orm vQthdrawal convul sions 
. 
from phenobarbitone . -.'1 e have suggested t hat there is an increase in the 
r a te of synthesis and. a."1 increased activity of dope.minergic neurons in 
the cortex and of noradrenergic neurons i n whole brain and a decreased 
activity of dopamir.ergic neurons in the striatum during convulsions , 
though t hese may r epresent the effect rather than the cause of convulsions . 
Further vTork on t his point is necessary t o study the extent to which the 
r ate of synthesis and utilizat ion of monoamines have been affected in 
phenobarbi tone wi thdra\'1al convulsions . 
Y- Aminobutyric acid is another neurotransmitter of interest . 
We have used a very sensitive me t hod f or its assay and the next step for 
studying the GABA system is t o look f or the effect of anticorrvulsant 
drugs on GABA at the ~ p t i c c levels , using the model suggeste by 
1,rlood and hi s co-workers (1979). Interestingl y , It! ood used the same 
principle for assaying GABA as that ,ole adopted . 
APPENDIX I 
FO i·lUIARY 
eha nter 
Reagents and buffer used for the formation of noradrenaline f l u o r r ~ h h r e e
Sodium acetate 20 . 5 gInS 
1 . 0 l' hydrochloric acid Q.S· 
Distilled i.,rater to 250 ml 
The sodium acetate was dissolved in about 220 ml of the ~ " ' a t e r r and the 
acidity of the soluti on was adjusted to pH 7.0 with the hydrochloric 
acid . The solution 1.,ras diluted to 250 ml "Ti th more ivater . 
Potassium ferricyanide 125 mg 
Distilled 'flater to 50 ml 
Alkali ascorbate solution 
2 ~ ~ scorbic acid solution 5 . 0 ml 
Ethylenediamine 1 . 0 ml 
5 . 0 M Sodium hydroxide solution to 50 ml 
Reagents and buf fer s used f or the formation of d01Jemine fluorophore 
Sodium dihydrogen phosphate 19.50 gIn . di ssolved in 
250 ml distilled water 
Disodium hydrogen phosphate 17 .74 gm . di ssolved in 
. 250 ml distilled i'Tater 
Sodium dihydrogen phosphate solution Has added gradually to the disodium 
hydrogen phosphate solution until pH 7 was obtained . 
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Periodate solution All-lays freshly preI8red before use 
Sodium :r:eriodate 50 mg 
Distilled l-later to 10 ml 
Anhydrous sodium sul phite 500 mg 
Distilled Tdater 4 ml -
5 .0 M sodium hydroxi de soluti on to 20 ml 
Ci t ric acid 26 . 27 ~ . .
5 .0 N Sodium hydroxide solution Q.9. 
Distilled \'la ter to 250 ml 
The citriC acid 'I'las dissolved in about 230 ml of the distilled 1'1ater and 
the acidity of this solution i'laS adjus ted to IiI 4.0 \\' i t h the sodium 
hydroxide solution . The solution was then diluted to 250 ml T;li th more 
distil led t'later . 
Chapter 5 
Buffer s used for the assay of 5-hydroxytryptamine and 5-hydroxyindole-
acetic acid 
Boric acid 6 . 1 9 s 
5 H Sodium hydroxide solution 
Distilled t'later t o 200 ml 
The boric acid i'laS dissolved in about 190 ml of the distille \'1 er a n 
the solution Has adjusted to pH 10 i-lith the s odium hydroxi e 301 tion . 
The solution was t hen diluted to 200 ml \-lith di s tilled '.Tater . 
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Boric aci d 2.47 gms 
5 M Sodium hydroxide solution Q.S. 
Distilled ~ ~ T a ater to 400 ml 
Frep:.red as 0 .5 N borate buffer but sodium chlori e . ~ a s s a dded ~ ' I i t h h shad. 
t ill saturation . The buffer was adjusted to pH 10 before use. 
Sodium dihydrogen phosphate 
Disodium hydrogen phosphate 
Prepared as described before . 
O . ~ ~ ~ _ ! h 0 0 P h ~ t t _ ~ u f ! ! E E ~ ~ _ ~ - 1 1
1 .95 gm dissolved in 250 ml 
distilled vIa ter 
1.77 gm dissolved in 250 ml 
distilled Hater 
Sodium dihydrogen phosphate 3.90 gm dissolved in 250 ml 
distilled water 
Disodi um hydrogen phosphate 3.55 gm dissolved in 250 ml 
distilled water 
Prepared 'as described before . 
Chapter 8 . 2 
eagents and b u f f e ~ s s used f or the enzymatic assay of GABA 
0 . 1 r ~ ~ Sodium pyrophosphate buffer at pH 8 . 4 
-------------------------------------------
Sodium pyrophosphate 4.46 gm 
1 .0 N Hydrochloric a cid Q.S. 
Di stilled '(later to 100 ml 
The sodium pyrophosphate "'las dissolved in about go ml of the di s tille ' .. I tar . 
'The solution ''las adjusted to rH 8 . 4 Hi th the hydrochloric a.cid solution ar.d 
brought u p to a final volume of 100 ml Ivith di stilled ,vater . he so 
I'Tas then trea ted. TITith ~ ~ o r i i t - A. and fil t ared to r emove fluorescent bo. ckrr o .. . . 
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Reconst itution of GARAse 
GABAse is a partially purified cell- free preparation from seudomonas 
fluore s cens conta i ning GABA- a- ketoglutarate transaminase a nd succini c semi -
aldehyde dehydr o ena se , p u r c ~ s e d d f rom Sigma Chemica l Company . 
Ten units of the enzyme ,Tere dissolved in its conta i ner vii th 5 ml 
of 0 . 075 H phosphate buffer at pH 7 . 2 containing 2570 (V Iv) gly cerol. 
l;lhile the container \·I3. S in ice bath , the enzyme solutio!"! '(-ras d ivi ed into 
50 ?Qrtions of 100 ~ l l each in 2 ml volume test tubes. T e t es t tubes 
ivere capped '!rith Parafilc and ke pt in deep freeze at a tempera ture belo· .... 
o 
- 20 C. One tube 'liaS used for the construction of enzyme r eaction mixtur e 
each time the assay of GABA vias performed . The phos phate buff er used f or 
the reconstitution of the enzyme i-ras 0 . 585/SOml sodium dihydro en phospha e , 
to which a solution of 0 . 532/50 ml d i ~ o d i u m m hydrogen phosphate ' .. ra s adde 
to pH 7 . 2 , follm/ed by the addition of 25% (V/V) glycer ol. 
Solut; ons used for the construction of enzyme r eaction m.ixtu.x:e 
..all freshly prepired 
Nj. D? 1 mH 
1 mg was dissolved in 1.2 ml distilled 'tlater 
50 ~ l l ivas dissolved in 7 ml distilled vTa ter 
O·26 __ ~ ~ : ~ = ~ ~ § ! ~ t a ~ ~ ~ ~
88 mg was dissolved in 9 ml of pyro pho sphate buffer, adjusted to 
pH 7 .9 and brought u p to ten millili tres "ri t h di s tilled Na ter . 
The construction of enzyme rea ction mixture 
To each tube conta ining 0 . 1 ml of QtaAse solution , one millilitre of 
pyro phosphate buffer i-ras a dded , follo'tT ed by 0 . 2 ml of NhD solution , 
0 . 2 ml of a- ketoglutarate solution and 0 . 2 ffil mer captoe t hanol s olu ion . 
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The mxture ~ ' T a s s mixed thorou hly and kept in ice bath until it I'Ta s u sed . 
For enzyme FRE3 r eaction mixture used for the tissue blanks , 0 . 1 nl of the 
Pflophosphate buffer ~ ' T a s s used to replace the 0 . 1 ml GABAse solution . 
Phos pha te solution was prepared by dissolving 15 . 2 gms sodium phoaphate 
(NA3P0412H20) and 5. 3 gm disoditi.!4l hydrogen phos phate in 100 ml "Tater 
(0 . 4 M F04 ; 0 . 2 11 HR\) 
Alkali neroxide \'la s prepared im:nedia tely before use by diluting 100 ul of 
37<1 hydrogen peroxi d.e to 10 ml loT i th 10 N sodium hydroxide solution. 
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